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Abstract: This thesis will describe the development of two transition metal catalyzed 
syntheses of organoboronic compounds. The first section describes relevant concepts and 
precedents for the conjunctive coupling reaction. In the second section of this thesis, nickel 
catalyzed conjunctive coupling reaction of carboxylic acid derivatives with 9-BBN derived 
ate complexes will be discussed, where -trialkylboryl ketones are obtained as the product. 
In the third section, the development of alkyl group migration in nickel-catalyzed 
conjunctive coupling with C(sp3) electrophiles will be discussed. Enantioenriched 
secondary boronic esters can be prepared from this reaction, and two alkaloid syntheses 
are disclosed as the application of the method. 
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1. Introduction  
Since the development of palladium catalyzed cross-coupling reactions,1 
transition metal catalyzed reactions have become widely adopted both in academia as 
well as in industry, becoming an integral part of modern organic chemistry as they enable 
challenging carbon-carbon and carbon-heteroatom bond formation by coupling 
nucleophilic and electrophilic species together.  The Nobel Prize in Chemistry in 2010 
was jointly awarded to Heck, Negishi, and Suzuki, “for palladium-catalyzed cross 
couplings in organic synthesis”2 which highlights the contribution of transition metal 
catalysis to the organic chemistry today. 
Among many classes of compounds, organoboron species are widely used motifs 
due to their versatile reactivity. For instance, carbon-boron bond in organoboron species 
can be stereospecifically transformed into carbon-carbon or carbon-heteroatom bonds.3 
Moreover, organoboronates can be used in Suzuki-Miyaura cross-coupling reactions.4 
                                                 
1 (a) Tamao, K.; Sumitani, K.; Kumada, M. J. Am. Chem. Soc. 1972, 94, 4374., (b) Heck, 
R. F.; Nolley, J. P. J. Org. Chem. 1972, 37, 2320. (c) Sonogashira, K.; Tohda, Y.; 
Hagihara, N. Tet. Lett. 1975, 16, 4467. (d) King, A. O.; Okukado, N.; Negishi, E. J. 
Chem. Soc., Chem. Comm. 1977, 19, 683. (e) Stille, J. K. J. Am. Chem. Soc. 1978, 100, 
3636. (f) Miyaura, N.; Yamada, K.; Suzuki, A. Tetrahedron Lett. 1979, 20, 3437. 
2 <https://www.nobelprize.org/prizes/chemistry/2010/summary/> Accessed: 3 Feb 2020. 
3 Sandford, C.; Aggarwal, V. K. Chem. Comm. 2017, 53, 5481. 
4 For review of Suzuki-Miyaura cross-coupling see: Miyaura, N.; Suzuki, A. Chem. Rev. 
1995, 95, 2457 
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Additionally, depending on the ligand on boron, these compounds can be stable to air and 
moisture, unlike many other organometallic reagents such as Grignard reagents.   
While much progress has been made, there still exists the gap where not all 
organoboronates are easily accessible by currently available methods. Therefore, 
developing preparative methods for organoboron species that start from simple starting 
materials is desirable. We wanted to tackle this challenge by developing transition metal 
catalyzed methodologies to synthesize organoboronates. Specifically, we utilized a 
process that was inspired from the Suzuki cross coupling reaction. In general terms, the 
mechanism of the Suzuki-Miyaura reaction involves oxidative addition of the transition 
metal catalyst into the electrophile, transmetalation of the transition metal catalyst with 
the organoboron reagent, and finally, reductive elimination of the C-C bonded product 
regenerates the catalyst to turn over the catalyst. For the newly developed conjunctive 
coupling reaction, instead of transmetallation of the functional group with the 
organoboron reagent, 1,2-metallate rearrangement of the vinyl boron ate complex enables 
regioselective dicarbonfunctionalization of vinyl boronates. 
In this section of the thesis, the underlying reactivity principle that inspired the 
conjunctive coupling reaction from the organoboronates (1,2-metallate rearrangment) as 
well as recent advances in the conjunctive coupling reactions using palladium and nickel 
will be discussed. The following two sections will demonstrate our contribution to the 
conjunctive coupling using nickel catalysts, and will describe the synthetic utility of such 




1.1 1,2-Metallate Rearrangement  
1.1.1 Background 
Scheme 1.1: Reactivity of organoboronates and formation of the “ate” complex 
 
An organoborane (1.1) typically exists in a trigonal planar geometry because it 
can only have three bonds in its neutral form by employing its three valence electrons. As 
this bonding does not satisfy the full octet, the boron atom contains an empty p-orbital 
that is orthogonal to the sp2-hybridized boron orbitals and can accept a pair of electrons. 
Lewis acidity of organoboranes originates from the tendency of the boron atom to accept 
a pair of electrons and achieve a full octet. Upon accepting a pair of electrons from a 
donor, it forms a boron “ate” complex (1.2). Although the formal negative charge is on 
boron atom for the “ate” complex, due to differences in electronegativity, the actual 
distribution of electron density is generally polarized away from boron atom.5 Typical 
ligands for boron are carbon (Pauling electronegativity = 2.55), oxygen (3.44), and 
nitrogen (3.04), all of which are more electronegative than the boron atom (2.04). The 
presence of electron density on the atoms adjacent to boron is considered to be the 
driving force that enables 1,2-metallate rearrangements. 
                                                 
5 Boron is less electronegative than many of typical atoms bonded to boron. 
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One of the most widely used examples of 1,2-metallate rearrangment of boronic 
esters and boranes is the oxidation to alcohols. In 1961, Brown and coworker6 have 
demonstrated that boranes can be stereoselectively oxidized by basic peroxides, where 
the alcohol is obtained with retention of configuration at the reacting carbon stereocenter 
(Scheme 1.2).  It was later found that boronic esters could also be oxidized in similar 
manner.7 
 
Scheme 1.2: 1,2-metallate rearrangement used for the oxidation of organoboronates 
 
As for the mechanism, first, when a trisubstituted organoboron (1.3) is treated 
with a basic peroxide, a four coordinate boron “ate” (1.4) is formed by peroxide anion 
attack on the empty p-orbital. The “ate” complex can then undergo 1,2-metallate 
rearrangement, where -carbon migrates to the adjacent oxygen atom, thereby displacing 
hydroxide by O-O -bond cleavage. Upon aqueous workup, the O-B bond is cleaved and 
the alcohol product (1.6) is obtained. It is notable that the configuration at the migrating 
carbon is retained, thus making this a stereospecific process. Since Brown’s report, a 
wide variety of stereospecific transformations that replace the C-B bond with C-C bond 
as well as C-heteroatom bonds have been developed that take advantage of the reactivity 
of boron.3  
                                                 
6 Brown, H. C.; Zweifel G. J. Am. Chem. Soc., 1961, 83, 2544. 
7 Stymiest, J. L.; Bagutski, V.; French, R. M.; Aggarwal, V. K. Nature 2008, 456, 778. 
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1.1.2 1,2-Metallate Rearrangements Induced by External Electrophiles  
When an alkenyl boron ate complex (1.7), that lacks a leaving group is formed, the 
1,2-metallate rearrangement does not occur (Scheme 1.3). However, when an appropriate 
external electrophile is introduced, it can induce rearrangement, leading to 1,2-
difunctionalized product 1.8. 
 
Scheme 1.3: Generalized scheme for external electrophile induced 1,2-metallate 
rearrangement  
 
An example of this type of reactivity was disclosed by Zweifel and coworkers in 
an olefination method.8 When an alkenyl derived boron ate complex (1.9) is treated with 
iodine, it is proposed to form an iodonium intermediate (1.10), which can undergo 1,2-
rearrangement to generate boryl iodide intermediate (1.11). Upon treatment with sodium 




                                                 
8 (a) Zweifel, G.; Arzoumanian, H.; Whitney, C. C. J. Am. Chem. Soc. 1967, 89, 3652., 
(b) Evans, D. A.; Crawford, T. C.; Thomas, R. C.; Walker, J. A. J. Org. Chem. 1976, 41, 
3947. 
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Scheme 1.4: Zweifel olefination 
 
Additionally, there are examples of 1,2-metallate rearrangement induced by carbon 
electrophiles that proceed without the elimination of the boryl functional group.  Utimoto 
and coworkers have reported that the ate complex derived from borane can participate in 
1,2-rearrangment with epoxides9 and aldehydes10 to produce diols after oxidation (Scheme 
1.5, (a) and (b)). Similarly, Deng and coworkers have reported that carbon dioxide can be 





















                                                 
9 Utimoto, K., Uchida, K.; Nozaki, H. Tetrahedron Lett. 1973, 14, 4527. 
10 Utimoto, K.; Uchida, K.; Nozaki, H. Tetrahedron, 1977, 33, 1949. 
11 Deng, M.-Z.; Lu, D. A.; Xu, W.-H. J. Chem. Soc. Chem. Commun. 1985, 21, 1478. 
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Scheme 1.5: 1,2-metallate rearrangement induced by carbon electrophiles  
 
1.1.3 Metal-Induced 1,2-Metallate Rearrangements 
As one can imagine, a transition metal species that is electron deficient may 
induce 1,2-rearrangement, and the product resulting from that may be used in cross 
coupling reactions (Scheme 1.6). 
 
Scheme 1.6: General Scheme for metal-induced 1,2-metallate rearrangements 
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  Along this line, Murakami and coworkers have developed methods that produce 
E-trisubstituted alkenylboranes (1.18) by palladium induced 1,2-rearrangement of 
alkynylborate (1.17) (Scheme 1.7).12 The authors propose a mechanism where oxidative 
addition of an aryl bromide gives aryl palladium species (1.21), it can then carbopalladate 
the alkyne in a syn fashion to produce (1.22). Subsequently, when XANTPhos is the 
ligand, the phenyl group on boron undergoes substitutive 1,2-migration to invert the 
stereochemistry, giving trans alkene product. Interestingly, the authors mention the use of 
P(o-tol)3 instead of XANTPhos results in the Z-isomer, which likely arises due to the less 













                                                 
12 Ishida, N.; Shimamoto, Y.; Murakami, M. Org. Lett. 2009, 11, 5434. 
13 Ishida, N.; Miura, T.; Murakami, M. Chem. Commun. 2007, 42, 4381. 
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Scheme 1.7: Metal induced 1,2-metallate rearrangement and proposed mechanism 
 
1.2 Suzuki-Miyaura Cross-Coupling  
A general reaction mechanism for the Suzuki-Miyaura cross-coupling is 
represented below (Scheme 1.8).4 In the generalized scheme, the catalytic cycle for the 
Suzuki-Miyaura cross coupling proceeds with the oxidative addition of aryl halide to 
form aryl palladium (II) species (1.25). Then, in order for the transmetallation to occur, 
association of an activated boron “ate” complex (1.29) can lead to formation of 
transmetallation intermediate (1.27). Alternatively, palladium (II) hydroxide (1.26) can 
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form first, and when organoboron species is added, it can also form transmetallation 
intermediate (1.27). After the transmetallation, palladium (II) species (1.28) is generated. 
Finally, after reductive elimination, two groups are coupled together into the desired 
product and regenerates catalyst (1.24). 
 
Scheme 1.8: Generalized mechanism of the Suzuki-Miyaura Cross-Coupling 
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1.3 Conjunctive Coupling Reaction and Recent Advances  
In 2016, the Morken group reported the first instance of the conjunctive coupling 
reaction with palladium and Mandyphos L1 catalyst complex (Scheme 1.9).14 In this 
report, enantioenriched secondary organoboronic esters can be prepared from vinylboron 
ate complex and C(sp2)-OTf.  
 
Scheme 1.9: Palladium-catalyzed conjunctive coupling reaction 
 
In contrast to the Suzuki-Miyaura cross-coupling reaction, the following catalytic 
cycle is proposed for a conjunctive coupling (Scheme 1.10). The cycle begins with the 
oxidative addition of an electrophile to form Pd(II) species (1.31). Then, the electrophilic 
palladium species can coordinate to alkene of the vinyl boron ate complex as shown in 
(1.32). After 1,2-rearrangement induced by palladium catalyst, (1.33) forms. Subsequent 
reductive elimination produces the desired secondary boronic ester and regenerates Pd(0) 
catalyst (1.30). There is a possibility that (1.31) can undergo transmetallation to form 
(1.34) or (1.35), which produces undesired Suzuki-Miyaura products.  
 
 
                                                 
14 Zhang, L.; Lovinger, G. J.; Edelstein, E. K.; Szymaniak, A. A.; Chierchia, M. P.; 
Morken, J. P. Science, 2016, 351, 70. 
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Scheme 1.10: Proposed mechanism for Pd-catalyzed conjunctive coupling reaction 
 
1.3.1 Catalytic Conjunctive Coupling Reactions with Palladium Catalysts 
Studies from the Morken group have demonstrated that Grignard reagents may be 
used instead of organolithium reagents.15  Additionally, the Morken group has found that 
bis(alkenyl) boron ate complexes may participate in the conjunctive coupling reaction 





                                                 
15 Lovinger, G. J.; Aparece, M. D.; Morken, J. P. J. Am. Chem. Soc. 2017, 139, 3153. 
16 Edelstein, E. K.; Namirembe, S.; Morken, J. P. J. Am. Chem. Soc. 2017, 139, 5027. 
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Scheme 1.11: Pd-catalyzed conjunctive coupling reaction with bis(alkenyl) boron ate 
complex 
 
More recently, the Morken group has developed conjunctive coupling methods 
that enable migration to substituted alkenes such as 1,1-disubstituted alkenes (Scheme 
1.12, (a)), and 1,2-disubstituted alkenes (Scheme 1.12, (b)).17 When the boron ate 
complex derived from 1,1-disubstituted alkene is subjected to the reaction conditions, 
enantioenriched tertiary boronic esters can be obtained. For reaction with 1,2-
disubstituted alkenes, high levels of enantioselectivity as well as the diastereoselectivity 
is observed for the product. For this reaction, a different diol ligand on boron was used to 







                                                 
17 a) Myhill, J. A.; Zhang, L.; Lovinger, J. P.; Morken, J. P. Angew. Chem. Int. Ed. 2018, 
57, 12799., b) Myhill, J. A.; Wilhelmsen, C. A.; Zhang, L.; Morken, J. P. J. Am. Chem. 
Soc. 2018, 140, 15181. 
 14 
Scheme 1.12: Migration to (a) 1,1-disubstituted alkenes, and (b) 1,2-disubstituted 
alkenes 
 
1.3.2 Catalytic Conjunctive Coupling Reactions with Nickel Catalysts 
In addition to palladium as the catalyst, the Morken group has reported that nickel 
catalysts can also induce 1,2-metallate rearrangement to facilitate conjunctive coupling 
reactions. Using nickel and a chiral diamine catalyst, the conjunctive coupling reaction 
with boron ate complexes derived from alkyl 9-BBN was demonstrated, which produces 





                                                 
18 Chierchia, M. P.; Law, C.; Morken, J. P. Angew. Chem. Int. Ed. 2017, 56, 11870. 
 15 
Scheme 1.13: Ni-catalyzed conjunctive coupling reaction with 9-BBN derived ate 
complexes 
 
Following the report of Ni-catalyzed conjunctive coupling reaction, the Morken 
group also demonstrated that alkyl electrophiles can be engaged in the reaction system 
using nickel/PyBOx catalysts (Scheme 1.14).19 This allowed the expansion of the class of 
competent electrophiles for the conjunctive coupling reaction, which were previously 
limited to aryl and alkenyl groups. 
 




                                                 
19 Lovinger, G. J.; Morken, J. P. J. Am. Chem. Soc. 2017, 139, 17293. 
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2. Catalytic Conjunctive Coupling of Carboxylic Acid Derivatives with 9-BBN-
Derived Ate Complexes 
2.1 Introduction  
Since the initial development of the conjunctive coupling reactions, all of the 
reports had been limited to aryl, alkenyl, and alkyl electrophiles.20 Therefore, we wanted 
to expand the scope of the reaction by engaging carboxylic acid derivatives as 
electrophiles. This modification produces -boryl carbonyl compounds, which is a useful 
type of compound as it contains two functional groups (ketone, and boryl) that may be 
transformed to other functionalized motifs. While a typical method to prepare this type of 
compound is conjugate borylation, 21  the conjunctive coupling method produces the 
product from a different set of starting materials, (three-component reaction) thereby 
making this complementary to existing methods.  Additionally, since the products formed 
are -trialkylboryl carbonyl compounds, they are novel compounds that had not been 
                                                 
20 a) Zhang, L.; Lovinger, G. J.; Edelstein, E. K.; Szymaniak, A. A.; Chierchia, M. P.; 
Morken, J. P. Science, 2016, 351, 70. b) Lovinger, G. J.; Aparece, M. D.; Morken, J. P. J. 
Am. Chem. Soc. 2017, 139, 3153. c) Edelstein, E. K.; Namirembe, S.; Morken, J. P. J. 
Am. Chem. Soc. 2017, 139, 5027. d) Chierchia, M. P.; Law, C.; Morken, J. P. Angew. 
Chem. Int. Ed. 2017, 56, 11870. e) Lovinger, G. J.; Morken, J. P. J. Am. Chem. Soc. 
2017, 139, 17293. f) Myhill, J. A.; Zhang, L.; Lovinger, J. P.; Morken, J. P. Angew. 
Chem. Int. Ed. 2018, 57, 12799. g) Myhill, J. A.; Wilhelmsen, C. A.; Zhang, L.; Morken, 
J. P. J. Am. Chem. Soc. 2018, 140, 15181. 
21Wu, H.; Garcia, J. M.; Haeffner, F.; Radomkit, S.; Zhugralin, A. R.; Hoveyda, A. H. J. 
Am. Chem. Soc. 2015, 137, 10585. Review: Collins, B. S. L.; Wilson, C. M.; Myers, E. 
L.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2017, 56, 11700. 
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previously studied, and may exhibit interesting reactivity that is absent in boronic ester 
counterpart.  
2.2 Background  
In the recent years, many research groups have reported a variety nickel catalyzed 
cross-coupling reactions with carboxylic acid derivatives as the electrophile (Scheme 
2.1). Rovis and coworkers reported monoalkylation of cyclic anhydrides (Scheme 2.1, 
(a)).22 Gong and coworkers have demonstrated the synthesis of ketones by reductive 
coupling of alkyl carboxylic acid and tertiary alkyl halides (Scheme 2.1, (b)).23 Another 
example of dialkyl ketone synthesis is shown by Weix and coworkers by reductive 
coupling of acid chloride and alkyl halides (Scheme 2.1, (c)).24 Reisman and coworkers 
have developed an enantioconvergent reductive coupling method to produce 
enantioenriched ,-disubstituted ketones from racemic secondary benzyl chlorides and 
acid chlorides (Scheme 2.1, (d)).25 Lastly, Doyle and coworkers showcased a method for 
direct acylation of alkylamines with nickel and photoredox catalysts (Scheme 2.1, (e)).26  
In the examples in Scheme 2.1, nickel catalysts and bidentate ligands are employed (bipy 
or bis(oxazoline) ligands), and they are able to couple acyl group to various reaction 
partners. It is noteworthy that in these cases, the Ni-acyl adduct was proposed as an 
                                                 
22 Bercot, E. A.; Rovis, T. J. Am. Chem. Soc. 2002, 124, 174. 
23 Zhao, C.; Jia, X.; Wang, X.; Gong, H. J. Am. Chem. Soc. 2014, 136, 17645. 
24 Wotal, A. C.; Weix, D. J. Org. Lett. 2012, 14, 1476. 
25 Cherney, A. H.; Kadunce, N. T.; Reisman, S. E. J. Am. Chem. Soc. 2013, 135, 7442. 
26 Joe, C. L.; Doyle, A. G. Angew. Chem. Int. Ed. 2016, 55, 4040 
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intermediate. Additionally, Coates and Rovis undertook a 13C labeling study and showed 
that the Ni-acyl adduct could undergo direct transmetalation with organozinc reagents.27 
This led us to hypothesize that the intermediate may be competent in conjunctive 
coupling reactions with nickel, and we decided to investigate the reaction. 
 
Scheme 2.1: Ni-catalyzed cross-coupling reactions with acyl electrophiles 
 
 
                                                 
27 Johnson, J. B.; Bercot, E. A.; Rowley, J. M.; Coates, G. W.; Rovis, T. J. Am. Chem. 
Soc. 2007, 129, 2718. 
 19 
2.3 Development of Conjunctive Coupling Reaction with Acyl Electrophiles28 
2.3.1 Reaction Optimization 
 The reaction optimization began with allylbenzene and 9-BBN derived boron ate 
complex (1), butyryl chloride, and nickel / bipyridine catalyst complex. 
Pinacolboratoboron-derived ate complex was not reactive and it did not yield product.  
With bipyridine ligand L1, after 1 hour of reaction time at room temperature, the product 
can be obtained in 65% yield after oxidation (Table 2.1, entry 1). Without the ligand L1, 
there is minimal background reaction between the boron ate complex and the electrophile 
(entry 2). At higher reaction temperature, the yield is diminished to 48% (entry 3). When 
bipyridine ligands L1-L5 with different electronic profile were examined, the ligand L3 
with electron withdrawing CF3 groups at 5,5’-position was able to offer highest yield 
(entry 1, 4, 7, 9, and 10). Although the reactivity difference between L1 and L3 was 
small for aliphatic acid chlorides, it was significant for aromatic acid chlorides (entry 5 
and 6), so the ligand L3 was chosen as the ligand for further study. Lastly, with ligand 






                                                 
28 Law, C.; Meng, Y.; Koo, S. M.; Morken, J. P. Angew. Chem. Int. Ed. 2019, 58, 6654. 
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Scheme 2.2: Additional survey of ligands  
 
In addition to ligands L1-5 that were shown in Table 2.1, more ligands were 
investigated. Bidentate ligands L6, L7, and L8 demonstrated modest to good yields. 
Additionally, in efforts to render the reaction enantioselective, various chiral bidentate 
ligands such as BOx ligands (L9-11), PyOx ligands (L12, L13), and diamine ligand 
(L14) were examined. However, only a modest enantioselectivity could be achieved.  
Therefore, we decided to focus on developing the racemic reaction. Lastly, tridentate 
ligands L15, L16, and L17 were not efficient for the conjunctive coupling reaction.  
 22 
2.3.2 Substrate Scope 
The scope of the conjunctive coupling with acyl electrophiles was investigated 
next (Scheme 2.3). In this study, various alkenes were used for the preparation of boron 
ate complexes with 9-BBN and vinyllithium. It was found that a variety of functional 
groups on the electrophile and migrating group are tolerated while products are produced 
in 43-81% yield. Both the unbranched and branched aliphatic acid chlorides (3-6, 8) 
produce good yields. Sterically bulkier tert-butyl substituents (7) on the carboxylic acid 
can be accommodated, while the yield is diminished at 32%. Aroyl chloride substituents 
with electron donating groups at the para position of the aromatic ring such as methoxy 
and dimethylamine groups (11, 14) were good yielding, while the electron withdrawing 
trifluoromethyl group at the para position (13) was lower yielding. It was later observed 
that the electrophile can undergo decarbonylation, which may contribute to lower yield.  
Using the silyl protected lithocholic acid derivative can also afford the product 20 
in 50% yield. Cyclohexene derived migrating group affords product in reasonable yield, 
without forming product from bicyclooctyl ligand migration from BBN ligand. Appended 
alkene (21), acetal (22), and silyl ether (18) can also be engaged in the reaction system.  
  
 23 
Scheme 2.3: Ni-catalyzed conjunctive coupling with alkenes and acid chlorides 
 
 
Under the optimized reaction conditions, the use of acid anhydrides resulted in a 
lower amount of product. This may be due to the lower electrophilicity of acid 
 24 
anhydrides compared to acid chloride, which results in slower oxidative addition 
process.29 In order to overcome this issue, a more electron donating ligand was used with 
the catalyst to accelerate the oxidative addition. Upon changing the ligand for the catalyst 
to unsubstituted bipyridine instead of CF3-bipyridine ligand, the reaction was more 
efficient (Scheme 2.4 (a)).  
Additionally, the reaction was tested to see if the product will be selective with a 
mixed anhydride (Scheme 2.4 (b)). When the mixed anhydride S-8 is used in the reaction 
as the electrophile, the reaction yielded only the product with incorporation of less 
substituted carbonyl.  
 
Scheme 2.4: Ni-catalyzed conjunctive coupling with (a) anhydride electrophiles and 
with (b) a mixed anhydride 
 
                                                 
29 Meng, G.; Szostak, M. Org. Biomol. Chem. 2016, 14, 5690. 
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2.3.3 Mechanistic Study 
In order to gain more mechanistic insight, some preliminary experiments for 
mechanistic studies were performed. A Ni(II)-acyl adduct 2.1 was independently 
synthesized and isolated according to a method reported by the Gong group (Scheme 2.5, 
(a)).23 This was performed to see whether Ni(II)-acyl adduct 2.1 is a catalytically 
competent species. When the reaction is conducted with stoichiometric amount of the 
nickel complex, conjunctive coupling product 10 can be obtained in 74% yield after 
oxidation, indicating that the Ni(II)-acyl adduct 2.1 is a competent species for the 
conjunctive coupling reaction (Scheme 2.5, (b)). In comparison to the catalytic reaction 
performed with ligand L3, the yield is similar. 
 






Prior to my participation in the project, my coworkers30 have found that when a 
chiral BOx ligand L6 is used for the reaction, variation of enantioselectivity based on the 
identity of the acid chloride electrophile can be observed (Scheme 2.6). This trend 
indicates that the oxidative addition of acid chloride electrophile to nickel occurs prior to 
the stereodetermining step, which is likely the irreversible 1,2-metallate rearrangement.   
 
Scheme 2.6: Electrophile dependent enantioselectivity trends  
 
With these data, the mechanism of the reaction is proposed as following (Scheme 
2.7): carboxylic acid derivative as the electrophile is first oxidatively added to the Ni-
bipyridine catalyst (A) to form complex (B). Then 1,2-metallate rearrangment occurs on 
the 9-BBN derived boron ate complex (C). Finally, reductive elimination of (D) yields -
boryl carbonyl compound and regenerates Ni-bipyridine catalyst complex (A) to turn 
over the cycle.  
                                                 
30 Chunyin Law, and Yan Meng 
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Scheme 2.7: Proposed catalytic cycle for the conjunctive coupling reaction with acyl 
electrophiles 
  
2.3.4 Brief Investigation of Properties of -trialkylboryl Ketones 
Because -trialkylboryl carbonyl compounds are novel set of compounds, their 
properties and reactivities were briefly investigated. For a typical trialkyl borane, the 11B 
NMR resonance is around  70-80 ppm.31 However, the-trialkylboryl ketone 28’s 11B 
NMR resonance was found to be  22.0 ppm. The upfield shift indicates that there is 
coordination between the boron and oxygen. Based on this finding, we hypothesized that 
the -proton of the carbonyl will have increased acidity due to lewis acid activation. 
                                                 
31 Wrackmeyer, B. Annu. Rep. NMR Spectrosc. 1988, 20, 61. 
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When 28 was treated with methyllithium, then with MeI, alkylation product 29 was 
obtained with high d.r. favoring the anti-alkylation product. The direct addition of 
methyllithium to the carbonyl was not observed. 
 
Scheme 2.8: Reactivity of -trialkylboryl carbonyl compounds. 
  
To get a better idea for the rationale of the observed diastereoselectivity, we 
attempted to get a crystal structure for 28. Although the attempts were unsuccessful, we 
were able to obtain a crystal structure for the imine 31.  
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Scheme 2.9: X-ray structure of the derivative (31) 
 
 X-ray structure of 31 (Scheme 2.9) demonstrates that there is coordination 
between boron and nitrogen. In 31’s crystal structure, the cyclohexyl group adjacent to 
boron is in axial position and may be able to block one face of the -carbon atom. 
Therefore, if a similar conformation is taken by 28 during the enolate formation, the 







In this section of the thesis, we describe a conjunctive coupling reaction where 9-
BBN derived boron ate complex and acyl electrophile is coupled together to form -
carbonyl boryl compounds. It presents a complementary route to such class of product, 
where the starting materials used are different from conjugate borylation. The product, -
trialkylboryl ketone, is a novel class of compound, which may present more opportunities 




2.5 EXPERIMENTAL INFORMATION 
2.5.1 General Information 
 
1H NMR spectra were recorded on either a Varian Gemini-500 (500 MHz), Varian 
Gemini-600 (600 MHz), or Varian Inova-500 (500 MHz) spectrometer. Chemical shifts 
are reported in ppm with the solvent resonance as the internal standard (CDCl3: 7.24 ppm). 
Data are reported as follows: chemical shift, integration, multiplicity (s = singlet, d = 
doublet, t = triplet, q = quartet, p = pentet, m = multiplet), and coupling constants (Hz). 13C 
NMR spectra were recorded on either a Varian Gemini-500 (125 MHz), Varian Gemini-
600 (150 MHz) or a Varian Inova-500 (125 MHz) spectrometer with complete proton 
decoupling. Chemical shifts are reported in ppm with the solvent resonance as the internal 
standard (CDCl3: 77.16 ppm). Chemical shifts are reported in ppm using phosphoric acid 
as the external standard (H3PO4: 0.0 ppm). 
11B NMR spectra were recorded on a Varian 
Gemini-500 (128 MHz) spectrometer. 19F NMR spectra were recorded on a Varian Gemini-
500 (470 MHz) spectrometer. Infrared (IR) spectra were recorded on a Bruker alpha-P 
Spectrometer. Frequencies are reported in wavenumbers (cm-1) as follows: strong (s), broad 
(br), medium (m), and weak (w). Optical rotations were measured on a Rudolph Analytical 
Research Autopol IV Polarimeter. High-resolution mass spectrometry (DART+) was 
performed at the Mass Spectrometry Facility, Boston College, Chestnut Hill, MA. Liquid 
chromatography was performed using forced flow (flash chromatography) on silica gel 
(SiO2, 230 x 450 Mesh) purchased from Silicycle. Thin layer chromatography (TLC) was 
performed on 25 μm silica gel glass backed plates from Silicycle. Visualization was 
performed using ultraviolet light (254 nm), ceric ammonium molybdate (CAM) in ethanol 
or phosphomolybdic acid, and cerium(IV) sulfate in ethanol with sulfuric acid (Seebach). 
Analytical chiral supercritical fluid chromatography (SFC) was performed on a 
TharSFC Method Station II equipped with Waters 2998 Photodiode Array Detector with 
isopropanol as the modifier.  
All reactions were conducted in oven- or flame-dried glassware under an inert 
atmosphere of nitrogen or argon. Tetrahydrofuran (THF), diethyl ether (Et2O), 
dichloromethane (DCM) and toluene were purified using Pure Solv MD-4 solvent 
purification system, from Innovative Technology, Inc., by passing the solvent through two 
activated alumina columns after purging with argon. Nickel(II) bromide-glyme was 
purchased from Sigma Aldrich, 9-Borabicyclo[3.3.1]nonane 0.5 M solution in THF was 
purchased from Alfa Aesar (of note,  cross coupling reactions resulted in slightly 
diminished yields when a BBN  solution from Sigma Aldrich was employed, or when 
borane reagents were prepared from BBN dimer). All other reagents were purchased from 
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Sigma Aldrich, Alfa Aesar, Oakwood Chemicals, Combi-Blocks, or Acros Organics and 




Optimization Studies (Tables 1 and S1) 
 
In a glovebox, under argon, an oven-dried 2-dram vial equipped with a magnetic 
stir bar was charged with a solution of 9-BBN in THF (0.52 mL, 0.5 M, 0.26 mmol, 1.30 
equiv.). The vial was cooled to 0 ℃, and allylbenzene (0.26 mmol, 1.30 equiv.) was added 
via a syringe. The reaction mixture was allowed to warm to room temperature and stir for 
3 hours before being cooled back to 0 ℃.  A solution of vinyllithium (for synthesis of 
halide free vinyllithium see ref32) in THF (0.16 mL, 1.38 M, 0.22 mmol, 1.10 equiv.) was 
added to the reaction mixture which was then warmed to room temperature and stirred for 
5 minutes. Meanwhile a solution of the appropriate nickel pre-catalyst (0.010 mmol, 0.050 
equiv.) and ligand (0.012 mmol, 0.060 equiv.) in THF (0.4 mL) was allowed to complex 
for 5 minutes under inert atmosphere. The catalyst solution was added to the boron ‘ate’ 
mixture at room temperature followed by addition of acyl chloride (0.20 mmol, 1.00 equiv.) 
The reaction vial was sealed with a septum cap, taken out of the glovebox and stirred at the 
appropriate temperature for the designated amount of time, after which point the reaction 
mixture was cooled to 0℃ and 30% H2O2 (0.5 mL) were added along with 3 M NaOH (0.5 
mL). The reaction mixture was allowed to warm up to room temperature and stirred for 3 
hours. Aq. saturated Na2S2O3 (1 mL) solution was then added to quench the remaining 
H2O2. The aqueous phase was EtOAc (3 x 2 mL). The combined organic layers were dried 
over MgSO4, filtered, concentrated under reduced pressure, and subsequently purified via 
silica gel column chromatography (20% EtOAc in hexanes) to obtain an isolated yield. 
 
  
                                                 
32 E. Edelstein, S. Namirembe, J. Morken, J. Am. Chem. Soc. 2017, 139, 5027. 
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2.5.2 Experimental Procedures 
 
2.5.2.1 Procedure for Preparation of Alkenyl Substrates and Acyl Electrophiles 
 
All alkenyl starting material and acyl electrophiles not mentioned below are 
commercially available and used as received. 
 
   2-(hex-5-enyl)furan (S-1). The title compound was prepared 
according to the procedure reported in the literature.33 All spectral data was in accordance 
with previously published results. 
 
 (E)-4,8-dimethylnona-1,3,7-triene (S-2). The title compound was 
synthesized in two steps starting with oxidation of geraniol as reported by Stahl et al.34 
followed by Wittig olefination. The spectral data was in accordance with the literature.35 
 
2-(but-3-en-1-yl)-1,3-dioxane (S-3). The title compound was 
synthesized from 4-pentenal according to the procedure reported by Karimi et al.36 The 
spectral data was in accordance with the literature. 
 
 (allyloxy)(tert-butyl)diphenylsilane (S-4). The title compound was 
prepared according to the procedure reported in the literature. All spectral data was in 
accordance with previously published results.37 
                                                 
33 S. Hobson, R. Marquez, Org. Biomol. Chem. 2006, 4, 3808. 
34 J. Hoover, S. Stahl, J. Am. Chem. Soc. 2011, 133, 16901. 
35 H. Davies, Ø Loe, D. Stafford, Org. Lett. 2005, 7, 5561. 
36 H. Firouzabadi, N, Iranpoor, B. Karimi, Synlett. 1999, 321. 
37 B. Lin, Y, Zhao, Y. Lai, T. Loh, Angew. Chem. Int. Ed. 2012, 51, 8041. 
 35 
9-phenyl-9-borabicyclo[3.3.1]nonane (S-5). The title compound was prepared 





dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid (S-6). 
The title compound was prepared according to the procedure reported in literature.39 All 




cyclopenta[a]phenanthren-17-yl)pentanoyl chloride (S-7). To an oven-dried 
scintillation vial was added S-6 (500 mg, 0.98 mmol). The vial was purged with nitrogen 
for 2 minutes. To it was added THF (1 mL) and Et2O (1 mL). The reaction mixture was 
cooled to 0oC at which point oxalyl chloride (137 mg, 1.08 mmol) was added followed by 
1 small drop of DMF. The reaction mixture was warmed up to room temperature and stirred 
overnight. Solvent was evaporated under vacuum to afford the product as a white solid 
(394mg, 79%).  
 
                                                 
38 G. Fang, O. Wallner, N. Di Blasio, X. Ginesta, J. Harvey, V. Aggarwal, J. Am. Chem. Soc. 2007, 129, 
14632. 
39 C. Joe, A. Doyle, Angew. Chem. Int. Ed. 2016, 55, 4040.  
 36 
1H NMR (400 MHz, CDCl3) δ 3.66-3.49 (m, 1H), 2.96-2.88 (m, 1H), 2.85-2.76 (m, 1H), 
1.95-1.02 (m, 26H), 0.92 (s, 3 H), 0.91 (s, 3H), 0.89 (s, 9H), 0.63 (s, 3H), 0.06 (s, 6H). 13C 
NMR (150 MHz, CDCl3) δ 174.4, 73.0, 56.5, 56.0, 44.6, 42.9, 42.4, 40.34, 40.26, 37.1, 
36.0, 35.7, 35.1, 34.7, 31.2, 31.2, 28.3, 27.4, 26.5, 26.1, 24.3, 23.5, 20.9, 18.5, 18.4, 12.2, 
-4.4. IR (neat) νmax 2930(s), 2863 (s), 1708 (s), 1447 (m), 1249 (m), 1093 (m), 870 (m), 
854 (m), 774 (m). HRMS (DART) for C30H53O2Si (M-Cl)
+ : Calc’d: 473.3815, found: 
473.3753. 
 
 butyric 2,6-dimethylbenzoic anhydride (S-8). The title 
compound was prepared according to the procedure reported in literature.7 All spectral data 




























2.5.2.2 General Procedure for Conjunctive Cross-Coupling 
 
 
In a glovebox, under argon, an oven-dried 2-dram vial equipped with a magnetic stir bar 
was charged with a solution of 9-BBN in THF (0.52 mL, 0.5 M, 0.26 mmol, 1.30 equiv.). 
The vial was cooled to 0℃, and the olefin (0.26 mmol, 1.30 equiv.) was added. The 
reaction mixture was allowed to warm to room temperature and stir for 3 hours before 
being cooled back to 0℃.  A solution of vinyllithium (for synthesis of halide free 
vinyllithium see ref) in THF (0.16 mL, 1.38 M, 0.22 mmol, 1.10 equiv.) was added to the 
reaction mixture which was then warmed to room temperature and stirred for 5 minutes. 
Meanwhile a solution of NiBr2-glyme (0.010 mmol, 0.050 equiv.) and L3 (see ref
40 for its 
synthesis) (0.012 mmol, 0.060 equiv.) in THF (0.4 mL) was allowed to complex for 5 
minutes under inert atmosphere. The catalyst solution was added to the boron ‘ate’ 
mixture at room temperature followed by addition of acyl chloride (0.20 mmol, 1.00 
equiv.) The reaction vial was sealed with a septum cap, taken out of the glovebox and 
stirred at room temperature for 1h, after which point the reaction mixture was cooled to 
0℃ and 30% H2O2 (0.5 mL) were added along with 3 M NaOH (0.5 mL). The reaction 
mixture was allowed to warm up to room temperature and stirred for 3 hours. Aq. 
saturated Na2S2O3 (1 mL) solution was then added to quench the reamining H2O2. The 
aqueous phase was EtOAc (3 x 2 mL). The combined organic layers were dried over 
MgSO4, filtered, concentrated under reduced pressure, and subsequently purified via 
silica gel column chromatography to provide the desired products. 
 
Note:  In all cases, a stock solution of 9-BBN derivatives could be prepared and stored in 
a freezer for as long as one month, before addition of vinyllithium, without any diminishing 
yield. 
 
The procedure for conjunctive cross-coupling reaction utilizing anhydrides as electrophiles 
is identical to the one reported above except the commercially available 2,2’-bipyridine is 




                                                 
40 Y. Forst, S. Becker, P. Caubere, Tetrahedron, 1994, 50, 11893. 
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2.5.2.3 Characterization of Conjunctive Cross Coupling Products 
 
 6-hydroxy-9-phenylnonan-4-one (3). The reaction was 
performed according to the general procedure with 9-BBN in THF (0.52 mL, 0.5 M, 0.26 
mmol, 1.30 equiv.), allylbenzene (30.7 mg, 0.26 mmol, 1.30 equiv.), halide-free 
vinyllithium in THF (0.16 mL, 1.38 M, 0.22 mmol, 1.10 equiv.), a solution of NiBr2-glyme 
(3.09 mg, 0.010 mmol, 0.050 equiv.) and L3 (3.51 mg, 0.012 mmol, 0.060 equiv.) in THF 
(0.4 mL), butanoyl chloride (21.3 mg, 0.20 mmol, 1.00 equiv.). The crude mixture was 
purified by column chromatography (20% EtOAc in hexanes, stain in KMnO4) to afford 
the product as a colorless oil (37 mg, 79% yield).   
 
1H NMR (400 MHz, CDCl3) δ 7.31-7.25 (m, 2H), 7.23-7.14 (m, 3H), 4.11-4.02 (m, 1H), 
3.06 (d, J = 3.4 Hz, 1H), 2.68-2.54 (m, 3H), 2.48 (dd, J = 17.6, 9.1 Hz, 1H), 2.39 (t, J = 7.3 
Hz, 2H), 1.87-1.74 (m, 1H), 1.73-1.48 (m, 4H), 1.46-1.36 (m, 1H), 0.91 (t, J = 7.4 Hz, 3H). 
13C NMR (150 MHz, CDCl3) δ 212.5, 142.4, 128.5, 128.4, 125.9, 67.6, 49.0, 45.6, 36.1, 
35.8, 27.4, 17.2, 13.8. IR (neat) νmax 3398 (br, s), 2932 (s), 1707 (s), 1603 (w), 1496 (w), 
1408 (m), 1375 (m), 1096 (m), 750 (s), 700 (s) cm-1. HRMS (DART) for C15H23O2 
[M+H]+: Calc’d: 235.1691, found: 235.1693.  
 
 5-hydroxy-2-methyl-8-phenyloctan-3-one (4). The 
reaction was performed according to the general procedure with 9-BBN in THF (0.52 mL, 
0.5 M, 0.26 mmol, 1.30 equiv.), allylbenzene (30.7 mg, 0.26 mmol, 1.30 equiv.), halide-
free vinyllithium in THF (0.16 mL, 1.38 M, 0.22 mmol, 1.10 equiv.), a solution of NiBr2-
glyme (3.09 mg, 0.010 mmol, 0.050 equiv.) and L3 (3.51 mg, 0.012 mmol, 0.060 equiv.) 
in THF (0.4 mL), isobutyryl chloride (21.3 mg, 0.20 mmol, 1.00 equiv.). The crude mixture 
was purified by column chromatography (20% EtOAc in hexanes, stain in KMnO4) to 
afford the product as a colorless oil (33.7 mg, 72% yield).   
 
1H NMR (500 MHz, CDCl3) δ 7.30-7.25 (m, 2H), 7.20-7.15 (m, 3H), 4.10-3.99 (m, 1H), 
3.28-3.01 (br s, 1H). 2.71-2.46 (m, 5H), 1.88-1.73 (m, 1H), 1.72-1.62 (m, 1H), 1.59-1.50 
(m, 1H), 1.48-1.38 (m, 1H), 1.10 (d, J = 6.9 Hz, 6H). 13C NMR (126 MHz, CDCl3) δ 216.3, 
142.4, 128.5, 128.4, 125.9, 67.6, 46.6, 41.6, 36.1, 35.9, 27.4, 18.2, 18.1.  IR (neat) 3479 
(br, m), 2969 (m), 2932 (s), 1706 (s), 1603 (w), 1496 (m), 1094 (m), 1043 (w), 751 (m), 
701 (m) cm-1. HRMS (DART) for C15H23O2 [M+H]
+: Calc’d: 235.1693, found: 235.1703.  
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 1-cyclohexyl-3-hydroxy-6-phenylhexan-1-one (5). The 
reaction was performed according to the general procedure with 9-BBN in THF (0.52 mL, 
0.5 M, 0.26 mmol, 1.30 equiv.), allylbenzene (30.7 mg, 0.26 mmol, 1.30 equiv.), halide-
free vinyllithium in THF (0.16 mL, 1.38 M, 0.22 mmol, 1.10 equiv.), a solution of NiBr2-
glyme (3.09 mg, 0.010 mmol, 0.050 equiv.) and L3 (3.51 mg, 0.012 mmol, 0.060 equiv.) 
in THF (0.4 mL), cyclohexanecarbonyl chloride (29.3 mg, 0.20 mmol, 1.00 equiv.). The 
crude mixture was purified by column chromatography (20% EtOAc in hexanes, stain in 
KMnO4) to afford the product as a colorless oil (43.9 mg, 80% yield).   
 
1H NMR (500 MHz, CDCl3) δ 7.37-7.33 (m, 2H), 7.28-7.22 (m, 3H), 4.17-4.04 (m, 1H), 
3.26 (d, J = 3.2 Hz, 1H), 2.74-2.66 (m, 3H), 2.57 (dd, J = 17.7, 9.2 Hz, 1H), 2.42-2.34 (m, 
1H), 1.96-1.82 (m, 5H), 1.78-1.69 (m, 2H), 1.65-1.57 (m, 1H), 1.55-1.46 (m, 1H), 1.44-
1.22 (m, 5H). 13C NMR (150 MHz, CDCl3) δ 215.8, 142.4, 128.6, 128.4, 125.9, 67.6, 51.5, 
46.9, 36.1, 35.9, 28.4, 27.4, 25.9, 25.7.  IR (neat) νmax 3457 (m), 2925 (m), 1670 (s), 1602 
(s), 1222 (m), 1023 (m), 969 (m), 827 (s), 613 (w), 580 (w) cm-1. HRMS (DART) for 
C18H27O2 [M+H]
+: Calc’d: 275.2006, found: 275.1996.  
 
 4-hydroxy-7-phenylheptan-2-one (6). The reaction was 
performed according to the general procedure with 9-BBN in THF (0.52 mL, 0.5 M, 0.26 
mmol, 1.30 equiv.), allylbenzene (30.7 mg, 0.26 mmol, 1.30 equiv.), halide-free 
vinyllithium in THF (0.16 mL, 1.38 M, 0.22 mmol, 1.10 equiv.), a solution of NiBr2-glyme 
(3.09 mg, 0.010 mmol, 0.050 equiv.) and L3 (3.51 mg, 0.012 mmol, 0.060 equiv.) in THF 
(0.4 mL), acetyl chloride (15.7 mg, 0.20 mmol, 1.00 equiv.). The crude mixture was 
purified by column chromatography (20% EtOAc in hexanes, stain in KMnO4) to afford 
the product as a colorless oil (37 mg, 76% yield).  
 
 1H NMR (600 MHz, CDCl3) δ 7.28-7.24 (m, 2H), 7.20-7.14 (m, 3H), 4.08-4.00 (m, 1H), 
3.02-2.94 (s, 1H), 2.66-2.57 (m, 3H), 2.51 (dd, J = 17.8, 9.2 Hz, 1H), 2.15 (s, 3H), 1.83-
1.74 (m, 1H), 1.70-1.60 (m, 1H), 1.56-1.49 (m, 1H), 1.45-1.38 (m, 1H). 13C NMR (126 
MHz, CDCl3) δ 210.1, 142.4, 129.5, 128.4, 125.9, 67.5, 50.1, 36.0, 35.8, 30.9, 27.4.  IR 
(neat) νmax 3457 (m), 2923 (m), 1668 (s), 1596 (s), 1459 (m), 1262 (m), 988 (m), 826 (m), 
746 (m), 701 (m), 580 (s), 552 (m). HRMS (DART) for C13H19O2 (M+H)
+: Calc’d: 
207.1380, found: 207.1370. 
 
 40 
 5-hydroxy-2,2-dimethyl-8-phenyloctan-3-one (7). The 
reaction was performed according to the general procedure with 9-BBN in THF (0.52 mL, 
0.5 M, 0.26 mmol, 1.30 equiv.), allylbenzene (30.7 mg, 0.26 mmol, 1.30 equiv.), halide-
free vinyllithium in THF (0.16 mL, 1.38 M, 0.22 mmol, 1.10 equiv.), a solution of NiBr2-
glyme (2.20 mg, 0.010 mmol, 0.050 equiv.) and L3 (3.51 mg, 0.012 mmol, 0.060 equiv.) 
in THF (0.4 mL), pivaloyl chloride (24.1 mg, 0.20 mmol, 1.00 equiv.). The crude mixture 
was purified by column chromatography (20% EtOAc in hexanes, stain in KMnO4) to 
afford the product as a colorless oil (15.9 mg, 32% yield).   
 
1H NMR (600 MHz, CDCl3) δ 7.28 (m, 2H), 7.18 (m, 3H), 4.02 (m, 1H), 3.27 (d, J = 3.1 
Hz, 1H), 2.67 (dd, J = 17.8, 2.5 Hz, 1H), 2.64 (t, J = 7.6 Hz, 2H), 2.53 (dd, J = 17.8, 9.2 
Hz, 1H), 1.81 (m, 1H), 1.69 (m, 1H), 1.56 (m, 1H), 1.45 (m, 1H), 1.13 (s, 9H). 13C NMR 
(151 MHz, CDCl3) δ 218.0, 142.4, 128.54, 128.45, 128.43, 128.41, 125.9, 67.8, 44.5, 
43.19, 43.16, 36.1, 35.9, 27.5, 26.44, 26.40, 26.35.  IR (neat) νmax 3454 (br, w), 3026 (w), 
2929 (m), 2861 (m), 1698 (s), 1603 (w), 1496 (m), 1478 (m), 1453 (m), 1394 (w), 1366 
(m), 1067 (m), 1030 (w), 1008 (w), 844 (w), 748 (s), 699(s), 578 (w), 537 (w) cm-1. 
HRMS (DART) for C16H25O2 [M+H]
+: Calc’d: 249.1849, found: 249.1840. 
 
 
 5-hydroxy-1,8-diphenyloctan-3-one (8). The reaction was 
performed according to the general procedure with 9-BBN in THF (0.52 mL, 0.5 M, 0.26 
mmol, 1.30 equiv.), allylbenzene (30.7 mg, 0.26 mmol, 1.30 equiv.), halide-free 
vinyllithium in THF (0.16 mL, 1.38 M, 0.22 mmol, 1.10 equiv.), a solution of NiBr2-glyme 
(3.09 mg, 0.010 mmol, 0.050 equiv.) and L3 (3.51 mg, 0.012 mmol, 0.060 equiv.) in THF 
(0.4 mL), hydrocinnamoyl chloride (33.7 mg, 0.20 mmol, 1.00 equiv.). The crude mixture 
was purified by column chromatography (20% EtOAc in hexanes, stain in KMnO4) to 
afford the product as a colorless oil (43.9 mg, 79% yield).   
 
1H NMR (600 MHz, CDCl3) δ 7.28 (m, 4H), 7.19 (m, 6H), 4.06 (m, 1H), 2.99 (m, 1H), 
2.91 (t, J = 7.6 Hz, 2H), 2.76 (t, J = 7.6 Hz, 2H), 2.64 (t, J = 7.7 Hz, 2H), 2.55 (dd, J = 
17.5, 3.0 Hz, 1H), 2.49 (dd, J = 17.5, 8.9 Hz, 1H), 1.79 (m, 1H), 1.67 (m, 1H), 1.53 (m, 
1H), 1.43 (m, 1H). 13C NMR (151 MHz, CDCl3) δ 211.2, 142.3, 140.8, 128.6, 128.6, 128.5, 
128.5, 128.40, 128.39, 128.37, 126.3, 125.9, 67.6, 49.4, 45.11, 36.0, 35.8, 29.6, 27.3. IR 
(neat) νmax 3445 (br, w), 3026 (w), 2923 (w), 2856 (w), 1705 (s), 1603 (w), 1496 (m), 1453 
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(m), 1406 (m), 1371 (m), 1091 (m), 1030 (m), 748 (m), 698 (s), 563 (w) cm-1. HRMS 
(DART) for C20H25O2 [M+H]
+: Calc’d: 297.1849, found: 297.1838. 
 
 8-hydroxy-11-phenylundec-1-en-6-one (9). The reaction 
was performed according to the general procedure with 9-BBN in THF (0.52 mL, 0.5 M, 
0.26 mmol, 1.30 equiv.), allylbenzene (30.7 mg, 0.26 mmol, 1.30 equiv.), halide-free 
vinyllithium in THF (0.16 mL, 1.38 M, 0.22 mmol, 1.10 equiv.), a solution of NiBr2-glyme 
(3.09 mg, 0.010 mmol, 0.050 equiv.) and L3 (3.51 mg, 0.012 mmol, 0.060 equiv.) in THF 
(0.4 mL), hex-5-enoyl chloride (26.5 mg, 0.20 mmol, 1.00 equiv.). The crude mixture was 
purified by column chromatography (20% EtOAc in hexanes, stain in KMnO4) to afford 
the product as a colorless oil (42.2 mg, 81% yield).   
 
1H NMR (500 MHz, CDCl3) δ 7.29-7.24 (m, 2H), 7.19-7.15 (m, 3H), 5.74 (ddt, J = 16.9, 
10.2, 6.7 Hz, 1H), 5.03-4.95 (m, 2H), 4.11-4.01 (m, 1H), 3.09 (br s, 1H), 2.63 (t, J = 7.7,Hz, 
2H), 2.55 (dd, J = 17.5, 2.8 Hz, 1H), 2.48 (dd, J = 17.5, 9.1 Hz, 1H), 2.41 (t, J = 7.4 Hz, 
2H), 2.04 (q, J = 7.1 Hz, 2H), 1.83-1.75 (m, 1H), 1.71-1.62 (m, 3H), 1.57-1.49 (m, 1H), 
1.46-1.38 (m, 1H). 13C NMR (150 MHz, CDCl3) δ 212.2, 142.3, 137.9, 128.5, 128.4, 
125.8, 115.5, 67.6, 49.2, 42.8, 36.0, 35.8, 33.1, 27.4, 22.6.  IR (neat) νmax 3448.8 (br, m), 
2933 (m), 1705 (m), 1640 (w), 1408 (m), 1276 (w), 1097 (m), 912 (m), 750 (s), 700 (s) cm-
1. HRMS (DART) for C17H25O2 [M+H]
+: Calc’d: 261.1849, found: 261.1853.  
 
 3-hydroxy-1,6-diphenylhexan-1-one (10). The reaction 
was performed according to the general procedure with 9-BBN in THF (0.52 mL, 0.5 M, 
0.26 mmol, 1.30 equiv.), allylbenzene (30.7 mg, 0.26 mmol, 1.30 equiv.), halide-free 
vinyllithium in THF (0.16 mL, 1.38 M, 0.22 mmol, 1.10 equiv.), a solution of NiBr2-glyme 
(3.09 mg, 0.010 mmol, 0.050 equiv.) and L3 (3.51 mg, 0.012 mmol, 0.060 equiv.) in THF 
(0.4 mL), benzoyl chloride (28.1 mg, 0.20 mmol, 1.00 equiv.). The crude mixture was 
purified by column chromatography (20% EtOAc in hexanes, stain in KMnO4) to afford 
the product as a colorless oil (40.3 mg, 75% yield). 
 
1H NMR (500 MHz, CDCl3) δ 7.95 (d, J = 7.4 Hz, 2H), 7.59 (t, J = 7.4 Hz, 1H), 7.47 (t, J 
= 7.7 Hz, 2H), 7.29 (t, J = 7.4 Hz, 2H), 7.24-7.16 (m, 3H),  4.30-4.19 (m, 1H), 3.28 (d, J = 
3.3 Hz, 1H), 3.15 (dd, J = 17.7, 2.6 Hz, 1H), 3.04 (dd, J = 17.9, 9.1 Hz, 1H), 2.68 (t, J = 
7.6 Hz, 1H), 1.94-1.83 (m, 1H), 1.80-1.71 (m, 1H), 1.71-1.63 (m, 1H), 1.61-1.52 (m, 1H). 
13C NMR (150 MHz, CDCl3) δ 201.0, 142.4, 136.9, 133.7, 128.8, 128.6, 128.4, 128.2, 
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125.9, 67.7, 45.2, 36.2, 35.9, 27.5. IR (neat) νmax 3481 (m), 2931 (w), 2901 (w), 1676 (s), 
1595 (w), 1219 (w), 1098 (m), 749 (m), 699 (m), 686 (s), 583 (m) cm-1. HRMS (DART) 
for C18H21O2 [M+H]
+: Calc’d: 269.1536, found: 269.1545. 
 
 3-hydroxy-1-(4-methoxyphenyl)-6-phenylhexan-
1-one (11). The reaction was performed according to the general procedure with 9-BBN in 
THF (0.52 mL, 0.5 M, 0.26 mmol, 1.30 equiv.), allylbenzene (30.7 mg, 0.26 mmol, 1.30 
equiv.), halide-free vinyllithium in THF (0.16 mL, 1.38 M, 0.22 mmol, 1.10 equiv.), a 
solution of NiBr2-glyme (3.09 mg, 0.010 mmol, 0.050 equiv.) and L3 (3.51 mg, 0.012 
mmol, 0.060 equiv.) in THF (0.4 mL), 4-methoxybenzoyl chloride (34.1 mg, 0.20 mmol, 
1.00 equiv.). The crude mixture was purified by column chromatography (20% EtOAc in 
hexanes, stain in KMnO4) to afford the product as a white solid (44.1 mg, 74% yield). 
 
1H NMR (400 MHz, CDCl3) 7.92 (d, J = 8.9 Hz, 2H), 7.33-7.24 (m, 2H), 7.21-7.13 (m, 
3H), 6.92 (d, J = 8.9 Hz, 2H), 4.30-4.10 (m, 1H), 3.86 (s, 3H), 3.41 (br s, 1H), 3.10 (dd, J 
= 17.5, 2.5 Hz, 1H), 2.95 (dd, J = 17.5, 9.1 Hz 1H), 2.67 (t, J = 7.5 Hz, 2H), 1.93-1.81 (m, 
1H), 1.80-1.59 (m, 2H), 1.58-1.46 (m, 1H). 13C NMR (150 MHz, CDCl3) δ 199.6, 164.0, 
142.5, 130.5, 130.0, 128.6, 128.4, 125.9, 114.0, 67.9, 55.7, 44.7, 36.2, 35.9, 27.5. IR (neat) 
νmax 3483 (br, s), 2926 (s), 1709 (s), 1603 (w), 1496 (w), 1168 (m), 1094 (m), 751 (m), 702 
cm-1. HRMS (DART) for C19H23O3 [M+H]




(12). The reaction was performed according to the general procedure with 9-BBN in THF 
(0.52 mL, 0.5 M, 0.26 mmol, 1.30 equiv.), allylbenzene (30.7 mg, 0.26 mmol, 1.30 equiv.), 
halide-free vinyllithium in THF (0.16 mL, 1.38 M, 0.22 mmol, 1.10 equiv.), a solution of 
NiBr2-glyme (3.09 mg, 0.010 mmol, 0.050 equiv.) and L3 (3.51 mg, 0.012 mmol, 0.060 
equiv.) in THF (0.4 mL), 4-chlorobenzoyl chloride (35.0 mg, 0.20 mmol, 1.00 equiv.). The 
crude mixture was purified by column chromatography (20% EtOAc in hexanes, stain in 
KMnO4) to afford the product as a colorless oil (40.6 mg, 67% yield). 
 
1H NMR (600 MHz, CDCl3) δ 7.87 (d, J = 8.3 Hz, 2H), 7.44 (d, J = 8.0 Hz, 2H), 7.28 (t, 
2H, J  = 7.5 Hz, 2H), 7.22-7.16 (m, 3H), 4.28-4.19 (m, 1H), 3.17 (d, J = 3.4 Hz, 1H), 3.08 
(dd, J = 17.7, 2.7 Hz, 1H), 3.01 (dd, J = 17.7, 9.1 Hz, 1H), 2.67 (t, J = 7.6 Hz, 2H), 1.92-
1.84 (m, 1H), 1.78-1.70 (m, 1H), 1.68-1.62 (m, 1H), 1.58-1.51 (m, 1H). 13C NMR (150 
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MHz, CDCl3) δ 199.7, 142.3, 140.2, 135.2, 129.6, 129.1, 128.6, 128.5, 125.9, 67.6, 45.2, 
36.1, 35.9, 27.5.  IR (neat) νmax 3484 (br, s), 2932 (w), 2901 (w), 1675 (s), 1588 (w), 1494 
(m), 1400 (m), 1092 (s), 1039 (m), 986 (m), 832 (m), 817 (s), 733 (s), 534 (s) cm-1. HRMS 
(DART) for C18H21O2Cl [M+H]
+: Calc’d: 303.1146, found: 303.1143.  
 
 3-hydroxy-6-phenyl-1-(4-
(trifluoromethyl)phenyl)hexan-1-one (13). The reaction was performed according to the 
general procedure with 9-BBN in THF (0.52 mL, 0.5 M, 0.26 mmol, 1.30 equiv.), 
allylbenzene (30.7 mg, 0.26 mmol, 1.30 equiv.), halide-free vinyllithium in THF (0.16 mL, 
1.38 M, 0.22 mmol, 1.10 equiv.), a solution of NiBr2-glyme (3.09 mg, 0.010 mmol, 0.050 
equiv.) and L3 (3.51 mg, 0.012 mmol, 0.060 equiv.) in THF (0.4 mL), 4-
(trifluoromethyl)benzoyl chloride (41.7 mg, 0.20 mmol, 1.00 equiv.). The crude mixture 
was purified by column chromatography (20% EtOAc in hexanes, stain in KMnO4) to 
afford the product as a white solid (30.0 mg, 44% yield). 
 
 
1H NMR (600 MHz, CDCl3) δ 8.04 (d, J = 7.6 Hz, 2H), 7.74 (d, J = 8.0 Hz, 2H), 7.29 (t, 
J = 8.0 Hz, 2H), 7.21-7.16 (m, 3H), 4.34-4.22 (m, 1H), 3.14 (dd, J = 17.7, 2.9 Hz, 1H), 
3.08 (dd, J = 17.7, 8.7 Hz, 1H), 3.02 (s, 1H), 2.68 (t, J = 7.6 Hz, 2H), 1.93-1.84 (m, 1H), 
1.79-1.71 (m, 1H), 1.70-1.63 (m, 1H), 1.60-1.52 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 
199.9, 142.3, 139.5, 128.58, 128.56, 128.5, 126.0, 125.9, 125.91, 125.88, 67.6, 45.7, 36.2, 
35.9, 27.5.  IR (neat) νmax 3485 (s), 2931 (w), 2900 (w), 1682 (s), 1579 (w), 1509 (m), 1327 
(s), 1169 (m), 892 (m), 844 (m), 703 (w), 606 (w) cm-1. HRMS (DART) for C19H20O2F3 
[M+H]+: Calc’d: 337.1410, found: 337.1396.  
 
1-(4-(dimethylamino)phenyl)-3-hydroxy-6-
phenylhexan-1-one (14).  The reaction was performed according to the general procedure 
with 9-BBN in THF (0.52 mL, 0.5 M, 0.26 mmol, 1.30 equiv.), allylbenzene (30.7 mg, 
0.26 mmol, 1.30 equiv.), halide-free vinyllithium in THF (0.16 mL, 1.38 M, 0.22 mmol, 
1.10 equiv.), a solution of NiBr2-glyme (3.09 mg, 0.010 mmol, 0.050 equiv.) and L3 (3.51 
mg, 0.012 mmol, 0.060 equiv.) in THF (0.4 mL), 4-(dimethylamino)benzoyl chloride (36.7 
mg, 0.20 mmol, 1.00 equiv.). The crude mixture was purified by column chromatography 
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(20% EtOAc in hexanes, stain in KMnO4) to afford the product as a colorless oil (48.0 mg, 
77% yield). 
 
1H NMR (500 MHz, CDCl3) δ 7.85 (d, J = 9.1 Hz, 2H), 7.34-7.26 (m, 2H),  7.22-7.13 (m, 
3H), 6.64 (d, J = 9.1 Hz, 2H), 4.24-4.16 (m, 1H),  3.73 (s, 1H), 3.10 (dd, J = 17.3, 2.4 Hz, 
1H), 3.06 (s, 6H), 2.88 (dd, J = 17.3, 9.3 Hz, 1H), 2.67 (t, J = 7.6 Hz, 2H), 1.93-1.83 (m, 
1H), 1.79-1.70 (m, 1H), 1.69-1.61 (m, 1H), 1.58-1.50 (m, 1H). 13C NMR (150 MHz, 
CDCl3) δ 199.1, 153.8, 142.5, 130.5, 128.6, 128.4, 125.8, 124.8, 110.7, 68.1, 43.9, 40.1, 
36.3, 36.0, 27.5. IR (neat) νmax 3468 (br, w), 2926 (w), 1650 (w), 1595 (s), 1530 (w), 1371 
(m), 1186 (m), 1169 (m), 819 (w), 750 (m), 700 (w), 579 (w) cm-1. HRMS (DART) for 
C20H26NO2 [M+H]
+: Calc’d: 312.1952, found: 312.1958. 
 
 6-hydroxytetradecan-4-one (15). The reaction was performed 
according to the general procedure with 9-BBN in THF (0.52 mL, 0.5 M, 0.26 mmol, 1.30 
equiv.), 1-octene ( mg, 0.26 mmol, 1.30 equiv.), halide-free vinyllithium in THF (0.16 mL, 
1.38 M, 0.22 mmol, 1.10 equiv.), a solution of NiBr2-glyme (3.09 mg, 0.010 mmol, 0.050 
equiv.) and L3 (3.51 mg, 0.012 mmol, 0.060 equiv.) in THF (0.4 mL), butanoyl chloride 
(21.3 mg, 0.20 mmol, 1.00 equiv.). The crude mixture was purified by column 
chromatography (20% EtOAc in hexanes, stain in KMnO4) to afford the product as a 
colorless oil (33.3 mg, 73% yield). 
 
 
1H NMR (500 MHz, CDCl3) δ 4.05-3.97 (m, 1H), 3.06 (br s, 1H), 2.57 (dd, J = 17.5, 2.8 
Hz, 1H), 2.47 (dd,  1H), 2.39 (t, J = 7.3 Hz, 2H), 1.59 (h, J = 7.3 Hz, 2H), 1.52-1.17 (m, 
14H), 0.90 (t, J = 7.4 Hz, 3H), 0.86 (t, J = 6.8 Hz, 3H). 13C NMR (150 MHz, CDCl3) δ 
212.6, 67.8, 49.1, 45.7, 36.6, 32.0, 29.69, 29.67, 29.4, 25.6, 22.8, 17.2, 14.2, 13.8. IR (neat) 
νmax 3244 (br, m), 2957 (m), 2916 
(s), 2848 (m), 1701 (s), 1465 (m), 1386 (m), 1132 (m), 1094 (m), 1027 (m), 889 (m), 724 
(m), 628 (m) cm-1. HRMS (DART) for C14H29O2 [M+H]
+: Calc’d: 229.2162, found: 
229.2172.  
 
 1-cyclohexyl-1-hydroxyhexan-3-one (16). The reaction was 
performed according to the general procedure with 9-BBN in THF (0.52 mL, 0.5 M, 0.26 
mmol, 1.30 equiv.), cyclohexene (21.4 mg, 0.26 mmol, 1.30 equiv.), halide-free 
vinyllithium in THF (0.16 mL, 1.38 M, 0.22 mmol, 1.10 equiv.), a solution of NiBr2-glyme 
(3.09 mg, 0.010 mmol, 0.050 equiv.) and L3 (3.51 mg, 0.012 mmol, 0.060 equiv.) in THF 
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(0.4 mL), butanoyl chloride (21.3 mg, 0.20 mmol, 1.00 equiv.). The crude mixture was 
purified by column chromatography (20% EtOAc in hexanes, stain in KMnO4) to afford 
the product as a colorless oil (26.2 mg, 66% yield). 
 
1H NMR (600 MHz, CDCl3) δ 3.79 (m, 1H), 2.97 (s, 1H), 2.58 (dd, J = 17.3, 2.4 Hz, 1H), 
2.49 (dd, J = 17.3, 9.6 Hz, 1H), 2.41 (t, J = 7.3 Hz, 2H), 1.85-1.80 (m, 1H), 1.77-1.70 (m, 
2H), 1.67-1.56 (m, 4H), 1.36-1.30 (m, 1H), 1.26-1.09 (m, 3H), 1.06-0.95 (m, 2H), 0.91 (t, 
J = 7.4 Hz, 3H). 13C NMR (151 MHz, CDCl3) δ 212.9, 71.9, 46.2, 45.8, 43.1, 29.0, 28.4, 
26.6, 26.3, 26.2, 17.2, 13.8. IR (neat) νmax 3448 (br, w), 2923 (s), 2852 (s), 1703 (s), 1450 
(m), 1407 (m), 1371 (m), 1308 (m), 1274 (m), 1127 (m), 1108 (m), 1065 (m), 1027 (m), 
989 (m), 957 (w), 892 (w), 531 (w) cm-1. HRMS (DART) for C12H23O2 [M+H]+: Calc’d: 
199.1693, found: 199.1688. 
 
 
 12-(furan-2-yl)-6-hydroxydodecan-4-one (17). 
The reaction was performed according to the general procedure with 9-BBN in THF (0.52 
mL, 0.5 M, 0.26 mmol, 1.30 equiv.), S-1 (39.0 mg, 0.26 mmol, 1.30 equiv.), halide-free 
vinyllithium in THF (0.16 mL, 1.38 M, 0.22 mmol, 1.10 equiv.), a solution of NiBr2-glyme 
(3.09 mg, 0.010 mmol, 0.050 equiv.) and L3 (3.51 mg, 0.012 mmol, 0.060 equiv.) in THF 
(0.4 mL), butanoyl chloride (21.3 mg, 0.20 mmol, 1.00 equiv.). The crude mixture was 
purified by column chromatography (20% EtOAc in hexanes, stain in KMnO4) to afford 
the product as a colorless oil (32.5 mg, 61% yield). 
 
1H NMR (500 MHz, CDCl3) δ 7.96 (d, J = 8.0 Hz, 2H), 7.59 (t, J = 7.4 Hz, 1H), 7.47 (t, J 
= 7.8 Hz, 2H), 7.29 (s, 1H), 6.29 – 6.24 (m, 1H), 5.97 (d, J = 3.1 Hz, 1H), 4.22 (m, 1H), 
3.24 (d, J = 3.2 Hz, 1H), 3.17 (dd, J = 17.6, 2.6 Hz, 1H), 3.04 (dd, J = 17.6, 9.0 Hz, 1H), 
2.62 (t, J = 7.6 Hz, 2H), 1.69-1.58 (m, 3H), 1.56-1.47 (m, 2H), 1.46-1.31 (m, 5H). 13C 
NMR (126 MHz, CDCl3) δ 201.1, 156.6, 140.8, 136.9, 133.6, 128.8, 128.2, 110.2, 104.7, 
67.9, 45.2, 36.6, 29.4, 29.2, 28.11, 28.07, 25.6. IR (neat) νmax 3454 (br, w), 2929 (m), 2856 
(w), 1677 (s), 1597 (m), 1580 (w), 1507 (w), 1449 (m), 1283 (w), 1210 (s), 1180 (w), 1146 
(m), 1072 (w), 1003 (s), 922 (w), 884 (w), 797 (w), 752 (s), 727 (s), 689 (s), 662 (w), 599 
(s), 587 (m), 536 (w) cm-1. HRMS (DART) for C19H25O3 [M+H]





one (18).  The reaction was performed according to the general procedure with 9-BBN in 
THF (0.52 mL, 0.5 M, 0.26 mmol, 1.30 equiv.), S-4 (77.1 mg, 0.26 mmol, 1.30 equiv.), 
halide-free vinyllithium in THF (0.16 mL, 1.38 M, 0.22 mmol, 1.10 equiv.), a solution of 
NiBr2-glyme (2.20 mg, 0.010 mmol, 0.050 equiv.) and L3 (3.51 mg, 0.012 mmol, 0.060 
equiv.) in THF (0.4 mL), butanoyl chloride (21.3 mg, 0.20 mmol, 1.00 equiv.). The crude 
mixture was purified by column chromatography (20% EtOAc in hexanes, stain in KMnO4) 
to afford the product as a colorless oil (59.4 mg, 72% yield). 
 
1H NMR (400 MHz, CDCl3) δ 7.70-7.64 (m, 4H), 7.46-7.34 (m, 6H), 4.11-4.01 (m, 1H), 
3.69 (t, J = 5.4 Hz, 1H), 3.24 (d, J = 3.2 Hz, 1H), 2.60-2.46 (m, 2H), 2.41 (t, J = 7.3 Hz, 
2H), 1.84-1.51 (m, 6H), 1.05 (s, 9H), 0.92 (t, J = 7.4 Hz, 3H). 13CNMR (126 MHz, CDCl3) 
δ 212.3, 135.7, 135.7, 129.7, 127.8, 67.6, 64.0, 49.2, 45.7, 33.3, 28.7, 27.0, 19.3, 17.2, 13.8.  
IR (neat) νmax 3399 (br, s), 2938 (s), 2857 (s), 1705 (s), 1472 (w), 1428 (m), 1112 (s), 741 
(m), 705 (s), 615 (m) cm-1. HRMS (DART) for C25H37O3Si [M+H]
+: Calc’d: 413.2507, 
found: 413.2505.  
 
 3-hydroxy-1,5,5-triphenylpentan-1-one (19). The reaction 
was performed according to the general procedure with 9-BBN in THF (0.52 mL, 0.5 M, 
0.26 mmol, 1.30 equiv.), 1,1-diphenylethylene (46.9 mg, 0.26 mmol, 1.30 equiv.), halide-
free vinyllithium in THF (0.16 mL, 1.38 M, 0.22 mmol, 1.10 equiv.), a solution of NiBr2-
glyme (3.09 mg, 0.010 mmol, 0.050 equiv.) and L3 (3.51 mg, 0.012 mmol, 0.060 equiv.) 
in THF (0.4 mL), benzoyl chloride (28.1 mg, 0.20 mmol, 1.00 equiv.). The crude mixture 
was purified by column chromatography (20% EtOAc in hexanes, stain in KMnO4) to 
afford the product as a colorless oil (53.5 mg, 66% yield). 
 
1H NMR (500 MHz, CDCl3) δ 7.90 (d, J = 7.1 Hz, 2H), 7.58 (t, J = 7.2 Hz, 1H), 7.46 (t, J 
= 8.0 Hz, 2H), 7.28-7.33 (m, 7H), 7.22-7.14 (m, 2H), 4.37 (dd, J = 10.4, 5.3 Hz, 1H), 4.06-
4.13 (m, 1H), 3.29 (d, J = 3.0 Hz, 1H), 3.15 (dd, J = 17.7, 3.0 Hz, 1H), 3.09 (dd, J = 17.9, 
8.6 Hz, 1H), 2.37-2.30 (m, 1H), 2.29-2.22 (m, 1H). 13C NMR (151 MHz, CDCl3) δ 200.8, 
145.3, 144.1, 136.8, 133.7, 128.8, 128.7, 128.6, 128.3, 128.1, 127.8, 126.5, 126.3, 65.7, 
47.1, 45.4, 42.4. IR (neat) νmax 3454 (br, w), 3059 (w), 3026 (w), 2933 (w), 1677 (m), 1597 
(m), 1580 (w), 1493 (m), 1449 (m), 1409 (w), 1361 (w), 1280 (w), 1207 (m), 1181 (w), 
1158 (w), 1076 (w), 1057 (w), 1031 (m), 1001 (w), 985 (w), 917 (w), 868 (w), 782 (w), 
 47 
752 (s), 739 (m), 698 (s), 619 (w), 590 (w), 551 (w) cm-1. HRMS (DART) for C23H23O2 





cyclopenta[a]phenanthren-17-yl)-7-hydroxy-10-phenyldecan-5-one (20).  The reaction 
was performed according to the general procedure with 9-BBN in THF (0.52 mL, 0.5 M, 
0.26 mmol, 1.30 equiv.), allylbenzene (30.7 mg, 0.26 mmol, 1.30 equiv.), halide-free 
vinyllithium in THF (0.16 mL, 1.38 M, 0.22 mmol, 1.10 equiv.), a solution of NiBr2-glyme 
(3.09 mg, 0.010 mmol, 0.050 equiv.) and L3 (3.51 mg, 0.012 mmol, 0.060 equiv.) in THF 
(0.4 mL), S-7 (101.9 mg, 0.20 mmol, 1.00 equiv.). The crude mixture was purified by 
column chromatography (20% EtOAc in hexanes, stain in KMnO4) to afford the product 
as a colorless oil (63.7 mg, 50% yield). 
 
1H NMR (400 MHz, CDCl3) δ 7.30-7.24 (m, 2H), 7.21-7.15 (m, 3H), 4.10-3.99 (m, 1H), 
3.62-3.53 (m, 1H), 3.09 (dd, J = 8.1, 3.4 Hz, 1H),  2.64 (t, J = 7.6 Hz, 2H), 2.59-2.39 (m, 
3H), 2.37-2.27 (m, 1H), 1.96-1.01 (m, 34H), 0.93-0.85 (m, 15H), 0.62 (s, 3H), 0.06 (s, 6H). 
13C NMR (150 MHz, CDCl3) δ 213.1, 142.4, 128.5, 128.4, 125.9, 73.0, 67.63, 67.59, 56.5, 
56.1, 49.02, 49.01, 42.9, 42.4, 40.7, 40.4, 40.3, 37.1, 36.1, 36.0, 35.9, 35.7, 35.4, 34.7, 31.2, 
29.7, 28.4, 27.43, 27.39, 26.5, 26.1, 24.3, 23.5, 21.0, 18.6, 18.5, 12.2, -4.4.  IR (neat) νmax 
3480 (br, m), 2929 (s), 2854 (m), 1699 (s), 1603 (w), 1496 (w), 1451 (m), 750 (m), 700 
(m) cm-1. HRMS (DART) for C41H69O3Si [M+H]
+: Calc’d: 637.5016, found: 637.5005.  
 
 (E)-6-hydroxy-10,14-dimethylpentadeca-
9,13-dien-4-one (21).  The reaction was performed according to the general procedure with 
9-BBN in THF (0.52 mL, 0.5 M, 0.26 mmol, 1.30 equiv.), S-2 (39.1 mg, 0.26 mmol, 1.30 
equiv.), halide-free vinyllithium in THF (0.16 mL, 1.38 M, 0.22 mmol, 1.10 equiv.), a 
solution of NiBr2-glyme (3.09 mg, 0.010 mmol, 0.050 equiv.) and L3 (3.51 mg, 0.012 
mmol, 0.060 equiv.) in THF (0.4 mL), butanoyl chloride (21.3 mg, 0.20 mmol, 1.00 
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equiv.). The crude mixture was purified by column chromatography (20% EtOAc in 
hexanes, stain in KMnO4) to afford the product as a colorless oil (22.9 mg, 43% yield). 
 
1H NMR (500 MHz, CDCl3) δ 5.14-5.10 (t, J = 6.8 Hz, 1H), 5.09-5.06 (t, J = 6.6 Hz, 1H), 
4.07-4.01 (m, 1H), 3.01 (d, J = 3.5 Hz, 1H), 2.59 (dd, J = 17.5, 2.8 Hz, 1H), 2.50 (dd, J = 
17.5, 9.1 Hz, 1H), 2.40 (t, J = 7.3 Hz, 2H), 2.17-2.03 (m, 4H), 2.01-1.95 (m, 2H), 1.67 (s, 
3H), 1.65-1.52 (m, 9H), 1.45-1.37 (m, 1H), 0.92 (t, J = 7.4 Hz, 3H). 13C NMR (150 MHz, 
CDCl3) δ 212.5, 136.0, 131.5, 124.4, 123.8, 67.4, 49.1, 45.7, 39.9, 36.6, 26.8, 25.8, 24.1, 
17.8, 17.2, 16.2, 13.8. IR (neat) νmax 3458 (br, m), 2963 (s), 2925 (s), 1707 (s), 1448 (m), 
1376 (m), 1127 (w), 1103 (m), 1037 (w), 835 (w)cm-1. HRMS (DART) for C16H25O3 
[M+H]+: Calc’d: 265.1804, found: 265.1796.  
 
 1-hydroxy-1-phenylhexan-3-one (22).  The reaction was 
performed according to the general procedure with slight modification. 9-phenyl-9-
borabicyclo[3.3.1]nonane (S-5) (51.5 mg, 0.26 mmol, 1.30 equiv.) was synthesized 
independently as mentioned above, diluted with 0.5 mL THF, and to it was added halide-
free vinyllithium in THF (0.16 mL, 1.38 M, 0.22 mmol, 1.10 equiv.), a solution of NiBr2-
glyme (2.20 mg, 0.010 mmol, 0.050 equiv.) and L3 (3.51 mg, 0.012 mmol, 0.060 equiv.) 
in THF (0.4 mL), followed by butanoyl chloride (21.3 mg, 0.20 mmol, 1.00 equiv.). The 
crude mixture was purified by column chromatography (20% EtOAc in hexanes, stain in 
KMnO4) to afford the product as a colorless oil (23.5 mg, 61% yield). 
 
1H NMR (400 MHz, CDCl3) δ 7.46-7.19 (m, 5H), 5.16 (dd, J = 8.7, 3.5 Hz, 1H), 3.38 (s, 
1H), 2.85 (dd, J = 17.4, 8.8 Hz, 1H), 2.78 (dd, J = 17.4, 3.6 Hz, 1H), 2.41 (t, J = 7.3 Hz, 
2H), 1.62 (h, J = 7.3 Hz, 2H), 0.92 (t, J = 7.3 Hz, 3H). 13CNMR (150 MHz, CDCl3) δ 
211.7, 143.0, 128.7, 127.8, 125.8, 70.1, 51.2, 45.7, 17.2, 13.8.  IR (neat) νmax 3400 (br, m), 
2961 (m), 1702 (s), 1494 (w), 1453 (m), 1370 (m), 1067 (m), 1030 (m), 757 (m), 701 (s) 
cm-1. HRMS (DART) for C12H20NO2 [M+H]
+: Calc’d: 210.1489, found: 210.1488. 
 
 10-(1,3-dioxan-2-yl)-6-hydroxydecan-4-one (23).  The 
reaction was performed according to the general procedure with 9-BBN in THF (0.52 mL, 
0.5 M, 0.26 mmol, 1.30 equiv.), S-3 (37.0 mg, 0.26 mmol, 1.30 equiv.), halide-free 
vinyllithium in THF (0.16 mL, 1.38 M, 0.22 mmol, 1.10 equiv.), a solution of NiBr2-glyme 
(3.09 mg, 0.010 mmol, 0.050 equiv.) and L3 (3.51 mg, 0.012 mmol, 0.060 equiv.) in THF 
(0.4 mL), butanoyl chloride (21.3 mg, 0.20 mmol, 1.00 equiv.). The crude mixture was 
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purified by column chromatography (20% EtOAc in hexanes, stain in KMnO4) to afford 
the product as a colorless oil (29.5 mg, 57% yield). 
 
1H NMR (500 MHz, CDCl3) δ 7.94 (d, J = 7.2 Hz, 2H), 7.57 (t, J = 7.5 Hz, 1H), 7.46 (t, J 
= 7.6 Hz, 2H), 4.51 (t, J = 5.1 Hz, 1H), 4.21 (m, 1H), 4.08 (dd, J = 10.7, 5.0 Hz, 2H), 3.74 
(td, J = 11.0, 2.0 Hz, 2H). 3.26 (m, 1H), 3.14 (dd, J = 17.5, 2.5 Hz, 1H), 3.02 (dd, J = 17.6, 
9.0 Hz, 1H), 2.11-2.01 (m, 1H), 1.67-1.56 (m, 3H), 1.55-1.47 (m, 2H), 1.46-1.35 (m, 3H), 
1.33-1.31 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 201.1, 136.9, 133.6, 128.8, 128.2, 
102.4, 67.8, 67.0, 45.1, 36.5, 35.3, 26.0, 25.6, 24.0. IR (neat) νmax 3454 (br, w), 2927 (w), 
2855 (w), 1678 (m), 1597 (w), 1580 (w), 1449 (w), 1431(w), 1404 (w), 1377 (w), 1283 
(w), 1240 (m), 1213 (m), 1181 (w), 1142 (s), 1092 (m), 993 (m), 936 (w), 894 (w), 864 
(w), 838 (w), 754 (m), 691 (m), 662 (w), 644 (w), 587 (w), 535 (w) cm-1. HRMS (DART) 
for C17H25O4 [M+H]
+: Calc’d: 293.1747, found: 293.1751. 
 
 methyl 7-hydroxy-5-oxo-10-phenyldecanoate 
(24). The reaction was performed according to the general procedure with 9-BBN in THF 
(0.52 mL, 0.5 M, 0.26 mmol, 1.30 equiv.), allylbenzene (30.7 mg, 0.26 mmol, 1.30 equiv.), 
halide-free vinyllithium in THF (0.16 mL, 1.38 M, 0.22 mmol, 1.10 equiv.), a solution of 
NiBr2-glyme (3.09 mg, 0.010 mmol, 0.050 equiv.) and L3 (3.51 mg, 0.012 mmol, 0.060 
equiv.) in THF (0.4 mL), methyl 5-chloro-5-oxopentanoate (32.9 mg, 0.20 mmol, 1.00 
equiv.). The crude mixture was purified by column chromatography (20% EtOAc in 
hexanes, stain in KMnO4) to afford the product as a colorless oil (47.4 mg, 81% yield).   
 
1H NMR (400 MHz, CDCl3) δ 7.27-7.22 (m, 2H), 7.18-7.13 (m, 3H), 4.07-3.98 (m, 1H), 
3.64 (s, 3H), 2.61 (t, J = 7.4 Hz, 2H), 2.57-2.43 (m, 4H), 2.31 (t, J = 7.4 Hz, 2H), 1.87 (p, 
J = 7.2 Hz, 2H), 1.80-1.71 (m, 1H), 1.70-1.57 (m, 1H), 1.56-1.46 (m, 1H), 1.45-1.34 (m, 
1H) .13C NMR (126 MHz, CDCl3) δ 211.2, 173.6, 142.3, 128.5, 128.4, 125.9, 77.5, 77.2, 
76.8, 67.6, 51.7, 49.2, 42.4, 36.1, 35.8, 33.0, 27.3, 18.7. IR (neat) νmax 3407 (br, w), 2937 
(m), 1734 (s), 1710 (m), 1603 (w), 1172 (m), 1086 (m), 750 (m), 701 (m) cm-1. HRMS 
(DART) for C17H25O4 [M+H-H2O]













anti-3-hydroxy-2-methyl-1,5-diphenylpentan-1-one (29). In a glovebox, under argon, an 
oven-dried 2-dram vial equipped with a magnetic stir bar was charged with a solution of 
9-BBN in THF (0.52 mL, 0.5 M, 0.26 mmol, 1.30 equiv.). The vial was cooled to 0℃, and 
styrene (27.1 mg, 0.26 mmol, 1.30 equiv.) was added. The reaction mixture was allowed 
to warm to room temperature and stir for 3 hours before being cooled back to 0℃.  A 
solution of vinyllithium (for synthesis of halide free vinyllithium see ref1) in THF (0.16 
mL, 1.38 M, 0.22 mmol, 1.10 equiv.) was added to the reaction mixture which was then 
warmed to room temperature and stirred for 5 minutes. Meanwhile a solution of NiBr2-
glyme (3.09 mg, 0.010 mmol, 0.050 equiv.) and L3 (see ref10 for its synthesis) (3.51mg, 
0.012 mmol, 0.060 equiv.) in THF (0.4 mL) was allowed to complex for 5 minutes under 
inert atmosphere. The catalyst solution was added to the boron ‘ate’ mixture at room 
temperature followed by addition of benzoyl chloride (28.1 mg, 0.20 mmol, 1.00 equiv.). 
The reaction vial was sealed with a septum cap, taken out of the glovebox and stirred at 
room temperature for 1h, after which point the reaction mixture was cooled to -78℃ and 
methyllithium in Et2O (0.15 mL, 1.6M, 0.24 mmol, 1.2 equiv.) was added dropwise 
through a syringe under inert atmosphere. The reaction mixture was allowed to warm up 
to 0℃ and stir for 30 minutes. After cooling the reaction mixture back to -78℃, 
iodomethane (113 mg, 0.60 mmol, 4.0 equiv.) was added dropwise. The reaction mixture 
was then warmed up to room temperature and stir for 2 hours. After cooling the reaction 
mixture to 0℃, 30% H2O2 (0.5 mL) was added along with pH=7 buffer solution (0.5 mL). 
The reaction mixture was allowed to warm up to room temperature and stir for 3 hours. 
Aq. saturated Na2S2O3 (1 mL) solution was then added to quench the remaining H2O2. The 
aqueous phase was EtOAc (3 x 2 mL). The combined organic layers were dried over 
MgSO4, filtered, concentrated under reduced pressure, and the crude mixture was purified 
by 2 runs of column chromatography (1st: 20% EtOAc in hexane, 2nd: 100% chloroform, 








1H NMR (600 MHz, CDCl3) δ 7.94 (d, J = 7.0 Hz, 2H), 7.58 (t, J = 7.2 Hz, 1H), 7.48 (t, J 
=  7.8 Hz, 2H), 7.29-7.25 (m, 3H), 7.22-7.16 (m, 2H), 3.93-3.85 (m, 1H), 3.59-3.52 (m, 
1H), 3.04 (d, J = 7.1 Hz, 1H), 2.96-2.88(m, 1H), 2.75-2.69 (m, 1H), 1.91-1.78 (m, 1H), 
1.27 (d, J = 7.2 Hz, 3H). 13C NMR (150 MHz, CDCl3) δ 206.0, 142.2, 136.7, 133.6, 128.9, 
128.6, 128.54, 128.52, 126.0, 73.6, 45.9, 37.0, 32.3, 29.9, 15.8. IR (neat) νmax 3489 (br, m), 
2927 (m), 1678 (s), 1596 (w), 1496 (m), 1454 (m), 1376 (w), 1210 (m), 972 (m), 702 (s) 
cm-1. HRMS (DART) for C18H21O2 [M+H]
+: Calc’d: 269.1542, found: 269.1536.  
 
The relative stereochemistry of the product was deteremined by comparison of 1H NMR 
spectrum with diastereochemically-enriched authentic sample prepared according to the 




Table S2. Survey of Base for Boron-Enolate Alkylation 
 
 
Base                         29 (%)               S-6 (%) 
iPrLi (1.7M pentane solution)  17%                            0% 
nBuLi (2.6M hexane solution)  39%                            0% 
MeLi (1.42M Et2O solution)  45%                            0% 
LDA  0%                              62% 
iPr2NEt  0%                              58% 
 
The formation of S-10 is presumably due to the inefficient deprotonation of 28 and its 
subsequent oxidation.  
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(31). In a glovebox, under argon, an oven-dried 2-dram vial equipped with a magnetic stir 
bar was charged with a solution of 9-BBN in THF (0.52 mL, 0.5 M, 0.26 mmol, 1.30 
equiv.). The vial was cooled to 0℃, and cyclohexene (21.4 mg, 0.26 mmol, 1.30 equiv.) 
was added. The reaction mixture was allowed to heat up to 60oC and stir for 3 hours before 
being cooled back to 0℃.  A solution of vinyllithium (for synthesis of halide free 
vinyllithium see ref1) in THF (0.16 mL, 1.38 M, 0.22 mmol, 1.10 equiv.) was added to the 
reaction mixture which was then warmed to room temperature and stirred for 5 minutes. 
Meanwhile a solution of NiBr2-glyme (3.09 mg, 0.010 mmol, 0.050 equiv.) and L3 (see 
ref10 for its synthesis) (0.012 mmol, 0.060 equiv.) in THF (0.4 mL) was allowed to complex 
for 5 minutes under inert atmosphere. The catalyst solution was added to the boron ‘ate’ 
mixture at room temperature followed by addition of cyclohexanecarbonyl chloride (29.3 
mg, 0.20 mmol, 1.00 equiv.).  The reaction vial was sealed with a septum cap, taken out of 
the glovebox and stirred at room temperature for 1h, after which point the reaction mixture 
was cooled to 0℃ and 40% methylamine aqueous solution (1 mL) was added. The reaction 
mixture was allowed to warm up to room temperature and stirred for 1h. The aqueous phase 
was EtOAc (3 x 2 mL). The combined organic layers were dried over MgSO4, filtered, 
concentrated under reduced pressure, and subsequently purified via silica gel column 
chromatography (20% CH2Cl2 in hexanes, stain in KMnO4) to provide 31 as a white solid 
(55.4 mg, 78%).  
 
1H NMR (400 MHz, CDCl3) δ 3.28 (s, 3H), 2.61-2.51 (m, 1H), 2.50-2.37 (m, 2H), 2.30-
2.18 (m, 1H), 2.10-1.94 (m, 1H), 1.93-0.98 (m, 31H), 0.94 (s, 1H), 0.39 (qd, J = 12.3, 3.6 
Hz, 1H), 0.31 (s, 1H) .13C NMR (126 MHz, CDCl3) δ 189.1, 40.4, 37.7, 36.9, 35.8, 35.1, 
34.3, 33.2, 31.9, 30.8, 30.7, 29.5, 29.4, 27.4, 27.3, 27.2, 26.0, 25.9, 25.8, 25.2, 24.2. IR 
(neat) νmax 2917 (s), 2840 (s), 1637 (m), 1447 (m), 1332 (w), 1029 (m), 905 (s), 734 (s) cm
-
1. HRMS (DART) for C24H43BN [M+H]
+: Calc’d: 356.3483, found: 356.3489. 
 
The structure was characterized by X-ray crystallography. Crystals were grown by slow 
evaporation with Et2O in a 1-dram vial at room temperature.  
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one (S-9).  In a glovebox, under argon, an oven-dried 2-dram vial equipped with a magnetic 
stir bar was charged with a solution of 9-BBN in THF (0.52 mL, 0.5 M, 0.26 mmol, 1.30 
equiv.). The vial was cooled to 0 ℃, and cyclohexene (21.4 mg, 0.26 mmol, 1.30 equiv.) 
was added via syringe. The reaction mixture was heated to 60 oC and stir for 3 hours before 
being cooled back to 0 ℃.  A solution of vinyllithium (for synthesis of halide free 
vinyllithium see ref1) in THF (0.16 mL, 1.38 M, 0.22 mmol, 1.10 equiv.) was added to the 
reaction mixture which was then warmed to room temperature and stirred for 5 minutes. 
Meanwhile a solution of NiBr2-glyme (0.010 mmol, 0.050 equiv.) and L3 (see ref
10 for its 
synthesis) (3.51 mg, 0.012 mmol, 0.060 equiv.) in THF (0.4 mL) was allowed to complex 
for 5 minutes under inert atmosphere. The catalyst solution was added to the boron ‘ate’ 
mixture at room temperature followed by addition of benzoyl chloride (28.1 mg, 0.20 
mmol, 1.00 equiv.). The reaction vial was sealed with a septum cap, taken out of the 
glovebox and stirred at room temperature for 1h. The crude mixture was concentrated in 
vacuo and purified by silica gel column chromatography (20% CH2Cl2 in hexane, stain in 
KMnO4) to afford the product as a yellow oil (37.0 mg, 55% yield). 
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1H NMR (500 MHz, CDCl3) δ 8.13 (d, J = 8.1 Hz, 2H), 7,74 (t, J = 7.5 Hz, 1H), 7.56 (t, J 
= 8.1 Hz, 2H), 3.48 (d, J = 19.4 Hz, 1H), 3.15 (dd, J = 19.4, 8.3 Hz, 1H), 2.06-1.87 (m, 
4H), 1.80-1.12 (m, 18H), 1.02-0.92 (m, 1H), 0.89-0.77 (m, 2H), 0.37 (dq, J = 12.2, 3.5 Hz, 
1H). 13C NMR (150 MHz, CDCl3) δ 212.9, 136.4, 131.2, 130.9, 129.4, 40.0, 38.1, 33.5, 
33.2, 32.6, 30.1, 27.2, 26.82, 26.77, 25.1. 11B NMR (150 MHz, CDCl3) δ 21.5. IR (neat) 
νmax 2917 (s), 2840 (s), 1637 (m), 1447 (m), 1332 (w), 1029 (m), 905 (s), 734 (s) cm
-1. 
HRMS (DART) for C23H34BO [M+H]
+: Calc’d: 337.2697, found: 337.2700. 
 
The resonances of the two diastereotopic protons adjacent to the carbonyl group in 1H 
NMR are identified by a series of COESY NMR and 1D NOESY NMR analysis presented 
below.   
 
From COESY NMR spectrum, it is clearly seen that the proton with resonance at 3.15 ppm 
couples with Hc with a resonance at 1.28 ppm, whereas the resonance at 3.48 ppm shows 
no appreciable   coupling with Hc. Therefore, it is determined that the 3.15 ppm resonance 
corresponds to Hb while the 3.48 ppm resonance corresponds to Ha. 
  




NOESY NMR was also carried out to support the findings about the resonances of the two 
diasterotopic protons. Selective irradiation of the resonance at 3.15 ppm led to NOE of Hc 
with resonance at 1.28ppm, whereas selective irradiation of the resonance at 3.48 ppm led 
to no observable NOE of Hc.  
 
1D-NOESY NMR of S-9 (selective irradiation at 3.15 ppm) 
                  
 
1D-NOESY NMR of S-9 (selective irradiation at 3.48 ppm) 




phenylpropan-1-one-2-d (26).  The reaction was performed according to the procedure 
for synthesis of S-7 with 9-BBN in THF (0.52 mL, 0.5 M, 0.26 mmol, 1.30 equiv.), 
cyclohexene (21.4 mg, 0.26 mmol, 1.30 equiv.), deuterium labeled vinyl lithium in THF 
(0.27 mL, 0.82 M, 0.22 mmol, 1.10 equiv.), a solution of NiBr2-glyme (3.09 mg, 0.010 
mmol, 0.050 equiv.) and L3 (3.51 mg, 0.012 mmol, 0.060 equiv.) in THF (0.4 mL), benzoyl 
chloride (28.1 mg, 0.20 mmol, 1.00 equiv.). The crude mixture was purified by column 
chromatography (20% CH2Cl2 in hexane, stain in KMnO4) to afford the product as a yellow 
oil (21.1 mg, 30% yield). 
 
1H NMR (500 MHz, CDCl3) δ 7.57 (d, J = 7.8 Hz, 2H), 7,75 (t, J = 7.5 Hz, 1H), 7.57 (t, J 
= 7.8 Hz, 2H), 3.48 (s, 1H), 2.13-1.88 (m, 3H), 1.81-1.40 (m, 3H), 1.36-1.11 (m, 5H), 1.04-
0.94 (m, 1H), 0.91-0.71 (m, 2H), 0.37 (dq, J = 12.2, 3.4 Hz, 1H).13C NMR (126 MHz, 
CDCl3) δ 213.0, 136.4, 131.3, 130.9, 129.4, 38.1, 33.50, 33.48, 32.6, 30.22, 30.15, 27.2, 
26.83, 26.77, 25.1. 11B NMR (150 MHz, CDCl3) δ 21.5. IR (neat) νmax 2922 (s), 2852 (m), 
1679 (m), 1598 (w), 1447 (s), 1272 (m), 1206 (m), 746 (s), 689 (s), 651 (w) cm-1.  
 
The relative stereochemistry was determined by comparison of its 1H NMR spectrum with 




2.5.2.7 Stoichiometric Experiments 
 
 Ni(II) oxidative addition complex (27). The title compound was 
prepared according to the procedure reported by Gong with slight modifications.43 In an 
argon filled glovebox, to an oven-dried scintillation vial was added Ni(COD)2 (248 mg, 
0.90 mmol, 1.0 equiv.) and Et2O (4 mL). The reaction mixture was allowed to stir for 
0.5h at room temperature at which point 4,4'-di-tert-butyl-2,2'-bipyridine (341 mg, 0.90 
mmol, 1.0 equiv.) in Et2O (4 mL) was added dropwise. The resulting mixture was 
allowed to stir at room temperature, at which point, a solution of iso-butyryl chloride 
(96.0 mg, 0.90 mmol, 1.0 equiv.) in Et2O (1 mL) was added via a syringe. The mixture 
was allowed to stir for 1h. The suspension was then allowed to settle down and the 
supernatant was removed via syringe leaving behind red solid which was triturated with 
Et2O (2 mL x 4). The red solid was then dried under vacuum, affording 27 (351 mg, 
90%). All spectral data was in accordance with the literature.13 
 
1H NMR (500 MHz, DMF-d7) δ 8.99 (br s, 1H), 8.72 (br s, 2H), 8.21 (br s, 1H), 7.88 (d, J 
= 40.3 Hz, 2H), 3.49 (s, 1H), 1.58 (s, 18H), 1.47 (s, 6H). 13C NMR (150 MHz, DMF-d7) δ 
260.0, 164.2, 163.3, 155.3, 152.2, 150.6, 148.0, 124.2, 123.2, 119.9, 118.7, 45.2, 35.6, 18.5.   
 




In a glovebox, under argon, an oven-dried 2-dram vial equipped with a magnetic stir bar 
was charged with a solution of 9-BBN in THF (0.40 mL, 0.5 M, 0.20 mmol, 1.00 equiv.). 
The vial was cooled to 0℃, and allylbenzene (23.6 mg, 0.20 mmol, 1.00 equiv.) was added. 
The reaction mixture was allowed to warm to room temperature and stir for 3 hours before 
being cooled back to 0℃.  A solution of vinyllithium (for synthesis of halide free 
                                                 
43 C. Zhao, J. Xiao, X. Wang, H. Gong, J. Am. Chem. Soc. 2014, 136, 17645. 
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vinyllithium see ref1) in THF (0.15 mL, 1.38 M, 0.22 mmol, 1.00 equiv.) was added to the 
reaction mixture which was then warmed to room temperature and stirred for 5 minutes. 
To the vial was added 27 (86.7 mg, 0.20 mmol, 1.0 equiv.) in one portion at room 
temperature. The reaction vial was sealed with a septum cap, taken out of the glovebox and 
stirred at room temperature for 1h, after which point the reaction mixture was cooled to 
0℃ and 30% H2O2 (0.5 mL) were added along with 3 M NaOH (0.5 mL). The reaction 
mixture was allowed to warm up to room temperature and stirred for 3 hours. Aq. saturated 
Na2S2O3 (1 mL) solution was then added to quench the reaction. The aqueous phase was 
EtOAc (3 x 2 mL). The combined organic layers were dried over MgSO4, filtered, 
concentrated under reduced pressure, and subsequently purified via silica gel column 































2.5.2.8 Experiments with Chiral Bis(oxazoline) Ligands 
 
 
In a glovebox, under argon, an oven-dried 2-dram vial equipped with a magnetic stir bar 
was charged with a solution of 9-BBN in THF (0.52 mL, 0.5 M, 0.26 mmol, 1.30 equiv.). 
The vial was cooled to 0℃, and the olefin (0.26 mmol, 1.30 equiv.) was added via syringe. 
The reaction mixture was allowed to warm to room temperature and stir for 3 hours before 
being cooled back to 0℃.  A solution of vinyllithium (for synthesis of halide free 
vinyllithium see ref1) in THF (0.16 mL, 1.38 M, 0.22 mmol, 1.10 equiv.) was added to the 
reaction mixture which was then warmed to room temperature and stirred for 5 minutes. 
Meanwhile a solution of NiBr2-glyme (3.09 mg, 0.010 mmol, 0.050 equiv.) and L6 (0.012 
mmol, 0.060 equiv.) in THF (0.4 mL) was allowed to complex for 5 minutes under inert 
atmosphere. The catalyst solution was added to the boron ‘ate’ mixture at room temperature 
followed by addition of acyl chloride (0.20 mmol, 1.00 equiv.) The reaction vial was sealed 
with a septum cap, taken out of the glovebox and stirred at room temperature for 1h, after 
which point the reaction mixture was cooled to 0℃ and 30% H2O2 (0.5 mL) were added 
along with 3 M NaOH (0.5 mL). The reaction mixture was allowed to warm up to room 
temperature and stirred for 3 hours. Aq. saturated Na2S2O3 (1 mL) solution was then added 
to quench the reaction. The aqueous phase was EtOAc (3 x 2 mL). The combined organic 
layers were dried over MgSO4, filtered, concentrated under reduced pressure, and 
subsequently purified via silica gel column chromatography to provide the desired 
products. 
 
 3-hydroxy-1,6-diphenylhexan-1-one (10). The reaction 
was performed according to the general procedure with 9-BBN in THF (0.52 mL, 0.5 M, 
0.26 mmol, 1.30 equiv.), allylbenzene (30.7 mg, 0.26 mmol, 1.30 equiv.), halide-free 
vinyllithium in THF (0.16 mL, 1.38 M, 0.22 mmol, 1.10 equiv.), a solution of NiBr2-glyme 
(3.09 mg, 0.010 mmol, 0.050 equiv.) and L6 (0.012 mmol, 0.060 equiv.) in THF (0.4 mL), 
benzoyl chloride (28.1 mg, 0.20 mmol, 1.00 equiv.). The crude mixture was purified by 
column chromatography (20% EtOAc in hexanes, stain in KMnO4) to afford the product 
as a colorless oil (19.3 mg, 36% yield). Its corresponding spectral data can be found above 
in the section “Characterization of Conjunctive Cross Coupling Products”.  
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Enantioselectivity was determined by chiral SFC. Racemic compound was prepared 
according to the general procedure with L3 (6 mol%) as the ligand.  
 
Chiral SFC (Chiracel AS-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-289 nm) 
 
                       Racemic material                                           Enantioenriched material 
         
 
 6-hydroxy-9-phenylnonan-4-one (3). The reaction was 
performed according to the general procedure with 9-BBN in THF (0.52 mL, 0.5 M, 0.26 
mmol, 1.30 equiv.), allylbenzene (30.7 mg, 0.26 mmol, 1.30 equiv.), halide-free 
vinyllithium in THF (0.16 mL, 1.38 M, 0.22 mmol, 1.10 equiv.), a solution of NiBr2-glyme 
(3.09 mg, 0.010 mmol, 0.050 equiv.) and L6 (0.012 mmol, 0.060 equiv.) in THF (0.4 mL), 
butanoyl chloride (21.3 mg, 0.20 mmol, 1.00 equiv.).  The crude mixture was purified by 
column chromatography (20% EtOAc in hexanes, stain in KMnO4) to afford the product 
as a colorless oil (20.2 mg, 43% yield). Its corresponding spectral data can be found above 
in the section “Characterization of Conjunctive Cross Coupling Products”.  
 
Enantioselectivity was determined by chiral SFC. Racemic compound was prepared 








Chiral SFC (Chiracel AS-H, 2% IPA, 3 mL/min, 100 bar, 35 °C, 210-289 nm) 
 





 5-hydroxy-2,2-dimethyl-8-phenyloctan-3-one (7). The 
reaction was performed according to the general procedure with 9-BBN in THF (0.52 mL, 
0.5 M, 0.26 mmol, 1.30 equiv.), allylbenzene (30.7 mg, 0.26 mmol, 1.30 equiv.), halide-
free vinyllithium in THF (0.16 mL, 1.38 M, 0.22 mmol, 1.10 equiv.), a solution of NiBr2-
glyme (2.20 mg, 0.010 mmol, 0.050 equiv.) and L6 (0.012 mmol, 0.060 equiv.) in THF 
(0.4 mL), pivaloyl chloride (24.1 mg, 0.20 mmol, 1.00 equiv.). The crude mixture was 
purified by column chromatography (20% EtOAc in hexanes, stain in KMnO4) to afford 
the product as a colorless oil (13.4 mg, 27% yield). Its corresponding spectral data can be 
found above in the section “Characterization of Conjunctive Cross Coupling Products”.  
 
Enantioselectivity was determined by chiral SFC. Racemic compound was prepared 








Chiral SFC (Chiracel OJ-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-289 nm) 
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                       Racemic material                                           Enantioenriched material 
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Table 1.  Crystal data and structure refinement for C24H42BN. 
Identification code  C24H42BN 
Empirical formula  C24 H42 B N 
Formula weight  355.39 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  C2/c 
Unit cell dimensions a = 17.528(3) Å = 90°. 
 b = 9.8218(11) Å = 96.902(3)°. 
 c = 24.925(3) Å  = 90°. 
Volume 4259.8(9) Å3 
Z 8 
Density (calculated) 1.108 Mg/m3 
Absorption coefficient 0.062 mm-1 
F(000) 1584 
Crystal size 0.500 x 0.360 x 0.220 mm3 
Theta range for data collection 1.646 to 28.776°. 
Index ranges -23<=h<=23, -13<=k<=13, -33<=l<=33 
Reflections collected 46241 
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Independent reflections 5543 [R(int) = 0.0329] 
Completeness to theta = 25.242° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7458 and 0.7053 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5543 / 0 / 236 
Goodness-of-fit on F2 1.032 
Final R indices [I>2sigma(I)] R1 = 0.0416, wR2 = 0.1070 
R indices (all data) R1 = 0.0505, wR2 = 0.1137 
Extinction coefficient n/a 
Largest diff. peak and hole 0.387 and -0.225 e.Å-3 
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 Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for C24H42BN.  U(eq) is defined as one third of  the trace of the orthogonalized U ij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
N(1) 5451(1) 5931(1) 3711(1) 13(1) 
C(1) 4978(1) 6901(1) 3972(1) 18(1) 
C(2) 5929(1) 6309(1) 3385(1) 13(1) 
C(3) 6421(1) 5158(1) 3231(1) 14(1) 
C(4) 6335(1) 4019(1) 3645(1) 13(1) 
C(5) 6011(1) 7718(1) 3162(1) 16(1) 
C(6) 6100(1) 7651(1) 2555(1) 21(1) 
C(7) 6152(1) 9084(1) 2325(1) 28(1) 
C(8) 6828(1) 9858(1) 2623(1) 35(1) 
C(9) 6780(1) 9900(1) 3229(1) 32(1) 
C(10) 6700(1) 8478(1) 3467(1) 23(1) 
C(11) 6957(1) 4094(1) 4141(1) 14(1) 
C(12) 6958(1) 5424(1) 4466(1) 16(1) 
C(13) 7550(1) 5397(1) 4970(1) 18(1) 
C(14) 8356(1) 5150(1) 4819(1) 20(1) 
C(15) 8382(1) 3833(1) 4496(1) 22(1) 
C(16) 7774(1) 3827(1) 3999(1) 19(1) 
C(17) 5191(1) 3569(1) 4313(1) 14(1) 
C(18) 5306(1) 2015(1) 4253(1) 18(1) 
C(19) 4844(1) 1357(1) 3755(1) 20(1) 
C(20) 4858(1) 2161(1) 3226(1) 19(1) 
C(21) 4794(1) 3718(1) 3282(1) 15(1) 
C(22) 4361(1) 3905(1) 4415(1) 17(1) 
C(23) 3737(1) 3736(1) 3928(1) 19(1) 
C(24) 3978(1) 4158(1) 3378(1) 18(1) 
B(1) 5441(1) 4243(1) 3766(1) 13(1) 
________________________________________________________________________________ 
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 Table 3.   Bond lengths [Å] and angles [°] for  C24H42BN. 
_____________________________________________________  
N(1)-C(2)  1.2889(12) 
N(1)-C(1)  1.4663(12) 
N(1)-B(1)  1.6638(13) 
C(1)-H(1A)  0.9800 
C(1)-H(1B)  0.9800 
C(1)-H(1C)  0.9800 
C(2)-C(3)  1.5002(13) 
C(2)-C(5)  1.5051(13) 
C(3)-C(4)  1.5417(13) 
C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
C(4)-C(11)  1.5491(13) 
C(4)-B(1)  1.6463(14) 
C(4)-H(4)  1.0000 
C(5)-C(10)  1.5402(14) 
C(5)-C(6)  1.5406(14) 
C(5)-H(5)  1.0000 
C(6)-C(7)  1.5267(15) 
C(6)-H(6A)  0.9900 
C(6)-H(6B)  0.9900 
C(7)-C(8)  1.5230(18) 
C(7)-H(7A)  0.9900 
C(7)-H(7B)  0.9900 
C(8)-C(9)  1.523(2) 
C(8)-H(8A)  0.9900 
C(8)-H(8B)  0.9900 
C(9)-C(10)  1.5311(15) 
C(9)-H(9A)  0.9900 
C(9)-H(9B)  0.9900 
C(10)-H(10A)  0.9900 
C(10)-H(10B)  0.9900 
C(11)-C(12)  1.5375(13) 
C(11)-C(16)  1.5388(13) 
C(11)-H(11)  1.0000 
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C(12)-C(13)  1.5290(13) 
C(12)-H(12A)  0.9900 
C(12)-H(12B)  0.9900 
C(13)-C(14)  1.5237(15) 
C(13)-H(13A)  0.9900 
C(13)-H(13B)  0.9900 
C(14)-C(15)  1.5274(15) 
C(14)-H(14A)  0.9900 
C(14)-H(14B)  0.9900 
C(15)-C(16)  1.5341(14) 
C(15)-H(15A)  0.9900 
C(15)-H(15B)  0.9900 
C(16)-H(16A)  0.9900 
C(16)-H(16B)  0.9900 
C(17)-C(22)  1.5428(13) 
C(17)-C(18)  1.5493(14) 
C(17)-B(1)  1.6225(14) 
C(17)-H(17)  1.0000 
C(18)-C(19)  1.5406(14) 
C(18)-H(18A)  0.9900 
C(18)-H(18B)  0.9900 
C(19)-C(20)  1.5382(14) 
C(19)-H(19A)  0.9900 
C(19)-H(19B)  0.9900 
C(20)-C(21)  1.5415(14) 
C(20)-H(20A)  0.9900 
C(20)-H(20B)  0.9900 
C(21)-C(24)  1.5387(14) 
C(21)-B(1)  1.6364(14) 
C(21)-H(21)  1.0000 
C(22)-C(23)  1.5426(14) 
C(22)-H(22A)  0.9900 
C(22)-H(22B)  0.9900 
C(23)-C(24)  1.5392(14) 
C(23)-H(23A)  0.9900 
C(23)-H(23B)  0.9900 
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C(24)-H(24A)  0.9900 











































































































































































Table 4.   Anisotropic displacement parameters  (Å2x 103) for C24H42BN.  The anisotropic 
displacement factor exponent takes the form:  -22[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
N(1) 14(1)  12(1) 13(1)  -1(1) 1(1)  1(1) 
C(1) 20(1)  15(1) 20(1)  -2(1) 6(1)  3(1) 
C(2) 14(1)  13(1) 12(1)  0(1) -2(1)  0(1) 
C(3) 16(1)  15(1) 13(1)  1(1) 3(1)  1(1) 
C(4) 16(1)  11(1) 12(1)  -1(1) 2(1)  1(1) 
C(5) 13(1)  14(1) 19(1)  4(1) 1(1)  0(1) 
C(6) 20(1)  23(1) 21(1)  8(1) 4(1)  3(1) 
C(7) 21(1)  28(1) 34(1)  19(1) 5(1)  4(1) 
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C(8) 18(1)  28(1) 58(1)  26(1) 4(1)  0(1) 
C(9) 21(1)  16(1) 55(1)  10(1) -6(1)  -4(1) 
C(10) 20(1)  15(1) 31(1)  4(1) -5(1)  -2(1) 
C(11) 15(1)  14(1) 14(1)  2(1) 2(1)  2(1) 
C(12) 15(1)  17(1) 14(1)  0(1) 1(1)  2(1) 
C(13) 20(1)  21(1) 14(1)  0(1) -1(1)  0(1) 
C(14) 16(1)  22(1) 21(1)  3(1) -2(1)  0(1) 
C(15) 17(1)  23(1) 25(1)  2(1) -1(1)  5(1) 
C(16) 17(1)  21(1) 20(1)  -1(1) 3(1)  5(1) 
C(17) 16(1)  15(1) 11(1)  0(1) 1(1)  -2(1) 
C(18) 21(1)  16(1) 17(1)  4(1) 2(1)  -1(1) 
C(19) 25(1)  14(1) 21(1)  -1(1) 2(1)  -3(1) 
C(20) 23(1)  17(1) 16(1)  -4(1) 1(1)  -2(1) 
C(21) 18(1)  16(1) 11(1)  0(1) 2(1)  -1(1) 
C(22) 18(1)  21(1) 14(1)  -1(1) 4(1)  -2(1) 
C(23) 16(1)  24(1) 18(1)  1(1) 3(1)  -1(1) 
C(24) 16(1)  22(1) 15(1)  2(1) -1(1)  -1(1) 
B(1) 15(1)  11(1) 12(1)  0(1) 1(1)  0(1) 
______________________________________________________________________________ 
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 Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for C24H42BN. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(1A) 5152 7830 3911 27 
H(1B) 5026 6717 4361 27 
H(1C) 4439 6804 3818 27 
H(3A) 6965 5449 3247 17 
H(3B) 6245 4840 2859 17 
H(4) 6376 3118 3463 16 
H(5) 5533 8242 3206 19 
H(6A) 6571 7134 2503 25 
H(6B) 5654 7170 2360 25 
H(7A) 6215 9027 1937 33 
H(7B) 5670 9583 2360 33 
H(8A) 6833 10799 2482 42 
H(8B) 7314 9412 2556 42 
H(9A) 6333 10461 3299 38 
H(9B) 7249 10339 3413 38 
H(10A) 6627 8557 3854 27 
H(10B) 7176 7952 3442 27 
H(11) 6840 3346 4390 17 
H(12A) 7074 6196 4233 19 
H(12B) 6441 5574 4576 19 
H(13A) 7538 6276 5163 22 
H(13B) 7416 4666 5216 22 
H(14A) 8724 5092 5152 24 
H(14B) 8509 5924 4601 24 
H(15A) 8293 3049 4730 26 
H(15B) 8898 3728 4379 26 
H(16A) 7785 2934 3816 23 
H(16B) 7907 4534 3742 23 
H(17) 5550 3900 4628 17 
H(18A) 5859 1839 4237 21 
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H(18B) 5163 1560 4581 21 
H(19A) 5052 434 3705 24 
H(19B) 4304 1254 3826 24 
H(20A) 4429 1841 2962 22 
H(20B) 5343 1950 3077 22 
H(21) 4911 4141 2936 18 
H(22A) 4225 3314 4711 21 
H(22B) 4348 4859 4543 21 
H(23A) 3576 2770 3906 23 
H(23B) 3283 4283 3995 23 
H(24A) 3608 3765 3088 22 
H(24B) 3943 5162 3346 22 
________________________________________________________________________________ 
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Symmetry transformations used to generate equivalent atoms:  
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3. Alkyl Group Migration in Ni-Catalyzed Conjunctive Coupling Reaction with 
C(sp3) Electrophiles 
3.1 Introduction 
Chiral organoboronic esters are a widely used class of chemicals in modern 
chemistry as they can be transformed into various functional groups in a stereospecific 
fashion44 (Scheme 3.1).  
 
Scheme 3.1: Some examples of stereospecific transformations of organoboronates 
 
                                                 
44 Sandford, C.; Aggarwal, V. K. Chem. Comm. 2017, 53, 5481. 
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Therefore, enantioselective methods to synthesize non-racemic alkyl boronates 
are highly desirable to many organic chemists.45 There are many literature precedents for 
the preparation of secondary boronic esters in catalytic and enantioselective fashion, such 
as hydroboration of an alkene. 
However, there are synthetic challenges. In many enantioselective catalytic 
methods for the preparation of secondary boronic esters, a directing group or functional 
group at a specific location of the substrate is required to achieve regioselectivity or 
enantioselectivity. To our knowledge, there is only one precedent, reported by Fu and 
coworkers, where there isn’t the requirement for specialized substrate.46  
  
                                                 
45 Collins, B. S. L; Wilson, C. M.; Myers, E. L., Aggarwal, V. K. Angew. Chem. Int. Ed. 
2017, 56, 11700. 
46 Schmidt, J.; Choi, J.; Liu, A. T.; Slusarczyk, M.; Fu, G. C. Science 2016, 354, 1265. 
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3.2 Background 
One method to prepare secondary enantioenriched boronic esters by regio- and 
enantioselective copper catalyzed hydroboration was reported by the Hartwig group.47 
This reaction can yield enantioenriched secondary boronic ester in 80% yield, 97% e.e. 
and 9.6 : 1 r.r. However, according to authors, changing the electronic nature of the 
benzoyl group would affect the regioselectivity of the hydroboration. For instance, with 
p-OMe benzoyl group, regioselectivity of the reaction is diminished to 5.8 : 1 r.r. This 
observation hints that the regioselectivity depends on the electronic bias of the parent 
alkene and is therefore substrate dependent. 
 
Scheme 3.2: Regio- and enantioselective Cu-catalyzed hydroboration of alkenes 
 
                                                 
47 Xi, Y.; Hartwig, J. F. J. Am. Chem. Soc. 2016, 138, 6703. 
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Scheme 3.3: Enantioconvergent Ni-catalyzed Negishi coupling reaction 
 
In a separate study, Fu and coworkers reported a method to produce 
enantioenriched secondary boronic esters.4545 In a stereoconvergent manner, 
enantioenriched secondary organoboronic esters were synthesized from racemic -halo 
boronates as the starting material.  The -chloroboronate can be prepared as a racemic 
mixture from a primary alkylboronate by Matteson homologation reaction.48 It is notable 
that this approach is modular and is not limited to a specialized set of substrates. 
 
Scheme 3.4: Ni-catalyzed enantioselective conjunctive coupling reaction with C(sp3) 
electrophiles 
 
After the initial report of conjunctive coupling reaction in 2016 with palladium 
catalyst,49 the Morken group also reported the conjunctive coupling reaction with C(sp3) 
                                                 
48 Matteson, D. S.; Majumdar, D. J. Am. Chem. Soc. 1980, 102, 7588 
49 Zhang, L.; Lovinger, G. J.; Edelstein, E. K.; Szymaniak, A. A.; Chierchia, M. P.; 
Morken, J. P. Science 2016, 351, 70. 
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electrophiles50 (Scheme 3.4). In the presence of a nickel catalyst, a boron ate complex 
derived from arylB(pin) and vinyllithium can undergo a 1,2-metallate rearrangement 
across the olefin in an anti-fashion and cross-couple to a C(sp3) electrophile to generate 
enantioenriched secondary boronic esters as products. A limitation to this process is that 
using alkyl migrating groups with C(sp3) electrophiles were low yielding. We sought to 
address this challenge as it can be used to prepare secondary boronic esters with various 
chain lengths in an enantioselective and regioselective fashion. 
3.3 Development of C(sp3)-C(sp3) Conjunctive Coupling Reaction51 
3.3.1 Initial Experiments and Optimization 
Our initial investigation started with the use of the boron ate complex derived 
from vinylB(pin) and n-butyllithium, and used iodopropylbenzene as the electrophile. 
The nickel/pybox catalyst complex reported in the previous report from our group4950 
(Scheme 3.5, (a)) was also employed. While this reaction was very poor yielding (4% 
yield), enantioselectivity was good at 99:1 e.r. Investigation of the byproducts revealed 
that O-alkylated product such as 3.152 was one of the byproduct as well as presence of 
Suzuki product such as 3.2 (Scheme 3.5, (b)). 
 
                                                 
50 Lovinger, G. J; Morken, J. P. J. Am. Chem. Soc. 2017, 139, 17293. 
51 Koo, S. M.; Vendola, A. J.; Momm, S. N.; Morken, J. P. Org. Lett. 2020, 22, 666. 
52 Proposed to form from (i) the nucloephilic SN2 reaction between the pinacolato boron 
ate complex and alkyliodide electrophile, or (ii) nucleophilic displacement of nickel-
electrophile adduct by pinacolato boron ate complex, followed by reductive elimination. 
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Scheme 3.5: (a) Results of initial investigation. (b) Undesired side products 
 
After the preliminary analysis, it was hypothesized that the steric environment as 
well as the nucleophilicity of the boron ate complex may be crucial for the reaction 
efficiency, we sought to change the nature of the boron ligands. Therefore, pinacol, 
neopentylglycol, and mac53 (methylated acenaphoquinone) diol were investigated 
(Scheme 3.6). The yield of the product was increased significantly to 41%, with the mac 
ligand on boron. The improvement may be because the mac ligand is less nucleophilic on 
the oxygen, and the mac ligand can provide enough steric environments to reduce the 
amount of transmetallation between the boron ate complex and the nickel catalyst, 
leading to Suzuki byproducts. 
 
 
                                                 
53 Myhill, J. A.; Wilhelmsen, C. A.; Zhang, L.; Morken, J. P. J. Am. Chem. Soc. 2018, 
140, 15181. 
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Scheme 3.6: Investigation of the ligand on boron 
  
Next, the ligand for the catalyst was examined. In comparison to Ph-PyBOx L1, 
other PyBOx ligands that were tested (methyl L2, isopropyl L3, indenyl L4, naphthyl L5, 
and o-chlorophenyl L6) showed substantially lower yields ranging between 3-24% 
(Scheme 3.7). Therefore, Ph-PyBOx was chosen as the ligand for nickel catalyst for 
further optimization studies. 
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Table 3.1: Additional optimization of the reaction conditions 
 
Nickel pre-catalysts such as Ni(COD)2, NiBr2-glyme, and Ni(acac)2 were 
surveyed but were lower yielding compared to the reaction with methallyl nickel chloride 
dimer (Table 3.1, entry 1-4). A variety of solvent mixtures were tested (Table 3.1, entry 
5-11), but only THF/DMSO mixture was able to improve the yield. The effects of DMSO 
are proposed as the following. i) DMSO may be able to sequester lithium cation and 
increase the nucleophilicity of the boron ate complex,54 or ii) DMSO may coordinate to 
                                                 
54 a) For effects of lithium cation sequestering by crown ether, see: Feeney, K.; Berionni, 
G.; Mayr, H.; Aggarwal, V. K. Org. Lett. 2015, 17, 2614. b) For an example of lithium-
DMSO interaction, see:  Eldik, R. V.; et. al. ChemPhysChem 2007, 8, 1315. 
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nickel and change the electronic nature of the catalyst.55 Lastly, by changing the ratio for 
the boron ate complex, where an excess boronic ester is introduced, the reaction yield 
was improved (Table 3.1, entry 12). The reason for the increased yield is proposed that 
any excess organolithium added during the boron ate formation is detrimental to the 
reaction efficiency, and by introducing additional boronic ester, that situation can be 
avoided. 
 
Scheme 3.8: Effects of mac ligand modifications   
 
After obtaining workable reaction conditions, an additional set of experiments 
were done to see if the mac ligand can be tuned further to increase the yield (Scheme 
3.8). Methyl substitution on the naphthyl ring were considered and o-dimethyl and m-
dimethyl mac were prepared. For both o- and m-dimethyl mac ligands, yields were 
similar. However, the drop in enantioselectivity for o-dimethyl mac indicates that the 
                                                 
55 Calculated value for the coordinating ability to transition metals of DMSO (0.3) is 
higher than that of THF (-0.3). Diaz-Torres, R.; Alvarez, S. Dalton Trans. 2011, 40, 
10742. 
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steric conjestion presents challenge. With m-dimethyl mac, yield is less affected, but a 
slight loss of enantioselectivity at 98.5:1.5 e.r. was observed.  
 
Scheme 3.9: Survey of additional ligands similar to Ph-PyBOx as the ligand for 
nickel catalyst 
 A further study of PyBOx ligands revealed that Ph-PyBOx L1 and 3,5-
dimethylphenyl-PyBOx L7 are the most competent amongst the ligands tested so far 
(Scheme 3.9). PyBOx ligands with substitution on 4-position of the pyridine ring with Cl 
L8, or CF3 group L9 diminished the yields. 3,5-dimethylphenyl-PyBOx L7 is able to 
yield 3-5% more product than with Ph-PyBOx L1. Although improvement in yield was 
observed, due to the fact that synthesis of 3,5-dimethylphenyl-PyBOx L750 requires a 





Table 3.2: Optimization for a more reproducible conjunctive coupling reaction 
 
During the optimization efforts, it was discovered that the reaction was not 
reproducible. We hypothesized that the issue originated from poor solubility of nickel 
pre-catalyst in THF, as well as the temperature dependent stability of methallyl nickel 
chloride dimer as the nickel pre-catalyst. In order to see if the issue can be circumvented, 
we investigated whether a more stable nickel pre-catalyst such as [(TMEDA)Ni(o-
Tol)Cl]56 could render the reaction to be more reliable. [(TMEDA)Ni(o-Tol)Cl] is bench 
stable and can be kept at room temperature, while methallyl nickel chloride dimer is 
moisture, and  air sensitive, and requires refrigeration for storage. Compared to methallyl 
nickel chloride dimer, reaction with [(TMEDA)Ni(o-Tol)Cl] was more reproducible at 
55% yield, with 99:1 e.r. (Table 3.2, entry 2). Upon lowering the reaction temperature to 
room temperature from 60 °C, we were pleased to find the reactivity improved and 
oxidized product 3 was obtained in 65% yield, with >99:1 e.r. This was the reaction 
condition used for the substrate scope investigation (Table 3.2, entry 3). 
 
  
                                                 
56 Shields, J. D.; Gray, E. E.; Doyle, A. G. Org. Lett. 2015, 17, 2166. 
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3.3.2 Substrate scope 
Scheme 3.10: Substrate scope of the nickel-catalyzed conjunctive coupling reaction 
of alkyl migrating group and C(sp3) electrophiles 
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With optimized condition in hand, the scope of the reaction was investigated 
(Scheme 3.10). The boron ate complex, can be prepared either from organolithium and 
vinylB(mac) (method A), or from alkylB(mac) and vinyllithium (method B). Results 
show that a variety of functional groups were compatible. Except for a few substrates, the 
products obtained demonstrated very high levels of enantioselectivity of 99:1 e.r. or 
higher. Substrate investigation revealed alkene, ether, ketal, and carbamate containing-
migrating groups can be accommodated (4-6, 21). Sterically bulkier migrating groups 
such as secondary and tertiary alkyl migrating groups showed lower yields, indicating 
that the reaction is sensitive to steric effects (18-20). It is notable that for these hindered 
substrates, using the boron ate complex derived from pinacolatoboronate for (18) and 
(19) resulted in slight boost in yield.  
For the electrophile, functional groups that are competent in the conjunctive 
coupling reaction are ethers (10-11), ketals (13), esters (14), Boc-protected amines (15), 
and boronic ester (16). Although it is lower yielding compared to that of primary alkyl 




3.3.3 Mechanistic Studies  
After the substrate scope was investigated, in order to gain some insight, 
experiments that probe the mechanism of the reaction were done. The reaction system 
behaved similarly with the previous report utilizing C(sp3)-I electrophiles from the 
Morken group, and similar results were obtained for the study with radical clock 
substrates. Radical clock substrates can be used to determine if the reaction involves 
radical behavior. As shown in (Scheme 3.11, (a)), when cyclopropylmethyliodide is used 
as the electrophile, a ring-opened butene fragment is incorporated into the product. 
Similarly, when 1-iodohexene is used as the electrophile, the presence of the ring-closed 
cyclopentylmethyl group is indicative of radical behavior (Scheme 3.11, (b)). Notably, it 
was possible to observe uncyclized substrate in the case of 1-iodohexene as the 
electrophile, which indicates that the rate of radical ring closure is within an order of 
magnitude to the rate of the chemoselectivity-determining step. 
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Scheme 3.11: Radical clock substrates for a) ring opening and b) cyclization 
 
 
Unlike previous enantioselective conjunctive coupling reactions, steric effects of 
the electrophile did not have observable impact on the enantioselectivity. As demonstrated 
in the substrate survey, in almost all cases, the enantioselectivity remained very high. In 
order to investigate this trend, secondary alkyl iodide electrophiles were used for the 
conjunctive coupling reaction. In these cases, no decrease in enantioselectivity was 
observed despite the lower yield.  For example, with cyclohexyl iodide as the electrophile, 
product is obtained in 17% yield, with 99:1 e.r. However, for isopropyl and tert-butyl 
migrating groups, the enantioselectivity was lower than 99:1. Thus, it was proposed that 
the 1,2-metalate shift onto metal could be occurring first, then followed by the oxidative 
addition of electrophile (Case 1). In this case, the e.r. could be independent of electrophile, 
but dependent on migrating group. Or, there may be two active nickel species in operation, 
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where nickel-electrophile complex (A) and nickel-nucleophile complex (D) may exchange 
ligands (or transmetallate), and lead to product formation by reductive elimination (Case 
2, Scheme 3.12).  Additional experiments were conducted such as increasing the amount 
of boron ate complex added to hexenyl iodide substrate, in order to monitor if the ratio of 
cyclized to uncyclized product changes. However, the results were inconclusive as the 
change in ratio was not significant. Therefore, we concluded that the absence of 
enantioselectivity variation based on the steric effects of the electrophile may be because 
the reduction in enantioselectivity caused by the electrophiles may be too small to be 
observable, and sterically demanding electrophiles simply lead to more unproductive 
consumption of the starting materials. 
 






Scheme 3.13: Proposed catalytic cycle 
 
In summary, the proposed mechanism (Scheme 3.13) remains similar as the 
previous work50, where the electrophile is oxidatively added to the nickel catalyst first 
(II-A), which is under equilibrium with the alkyl radical species (II-B). An alternative 
pathway is where alkyl radical is initially generated by halide abstraction (II-B), followed 
by the radical recombination with the metal catalyst to generate (II-A).50 The 1,2-
metallate rearrangement is proposed to be the next step (III). Upon reductive elimination 





3.3.4 Gram Scale Synthesis 
The typical reaction was run in a small scale for the reaction development, In 
order to demonstrate the applicability of this method in a larger scale setting, a gram scale 
reaction was conducted (Scheme 3.14). VinylB(mac) was first placed in an oven dried 
100 mL round bottom flask, then n-BuLi was added over about 5 min. Subsequently, 
solvents were removed under reduced pressure. While the boron ate complex was being 
prepared in a 100 mL RBF, a catalyst complex solution was prepared in a 20 mL 
scintillation vial and allowed to stir for about 30 minutes. After the electrophile was 
added to the flask containing boron ate complex, the catalyst complex solution was 
added. After letting the reaction mixture stir for 22 hours at the room temperature, the 
scaled up reaction resulted in similar yields and enantioselectivity as the smaller 
counterpart, yielding 1.57 g of enantioenriched product 2, which demonstrates that 
reaction behavior is similar in larger scale.  
 




3.3.5 Application of the Method for Syntheses of Alkaloid Targets  
In order to demonstrate the utility of this Ni-catalyzed coupling method, we 
investigated whether it can be used for the synthesis of alkaloids. Two targets (Scheme 
3.15), (R)-N-Boc-Coniine, 24, and (-)-Indolizidine 209D, 28, were selected for study.57,58  
Scheme 3.15: Alkaloid targets of interest 
 
3.3.5.1 Synthesis of (R)-N-Boc-Coniine  
One of the first alkaloids we sought to synthesize was coniine, as it has a 
relatively simple molecular structure, which contains only one stereocenter. To reach the 
goal, we considered applying stereospecific amination methods that were reported by the 
Morken group.59,60  However, one challenge remained that in both cases, the substituted 
amine (RNHOMe) was not a substrate that was compatible with the methodology. 
Although it was unreactive in the intermolecular reaction, we proposed that for an 
appropriately sized ring, intramolecular amination of a substituted amine may be 
possible. Thus, it was planned that the secondary boronic ester resulting from the 
conjunctive coupling reaction would be subjected to intramolecular amination to furnish 
the product. 
                                                 
57 Hotti, H.; Rischer, H. Molecules 2017, 22, 1962. 
58 Daly, J. W.; Spande, T. F.; Garraffo, H. M. J. Nat. Prod. 2005, 68, 1556. 
59 Mlynarski, S. N.; Karns, A. S.; Morken, J. P. J. Am. Chem. Soc. 2012, 134, 16449 
60 Edelstein, E. K.; Grote, A. C.; Palkowitz, M. D.; Morken, J. P. Synlett 2018, 29, 1749 
 154 
In order to test the hypothesis for intramolecular amination, we had to access the 
precursor (3.3). Two different approaches were proposed (Scheme 3.16), where a 
methoxyaminoboronate can be prepared from either nucloephilic substitution of a 
chloride (Scheme 3.16, route a), or deprotection of Boc-protected methoxyamine 
(Scheme 3.16, route b). After finding out that the chloride electrophile was unreactive to 
the reaction conditions during the optimization stage, we sought to investigate the iodo-
chloro electrophiles. 
 
Scheme 3.16: Initial proposals for the alkaloid synthesis 
 
Efforts testing the conjunctive reaction with 1-chloro-2-iodoethane or 1-chloro-3-
iodopropane were not successful (Scheme 3.17). Therefore, the alternate route was 
employed to test the hypothesis. Instead of installing the methoxyamine group after the 
conjunctive coupling reaction, the electrophile that contains Boc-protected 






Scheme 3.17: Unsuccessful conjunctive coupling with iodochloro electrophiles 
 
 
Scheme 3.18: Preparation of the electrophile for the synthesis of coniine and test 
reaction 
 
 First, an electrophile with appropriate carbon linker was synthesized (Scheme 
3.18). Starting from methoxyamine hydrochloride, the amine can be Boc protected61 and 
then undergo nucleophilic aliphatic substitution, followed by Finkelstein reaction51 to 
form the alkyl iodide electrophile (S11). Compound S11 was used in the test reaction 
with boron ate complex derived from n-butylB(mac) and vinyllithium to yield 
aminoboronate in 62% yield with 99:1 e.r.  
 
                                                 
61 Miyabe, H.; Asada, R.; Takemoto, Y. Org. Biomol. Chem. 2012, 10, 3519. 
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Scheme 3.19: Synthesis of aminoboronate (23) by Ni-catalyzed conjunctive coupling 
reaction for the (R)-N-Boc-coniine 
 
The synthetic route for the (R)-N-Boc-Coniine is shown (Scheme 3.19). With the 
knowledge that conjunctive coupling reaction works well with the electrophile (S11), the 
boron ate complex derived from propylB(mac) and vinyllithium and electrophile (S11) 
were subjected to conjunctive coupling reaction.  The secondary boronic ester (22) is 
obtained in good yield and excellent enantioselectivity. The boronic ester (22) was 
treated with trifluoroacetic acid to remove Boc group, which we did not observe any 
protodeboration. With aminoboronate (23) in hand, the reaction conditions for 






Table 3.3: Optimization table for the intramolecular amination 
 
Initially, the intramolecular amination was tested on a model substrate with 
similar reaction condition as the one reported for the Morken group,60 but with 
modification of the reaction temperature to 110 °C. Subsequent optimization efforts 
revealed that 110 °C was optimal reaction temperature (Table 3.3, entry 1, 2, and 3). 
After the optimal reaction temperature was found, the number of equivalents of 
potassium tert-butoxide was investigated. It was found that a higher amount of KOtBu 
led to diminished yield of amination product (Table 3.3, entry 4, and 5). Lastly, further 
fine tuning of the reaction condition was conducted for coniine, changing the amount of 
KOtBu was done to demonstrate 1.1 equiv. of KOtBu was optimal (Table 3.3, entry 6, 7, 
and 8) and was used to obtain 90% isolated yield.  
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Scheme 3.20: Synthesis of (R)-N-Boc-coniine by intramolecular amination 
 
Then, using the optimized condition as described in Table 3.3, intramolecular 
amination was performed with aminoboronate (23). Product (24) was successfully 
obtained after Boc protection for the ease of isolation (Scheme 3.20). Additionally, we 
were able to compare the specific optical rotation for the product and compare to a 
known literature value to confirm the absolute stereochemistry. 
3.3.5.2 Synthesis of (-)-indolizidine 209D 
Another application in alkaloid synthesis was undertaken in the preparation of (-)-
indolizidine 209D. In this synthesis, diastereoselective reductive amination was 
proposed as the key step to form the product as shown in the retrosynthetic analysis 







Scheme 3.21: Retrosynthetic analysis for (-)-indolizidine 209D 
 
In order to test the proposed synthetic route, the alkyl electrophile S12 with 
appropriately distanced acetal can be prepared from a known intermediate 3.4 (alcohol)62 
by an Appel reaction51 (Scheme 3.22). 
Scheme 3.22: Preparation of electrophile for indolizidine 209D synthesis 
 
The synthetic route for the (-)-indolizidine 209D is shown (Scheme 3.23). Using 
the conjunctive coupling method with the boron ate derived from n-hexylB(mac) and 
vinyllithium, and with S12 as the electrophile, the secondary boronic ester product 25 can 
be obtained in good yield and enantioselectivity. Following the procedure for the 
amination of boronic esters,60 the free amine intermediate 26 can be obtained in 90% 
                                                 
62 Liu, J.-H.; Song, L.-D.; Long, Y.-Q. Tetrahedron Lett. 2009, 50, 4587. 
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yield. Upon treatment of the intermediate with acid, it results in both the deprotection of 
the acetal as well as formation of the imine. The imine intermediate can then be 
diastereoselectively hydrogenated to produce syn-2,6-substituted piperidine 27,63 which 
is a known intermediate to indolizidine 209D, 28.64 The piperidine intermediate 27 is first 
debenzylated under acidic reduction condition, and then it was cyclized to indolizidine 
209D.64 
 
Scheme 3.23: Synthesis of (-)-indolizidine 209D by Ni-catalyzed conjunctive coupling 
reaction 
 
                                                 
63 Simon, R. C.; Grischek, B.; Zepeck, F.; Steinreiber, A.; Belaj, F.; Kroutil, W. Angew. 
Chem. Int. Ed. 2012, 51, 6713. 
64 Coia, N.; Mokhtari, N.; Vasse, J.-L.; Szymoniak, J. Org. Lett. 2011, 13, 6292. 
 161 
Similarly as with coniine, we were able to compare the specific optical rotation 
for the product and compare to a known literature value to confirm the absolute 
stereochemistry. 
3.4 Conclusion 
In this chapter, I have discussed the development of the conjunctive coupling 
reaction using alkyl migrating groups with C(sp3)-iodide electrophiles. This methodology 
contributes to the area expanding the use of non-specialized substrates that do not contain 
directing groups or functional groups for reaction. This work represents a step towards 
broadening the scope of the conjunctive coupling reaction as a wide variety of functional 
groups are compatible with the method, and its utility is demonstrated by showcasing 
syntheses of two alkaloid targets, coniine and indolizidine 209D. However, the limitation 
still remains that the nature of alkene that is being difunctionalized have to be 
monosubstituted, with disubstituted alkenyl boronates like isopropenyl and propenyl 
boronates not competent in the reaction. Therefore, developing the reaction that 
accommodates such limitation may be helpful.  
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3.5 EXPERIMENTAL INFORMATION 
3.5.1 General Information 
 
1H NMR spectra were recorded on either a Varian Gemini-500 (500 MHz), Varian 
Gemini-600 (600 MHz), or Varian Inova-500 (500 MHz) spectrometer. Chemical shifts 
are reported in ppm with the solvent resonance as the internal standard (CDCl3: 7.26 ppm). 
Data are reported as follows: chemical shift, integration, multiplicity (s = singlet, d = 
doublet, t = triplet, q = quartet, p = pentet, m = multiplet), and coupling constants (Hz). 13C 
NMR spectra were recorded on either a Varian Gemini-500 (126 MHz), Varian Gemini-
600 (151 MHz) or a Varian Inova-500 (126 MHz) spectrometer with complete proton 
decoupling. Chemical shifts are reported in ppm with the solvent resonance as the internal 
standard (CDCl3: 77.16 ppm). 
11B NMR spectra were recorded on a Varian Gemini-500 
(128 MHz) spectrometer. Chemical shifts are reported in ppm using BF3-Et2O as the 
external standard (BF3-Et2O: 0.0ppm). Infrared (IR) spectra were recorded on a Bruker 
alpha-P Spectrometer. Frequencies are reported in wavenumbers (cm-1) as follows: strong 
(s), broad (br), medium (m), and weak (w). Optical rotations were measured on a Rudolph 
Analytical Research Autopol IV Polarimeter. High-resolution mass spectrometry 
(DART+) was performed at the Mass Spectrometry Facility, Boston College, Chestnut 
Hill, MA. Liquid chromatography was performed using forced flow (flash 
chromatography) on silica gel (SiO2, 230 x 450 Mesh) purchased from Silicycle. Thin layer 
chromatography (TLC) was performed on aluminum backed 200 μm silica gel plates from 
Silicycle with F254nm indicator. Visualization was performed using ultraviolet light (254 
nm), ceric ammonium molybdate (CAM), potassium permanganate (KMnO4), or 
ninhydrin. 
Analytical chiral supercritical fluid chromatography (SFC) was performed on a 
TharSFC Method Station II equipped with Waters 2998 Photodiode Array Detector with 
isopropanol as the modifier.  
All reactions were conducted in oven- or flame-dried glassware under an inert 
atmosphere of nitrogen or argon. Tetrahydrofuran (THF), diethyl ether (Et2O), 
dichloromethane (CH2Cl2) and toluene were purified using Pure Solv MD-4 solvent 
purification system, from Innovative Technology, Inc., by passing the solvent through two 
activated alumina columns after purging with argon. VinylB(pin) was purchased from 
Combi-Blocks and was distilled prior to use. Anhydrous DMSO was purchased from Acros 
Organics and used without further purification. [(TMEDA)Ni(o-tol)Cl] and (R,R)-Ph-
Pybox were purchased from Strem Chemicals and used without further purification. (S,S)-
Ph-Pybox was purchased from Combi-Blocks and used without further purification.  All 
other reagents were purchased from Sigma-Aldrich, Alfa Aesar, Oakwood Chemicals, 
Combi-Blocks, Frontier Scientific, or Acros Organics and used without further purification 
unless noted.  
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3.5.2 Experimental Procedures 
 
3.5.2.1 Procedures for the Preparation of Alkenyl and Alkyl Boronic Esters 
 
 
Method 1: According to a modified literature procedure1. Into a flame-dried 50 mL round 
bottom flask with a stir bar, boronic acid (4.67 mmol, 1.0 equiv.) was added. Acetonitrile 
(23.4 mL), and iron trichloride (37.9 mg, 0.234 mmol, 5 mol %) were then added, followed 
by imidazole (953.8 mg, 14.01 mmol, 3.0 equiv.), and then 1,2-dimethylacenaphthylene-
1,2-diol1 (1.00 g, 4.67 mmol, 1.0 equiv).  The solution was allowed to stir at room 
temperature for three hours. The reaction mixture was then dried over sodium sulfate, 
filtered, and then concentrated under reduced pressure. The boronic ester was purified by 
silica gel chromatography to afford the pure product. (In cases of alkyl boronic esters of 
low polarity, passing the raw reaction mixture through a pad of silica gel eluting with Et2O 






Method 2: According to a modified literature procedure1. Into a flame-dried 50 mL round 
bottom flask with a stir bar, alkyl potassium trifluoroborate salt (4.67 mmol, 1.0 equiv.) 
was added, then MeCN:H2O (1:1, 23.4 mL), iron trichloride (37.9 mg, 0.234 mmol, 5 mol 
%) was then added, followed by imidazole (953.8 mg, 14.01 mmol, 3.0 equiv.), and then 
1,2-dimethylacenaphthylene-1,2-diol1 (1.00 g, 4.67 mmol, 1.0 equiv.).  The solution was 
allowed to stir at room temperature for one hour. The reaction mixture was then passed 
through a fritted funnel containing silica gel, eluting with CH2Cl2, and then concentrated 
under reduced pressure. The boronic ester was then purified via silica gel chromatography 
to afford the pure product. (In cases of alkyl boronic esters of low polarity, passing the raw 
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Method 3: Step one was performed in direct correlation with a literature procedure to 
afford the pinacol boronic ester.2 The transformation of the boronic ester into the 
trifluoroborate salt was performed according to a modified literature procedure as follows.3 
In a scintillation vial equipped with a stir bar was added alkylB(pin) (2.28 mmol, 1.0 
equiv.), followed by MeOH (11.4 mL). KHF2 (4.5 M in H2O, 2.28 mL, 10.26 mmol, 4.5 
equiv.) was then added dropwise to the solution, and then allowed to stir for one hour. The 
solution was then concentrated under reduced pressure, and then redissolved in a minimal 
amount of acetone. The salt was then precipitated with diethyl ether, and was filtered on a 







Method 4: This method was adapted from a literature procedure.4 In a flame dried round 
bottom flask was added alkene (15 mmol, 1.0 equiv.) and triethylsilane (15.90 mmol, 1.13 
equiv.), and then the flask was purged with nitrogen gas and cooled to -78 °C. Then, boron 
trichloride (1 M in hexanes, 16.95 mL, 16.95 mmol, 1.13 equiv.) was added dropwise and 
allowed to stir for 40 minutes.  The solution was then allowed to warm to room temperature 
over the course of two hours.  The reaction was then cooled to 0 °C, and ether and water 
(20 mL of each) were added and the reaction was allowed to stir for 30 minutes at room 
temperature. The crude mixture was then washed with ether three times, the organic layers 
dried with sodium sulfate, and then concentrated under reduced pressure. To the unpurified 
mixture was then added KHF2 (63.0 mmol, 4.2 equiv.), and 20 mL of ether. Next, 1 mL of 
H2O was added dropwise over the course of an hour. Sodium sulfate was then added; 
acetone was then added and the mixture filtered and concentrated. The crude material was 
redissolved in a minimal amount of acetone, and the borate salt precipitated by addition of 
ether. Method 2 was then used to prepare the boronic ester. (Method 4 provides for a faster 
route to boronic esters from available alkenes without the use of a pinacol boronic ester 
intermediate). 
 
11B NMR spectra were recorded on a Varian Gemini-500 (160 MHz), with external 
standard (BF3·Et2O): 0.0 ppm. If the value is not specified, the 
11B chemical shifts for the 





Title compound was prepared by Method 2 with commercially available potassium 
vinyltrifluoroborate. The crude product was purified using silica gel chromatography (1% 
EtOAc/hexanes, stained in CAM) to afford white solid (98% yield). Title compound was 
recrystallized in hot hexanes to afford colorless, clear, and crystalline solid. 1H NMR (500 
MHz, CDCl3) δ 7.79 (dd, J = 8.0, 0.9 Hz, 2H), 7.63 – 7.55 (m, 4H), 6.11 (dd, J = 19.7, 4.0 
Hz, 1H), 5.95 (dd, J = 13.8, 4.0 Hz, 1H), 5.80 (dd, J = 19.6, 13.7 Hz, 1H), 1.81 (s, 6H). 13C 
NMR (126 MHz, CDCl3) δ 144.8, 137.4, 134.9, 131.5, 128.6, 125.4, 119.6, 92.1, 22.2. Due 
to the quadrupolar nature of boron, the carbon adjacent to boron was not detectable.  11B 
NMR (160 MHz, CDCl3) δ 30.5. IR (neat) νmax 3061 (w), 2974 (w), 2110 (w), 1618 (m), 
1499 (w), 1434 (m), 1373 (w), 1317 (s), 1250 (m), 1212 (w), 1175 (w), 1117 (m), 1077 
(m), 1015 (w), 968 (m), 892 (w), 826 (m), 805 (w), 779 (m), 760 (w), 731 (w), 710 (m), 
668 (w), 639 (w), 573 (w), 545 (w), 538 (w)  cm
-1. HRMS (DART+) for C16H16BO2 
[M+H]+: Calc’d: 251.1238, found: 251.1237. 
  
8-butyl-6b,9a-dimethyl-6b,9a-dihydroacenaphtho[1,2-d][1,3,2]dioxaborole (S2).  
The reaction was performed according to Method 1 with n-butylboronic acid (952.1 mg, 
9.34 mmol, 1.0 equiv.), 1,2-dimethylacenaphthylene-1,2-diol (2.00 g, 9.34 mmol, 1.0 
equiv.), iron trichloride (75.8 mg, 0.467 mmol, 5 mol %), imidazole, (1.91 g, 28.0 mmol, 
3.0 equiv.), and MeCN (46.7 mL). The product was then purified by silica gel 
chromatography (15% EtOAc in hexanes, stained in CAM) to afford a yellow solid. (2.3 
g, 89%). 1H NMR (500 MHz, CDCl3) δ 7.79 (d, J = 8.0 Hz, 2H), 7.59 (t, J = 7.5 Hz, 2H), 
7.54 (d, J = 6.9 Hz, 2H), 1.77 (s, 6H), 1.32 (p, J = 7.6 Hz, 2H), 1.23 (tq, J = 14.6, 7.7 Hz, 
2H), 0.80 (t, J = 7.3 Hz, 3H), 0.72 (t, J = 7.8 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 
145.0, 134.7, 131.4, 128.5, 125.3, 119.5, 91.7, 26.2, 25.4, 22.2, 13.9. Due to the 
quadrupolar nature of boron, the carbon adjacent to boron was not detectable. IR (neat) 
νmax 3044 (w), 2955 (w), 2928 (w), 2870 (w), 1348 (m), 1308 (m), 1116 (s), 1077 (s), 825 
(s), 776 (s) cm-1. HRMS (DART+) for C18H22BO2 [M+H]




Title compound was prepared from following Method 2 using but-3-en-1-yltrifluoro-λ4-
borane, potassium salt (prepared from commercially available 2-(but-3-en-1-yl)-4,4,5,5-
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tetramethyl-1,3,2-dioxaborolane, following a literature procedure3). The crude product was 
purified using silica gel chromatography (1% EtOAc/Hexanes, stained in CAM) to afford 
a white solid (64% yield over 2 steps). 1H NMR (600 MHz, CDCl3) δ 7.79 (d, J = 8.2 Hz, 
2H), 7.60 (dd, J = 8.1, 7.0 Hz, 2H), 7.55 (d, J = 6.9 Hz, 2H), 5.80 (ddt, J = 16.9, 10.2, 6.4 
Hz, 1H), 4.89 (dq, J = 17.1, 1.7 Hz, 1H), 4.79 (ddt, J = 10.2, 2.2, 1.3 Hz, 1H), 2.10 (tdt, J 
= 7.8, 6.4, 1.4 Hz, 2H), 1.77 (s, 6H), 0.84 (t, J = 7.8 Hz, 2H). 13C NMR (151 MHz, CDCl3) 
δ 145.0, 140.7, 134.8, 131.5, 128.6, 125.4, 119.6, 113.2, 91.9, 28.1, 22.3. Due to the 
quadrupolar nature of boron, the carbon adjacent to boron was not detectable.  11B NMR 
(160 MHz, CDCl3) δ 34.6. IR (neat) νmax  3044 (w), 2975 (w), 2930 (w), 1640 (w), 1499 
(w), 1433 (w), 1402 (w), 1370 (s), 1307 (s), 1263 (w), 1246 (m), 1212 (w), 1174 (m), 1116 
(s), 1078 (s), 1041 (w), 995 (w), 967 (m), 907 (m), 825 (s), 805 (w), 777 (s), 638 (w), 552 
(w) cm-1. HRMS (DART+) for C18H20BO2 [M+H]
+: Calc’d: 279.1551, found: 279.1550. 
 
2-(4-(benzyloxy)butyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
Title compound was prepared from ((but-3-en-1-yloxy)methyl)benzene5 using literature 




The title compound was prepared from following Method 2 using (4-
(benzyloxy)butyl)trifluoro-λ4-borane, potassium salt (which was prepared from 2-(4-
(benzyloxy)butyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane following literature 
procedure3). The crude product was purified using silica gel chromatography (5% 
EtOAc/Hexanes, stained in CAM) to afford a white solid (57% over two steps). 1H NMR 
(600 MHz, CDCl3) δ 7.79 (d, J = 8.2 Hz, , 2H), 7.59 (dd, J = 8.1, 7.0 Hz, 2H), 7.55-7.53 
(m, 2H), 7.33 – 7.28 (m, 4H), 7.27 – 7.24 (m, 1H), 4.41 (s, 2H), 3.39 (t, J = 6.7 Hz, 2H), 
1.77 (s, 6H), 1.58 – 1.52 (m, 2H), 1.43 (p, J = 7.5 Hz, 2H), 0.75 (t, J = 7.9 Hz, 2H). 13C 
NMR (151 MHz, CDCl3) δ 145.0, 138.9, 134.8, 131.5, 128.6, 128.4, 127.7, 127.5, 125.4, 
119.6, 91.8, 72.8, 70.4, 32.3, 22.3, 20.6. Due to the quadrupolar nature of boron, the carbon 
adjacent to boron was not detectable. 11B NMR (160 MHz, CDCl3) δ 35.6. IR (neat) νmax  
3030 (w), 2972 (w), 2932 (m), 2861 (m), 2362 (w), 1497 (w), 1454 (w), 1375 (s), 1310 
(m), 1263 (m), 1232 (w), 1213 (w), 1175 (m), 1117 (s), 1079 (s), 1029 (w), 967 (w), 894 
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(w), 826 (s), 779 (s), 736 (m), 698 (m), 669 (w), 639 (w), 609 (w), 572 (w), 546 (w), 537 
(w) cm-1. HRMS (DART+) for C25H28BO3 [M+H]
+: Calc’d: 387.2126, found: 387.2125. 
 
6b,9a-dimethyl-8-(3-phenylpropyl)-6b,9a-dihydroacenaphtho[1,2-
d][1,3,2]dioxaborole (S5).  
The reaction was performed according to Method 2 with trifluoro-(3-phenylpropyl)-
potassio-boron (1.60 g, 7.08 mmol, 1.0 equiv.), 1,2-dimethylacenaphthylene-1,2-diol (1.52 
g, 7.08 mmol, 1.0 equiv.), iron trichloride (57.4 mg, 0.354 mmol, 5 mol %), imidazole, 
(1.45 g, 21.2 mmol, 3.0 equiv.), and MeCN:H2O (1:1, 35.4 mL). The product was then 
purified by silica gel chromatography (15% ether in pentane, stained in CAM) to afford a 
yellow solid. (2.0 g, 83%). 1H NMR (500 MHz, CDCl3) δ 7.78 (d, J = 8.2 Hz, 2H), 7.59 (t, 
J = 7.7 Hz, 2H), 7.53 (d, J = 6.9 Hz, 2H), 7.20 (t, J = 7.6 Hz, 2H), 7.08 (t, J = 7.3 Hz, 1H), 
7.07 (d, J = 7.6 Hz, 2H), 2.52-2.47 (m, 2H), 1.76 (s, 6H), 1.66 (p, J = 7.7 Hz, 2H), 0.77 (t, 
J = 7.9 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 144.9, 142.7, 134.7, 131.5, 128.6 (2), 
128.2, 125.6, 125.3, 119.5, 91.7, 38.5, 26.1, 22.2. Due to the quadrupolar nature of boron, 
the carbon adjacent to boron was not detectable. IR (neat) νmax 3025 (w), 2978 (w), 2932 
(w), 1496 (w), 1372 (s), 1308 (m), 1116 (m), 1078 (m), 778 (s), 744 (m), 699 (m) cm-1. 
HRMS (DART+) for C23H24BO2 [M+H]




The reaction was performed according to Method 3 with 2-but-3-enyl-2-methyl-1,3-
dioxolane (526.1 mg, 3.70 mmol, 1.0 equiv.), 4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(568.2 mg, 4.44 mmol, 1.2 equiv.), Bis(1,5-cyclooctadiene)diiridium(I) dichloride (37.3 
mg, 0.056 mmol, 1.5 mol %), bis(diphenylphosphino)methane (42.7 mg, 0.111 mmol, 3.0 
mol %), and dichloromethane (12.33 mL) to afford the 4,4,5,5-tetramethyl-2-[4-(2-methyl-
1,3-dioxolan-2-yl)butyl]-1,3,2-dioxaborolane intermediate. Then, to this intermediate was 
added KHF2 (4.5 M in H2O, 3.7 mL, 16.65 mmol, 4.5 equiv.), followed by MeOH (11.4 
mL), to afford the trifluoro-[4-(2-methyl-1,3-dioxolan-2-yl)butyl]-potassio-boron 
intermediate. Then to this was added 1,2-dimethylacenaphthylene-1,2-diol (353.8 mg, 1.65 
mmol, 1.0 equiv.), iron trichloride (13.4 mg, 0.083 mmol, 5 mol %), imidazole, (337.3 mg, 
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4.95 mmol, 3.0 equiv.), and MeCN:H2O (1:1, 8.3 mL). The product was then purified by 
silica gel chromatography (50% ether in hexanes) to afford a white solid. (469 mg, 78%). 
1H NMR (600 MHz, CDCl3) δ 7.78 (d, J = 8.1 Hz, 2H), 7.59 (t, J = 7.4 Hz, 2H), 7.54 (d, J 
= 6.8 Hz, 2H), 3.91-3.81 (m, 4H), 1.77 (s, 6H), 1.56-1.51 (m, 2H), 1.39-1.32 (m, 2H), 1.32-
1.25 (m, 2H), 1.21 (s, 3H), 0.74 (t, J = 7.7 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 144.9, 
134.6, 131.4, 128.5, 125.2, 119.4, 110.1, 91.6, 64.5, 38.8, 26.7, 24.2, 23.7, 22.1. Due to the 
quadrupolar nature of boron, the carbon adjacent to boron was not detectable. IR (neat) 
νmax 2979 (w), 2935 (w), 2870 (w), 1715 (w), 1372 (m), 1116 (m), 1077 (m), 1052 (m), 
967 (w), 947 (w), 778 (m) cm-1. HRMS (DART+) for C22H28BO4 [M+H]
+: Calc’d: 




The reaction was prepared according to Method 4 with 4-methylpent-1-ene (1.26 g, 15 
mmol, 1.0 equiv.), triethylsilane (1.85 g,  15.9 mmol, 1.06 equiv.), and trichloroborane (1M 
in hexanes, 16.95 mL, 16.95 mmol, 1.13 equiv.), and Et2O:H2O (1:1, 40.0 mL), and then 
KHF2 (4.92 g, 63.0 mmol, 4.2 equiv.), and H2O (1 mL) to afford the trifluoro-isohexyl-
potassio-boron intermediate. To a portion of this intermediate was then added 1,2-
dimethylacenaphthylene-1,2-diol (353.8 mg, 3.0 mmol, 1.0 equiv.), iron trichloride (13.4 
mg, 0.083 mmol, 5 mol %), imidazole, (337.3 mg, 4.95 mmol, 3.0 equiv.), and MeCN:H2O 
(1:1, 8.3 mL). The product was then purified by silica gel chromatography (50% ether in 
hexanes) to afford a white solid. (469 mg, 78%). 1H NMR (600 MHz, CDCl3) δ 7.79 (d, J 
= 8.2 Hz, 2H), 7.61-7.57 (m, 2H), 7.55 (d, J = 6.9 Hz, 2H), 1.77 (s, 6H), 1.43 (dq, J = 13.3, 
6.7 Hz, 1H), 1.33 (p, J = 7.8 Hz, 2H), 1.08-1.03 (m, 2H), 0.77 (d, J =  6.6 Hz, 6H), 0.70 (d, 
J = 7.9 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 145.0, 134.8, 131.5, 128.6, 125.3, 119.5, 
91.7, 41.9, 27.8, 22.7, 22.2, 21.8. Due to the quadrupolar nature of boron, the carbon 
adjacent to boron was not detectable. IR (neat) νmax 3044 (w), 2952 (m), 2930 (m), 2867 
(w), 1499 (w), 1373 (m), 1306 (m), 1263 (m), 1238 (m), 1116 (s), 1078 (s), 825 (m), 777 
(m), 744 (m) cm-1. HRMS (DART+) for C20H26BO2 [M+H]







The reaction was performed according to Method 1 with cyclopentylboronic acid (400 mg, 
3.51 mmol, 1.0 equiv), 1,2-dimethylacenaphthylene-1,2-diol (752.1 mg, 3.51 mmol, 1.0 
equiv.), iron trichloride (28.5 mg, 0.176 mmol, 5 mol %), imidazole (717 mg, 10.5 mmol, 
3.0 equiv.), and MeCN (17.6 mL). The product was then purified by concentrating the 
crude mixture, dissolving in dichloromethane, and passing through a fritted funnel of silica 
gel to afford a white solid. (952 mg, 93%). 1H NMR (500 MHz, CDCl3) δ 7.78 (d, J = 8.0 
Hz, 2H), 7.59 (t, J = 7.5 Hz, 2H), 7.55 (d, J = 6.9 Hz, 2H), 1.76 (s, 6H), 1.72-1.63 (m, 2H), 
1.54-1.49 (m, 2H), 1.47-1.32 (m, 4H), 1.11 (p, J = 9.0 Hz, 1H). 13C NMR (126 MHz, CDCl3) 
δ 145.1, 134.8, 131.4, 128.5, 125.2, 119.5, 91.6, 28.7, 26.9, 22.2. Due to the quadrupolar 
nature of boron, the carbon adjacent to boron was not detectable. IR (neat) νmax 3045 (w), 
2983 (w), 2950 (w), 2863 (w), 1370 (m), 1304 (m), 1211 (m), 1114 (m), 1073 (m), 882 
(m), 644 (w) cm-1. HRMS (DART+) for C19H22BO2 [M+H]




Title compound was prepared according to the literature procedure.8 Spectral data matches 





Title compound was prepared from Method 1 with commercially available n-
propylboronic acid. The crude product was purified using silica gel chromatography (1% 
EtOAc/Hexanes, stained in CAM) to afford a white solid (84% yield). 1H NMR (500 MHz, 
CDCl3) δ 7.81 – 7.77 (m, 2H), 7.60 (dd, J = 8.1, 6.9 Hz, 2H), 7.55 (d, J = 6.5 Hz, 2H), 1.78 
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(s, 6H), 1.38 (h, J = 7.5 Hz, 2H), 0.84 (t, J = 7.4 Hz, 3H), 0.73 (t, J = 7.7 Hz, 2H). 13C 
NMR (126 MHz, CDCl3) δ 145.1, 134.8, 131.5, 128.6, 125.3, 119.5, 91.7, 22.3, 17.5, 17.0. 
Due to the quadrupolar nature of boron, the carbon adjacent to boron was not detectable. 
11B NMR (160 MHz, CDCl3) δ 34.87. IR (neat) νmax  3044 (w), 2955 (w), 2930 (w), 2870 
(w), 1498 (w), 1458 (w), 1405 (w), 1371 (s), 1324 (m), 1305 (s), 1267 (m), 1211 (m), 1174 
(m), 1117 (s), 1079 (s), 968 (m), 903 (w), 883 (w), 826 (s), 779 (s), 728 (w) cm-1. HRMS 
(DART+) for C17H20BO2 [M+H]
+: Calc’d: 267.1551, found: 267.1548. 
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3.5.2.2 Procedures for the Preparation of Alkyl Iodides 
A. General Procedure for the Preparation of Alkyl Iodides from Alkyl Bromides. 
 
To a solution of alkyl bromide (1.0 equiv.) in acetone (1.5M), sodium iodide (2.0 equiv.) 
was added. The mixture was stirred at room temperature for 16 h. Solvent was removed 
under reduced pressure, then EtOAc (20 mL) and water (15 mL) are added to the residue. 
It was extracted with EtOAc 3 times. Next, the organic layer was washed with Na2S2O3 
(sat. aq.) solution, then brine, then dried over Na2SO4. The crude residue was purified by 
silica gel column (1-5% EtOAc/hexanes) followed by distillation if it was possible without 
decomposition of the alkyl iodide. 
 
(3-iodopropyl)benzene 
The title compound was prepared according to general procedure with (3-
bromopropyl)benzene (95% yield). Spectral data were in accordance with literature report.9 
The title compound was distilled prior to use to yield colorless oil. 
 
1-Iodobutane. 
The title compound was prepared according to the procedure reported in the 




The title compound was prepared according to the procedure reported in the literature.11 
All spectral data were in accordance with the literature.11 
 
 (2-iodoethyl)cyclohexane.  
The title compound was prepared according to the procedure reported in the literature.12 
All spectral data were in accordance with the literature.12 
 
((4-iodobutoxy)methyl)benzene 
The title compound was prepared according to the literature procedure.13 All spectral data 
were in accord with the literature.13 
 
 tert-butyl (3-iodopropyl)carbamate.  
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The title compound was prepared according to the general procedure with corresponding 
tert-butyl (3-bromopropyl)carbamate (75% yield). All spectral data were in accord with 
the literature.14 
5-iodopentan-2-one.  
The title compound was prepared according to the procedure reported in the literature.15 
All spectral data were in accordance with the literature.15 
2-(3-iodopropyl)-2-methyl-1,3-dioxolane. 
The title compound was prepared according to the procedure reported in the literature.16 





The synthesis of but-3-enoxy-tert-butyl-dimethyl-silane was conducted through methods 
described in the literature.17 The synthesis of tert-butyl-dimethyl-[4-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)butoxy]silane was prepared in accordance with the literature.6 In 
a two dram vial with a stir bar was added lithium aluminum hydride (38.0 mg, 0.536 mmol, 
10 mol %), but-3-enoxy-tert-butyl-dimethyl-silane (1.00 g, 5.37 mmol, 1.0 equiv.), and 
4,4,5,5-tetramethyl-1,3,2-dioxaborolane (0.856 mL, 5.90 mmol, 1.1 equiv), and stirred at 
110 °C in oil bath for 24 hours. The crude material was then filtered through a silica gel 
plug using dichloromethane, and concentrated under reduced pressure. The crude material 
was purified via silica gel chromatography (5% EtOAc in hexanes) to afford the product 
as a colorless liquid (1.24 g, 3.94 mmol, 74%). Then to a round bottom flask was added 
tert-butyl-dimethyl-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butoxy]silane (940 
mg, 2.99 mmol, 1.0 equiv.) followed by tetrabutyl ammonium fluoride (1M in THF, 12 
mL, 12 mmol, 4.0 equiv.), and allowed to stir at room temperature for 24 hours. Water was 
then added to the reaction, and the aqueous layer was extracted three times using EtOAc, 
dried with sodium sulfate, and then concentrated under reduced pressure. The crude 
material was then purified via silica gel chromatography (40% Et2O in pentane), to afford 
a colorless liquid (374 mg, 1.87 mmol, 63%). Then, to a round bottom flask was added 
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triphenylphosphine (588 mg, 2.24 mmol, 1.2 equiv.), followed by dichloromethane (3.7 
mL), followed by iodine (588 mg, 2.43 mmol, 1.3 equiv.). 4-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)butan-1-ol was then added to a round bottom flask (374 mg, 0.187 
mmol, 1.0 equiv) at 0 °C, and allowed to warm to room temperature and stirred for 18 
hours. The reaction was then filtered by vacuum filtration and concentrated under reduced 
pressure. To the filtrate was added saturated sodium thiosulfate, and the solution was 
extracted three times with a solution of 20% EtOAc in hexanes. The organic layers are then 
dried with sodium sulfate, and concentrated under reduced pressure. The crude material 
was then purified via silica gel chromatography (40% diethyl ether in hexanes) to afford a 
light brown liquid (350 mg, 1.13 mmol, 60%). 1H NMR (500 MHz, CDCl3) δ 3.18 (t, J = 
7.1 Hz, 2H), 1.84 (p, J = 7.2 Hz, 2H), 1.51 (dt, J = 15.3, 7.7 Hz, 2H), 1.24 (s, 12H), 0.79 
(t, J = 7.9 Hz, 2H). 13C NMR (126 MHz, CDCl3) δ 83.2, 36.3, 30.5, 25.2, 25.0, 6.9. 
11B 
NMR (160 MHz, CDCl3) δ 34.8. IR (neat) νmax 2977 (s), 2928 (s), 2856 (m), 1460 (w), 
1407 (m), 1379 (s), 1322 (s), 1241 (m), 1200 (m), 1145 (s), 968 (m), 846 (m), 724 (w), 672 
(w), 601 (w), 571 (w), 551 (w), 538 (w) cm-1. HRMS (DART+) for C10H21BO4I [M+H]
+: 
Calc’d: 311.0674, found: 311.0671. 
 
   
tert-butyl (3-iodopropyl)(methoxy)carbamate (S11). 
Sodium hydride (90% purity, 186.6 mg, 7.00 mmol, 1.03 equiv.) was placed into an oven 
dried round bottom flask with a stir bar, inside glovebox, which was sealed with rubber 
septum, then brought outside of glovebox. DMF (10.0 mL) was added while under nitrogen 
atmosphere and tert-butyl N-methoxycarbamate18 (1.00 g, 6.79 mmol, 1.0 equiv.) in 3.0 
mL DMF was slowly added at 0 °C. The mixture was allowed to stir for 1 hour at room 
temperature. Then 1,3-dibromopropane (5.49 g, 27.2 mmol, 2.76 mL, 4.0 equiv.) was 
added in one portion. The mixture was left to stir overnight at room temperature under 
nitrogen atmosphere. It was first diluted with EtOAc (100 mL), then water (25 mL) was 
carefully added. Organic compound was extracted with EtOAc, washed with water, brine, 
and dried over Na2SO4. Solvents were removed to afford pale yellow oil. Which was 
purified by silica gel chromatography (5-10% EtOAc/Hexanes), which was then treated 
with NaI (2.00 g, 13.4 mmol, 2.0 equiv.) in 10 mL of acetone. It was allowed to stir 
overnight at room temperature, open to air. Na2S2O3 (aq. sat.) was added to quench excess 
iodide, then organic compound was extracted with EtOAc. Title compound was purified 
using silica gel chromatography (10% EtOAc/Hexanes) to yield pale yellow oil (1.57g, 
73% over two steps). 1H NMR (500 MHz, CDCl3) δ 3.68 (s, 3H), 3.53 (t, J = 6.7 Hz, 2H), 
3.20 (t, J = 6.9 Hz, 2H), 2.13 (p, J = 6.8 Hz, 2H), 1.50 (s, 9H). 13C NMR (126 MHz, CDCl3) 
δ 156.3, 81.7, 62.4, 49.5, 31.4, 28.5, 3.0. IR (neat) νmax 2976 (m), 2933 (w), 2161 (w), 1701 
(s), 1476 (w), 1435 (w), 1392 (m), 1367 (s), 1288 (w), 1236 (m), 1154 (s), 1085 (m), 1016 
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(w), 977 (w), 855 (w), 765 (w) cm-1. HRMS (DART+) for C9H19NO3I [M+H]
+: Calc’d: 




To a 100 mL round-bottom flask, equipped with a magnetic stir bar, 2-(2-(3-
(benzyloxy)propyl)-1,3-dioxolan-2-yl)ethan-1-ol19 (1.45 g, 5.44 mmol, 1.0 equiv.), I2 (1.66 
g, 6.53 mmol, 1.2 equiv.), Imidazole (0.444 g, 6.53 mmol, 1.2 equiv), PPh3 (1.71g, 6.53 
mmol, 1.2 equiv) were added and dissolved in THF (10.0 mL). The mixture was allowed 
to stir at room temperature overnight. It was then diluted with EtOAc, quenched with 
Na2S2O3 (aq. sat.) solution, extracted with EtOAc three times. It was washed with brine, 
and dried with Na2SO4. Solvents were removed under reduced pressure to give a solid 
residue. Crude material was purified by silica gel chromatography (5% EtOAc/Hexanes, 
KMnO4 stain) to yield a pale yellow oil (1.87 g, 91% yield). 
1H NMR (500 MHz, CDCl3) 
δ 7.36-7.33 (m, 4H), 7.29-7.26 (m, 1H), 4.50 (s, 2H), 3.94 (s, 4H), 3.47 (m, 2H), 3.16-3.13 
(m, 2H), 2.29-2.26 (m, 2H), 1.69-1.67 (m, 4H). 13C NMR (126 MHz, CDCl3) δ 138.7, 
128.5, 127.8, 127.7, 111.5, 73.0, 70.3, 65.3, 42.8, 33.9, 24.2, -2.1. IR (neat) νmax 3028 (w), 
2956 (s), 2879 (s), 2358 (w), 1495 (w), 1453 (m), 1360 (m), 1207 (m), 1100 (s), 1028 (m), 
949 (m), 858 (w), 737 (m), 698 (m) cm-1. HRMS (DART+) for C15H22O3I [M+H]
+: Calc’d: 




3.5.2.3 General Procedure for the Conjunctive Cross-Coupling 
 
A. General Procedure A (using vinyl boronic ester, and alkyl organolithium 
reagents) 
 
Inside the glovebox, an oven-dried 2 dram vial equipped with a stir bar was charged with 
6b,9a-dimethyl-8-vinyl-acenaphthyleno[1,2-d][1,3,2]dioxaborole (vinylB(mac)), (55.0 
mg, 0.22 mmol, 1.1 equiv).  The boronic ester was dissolved in 0.5 mL Et2O, capped with 
septum, taped, and was removed from the glovebox. The vial was placed under positive 
pressure of N2, cooled to 0 °C in ice bath, then the organolithium reagent (0.2 mmol, 1.0 
equiv) was added dropwise over about 5 min. After the addition was complete, the vial was 
removed from the ice bath and allowed to stir for 5 minutes at room temperature. Then the 
solvent was carefully removed under reduced pressure while not being exposed to air, and 
put under vacuum for 15 min.  
 
Inside the glovebox, to another oven-dried 2 dram vial equipped with a stir bar, catalyst 
stock solution was prepared. It was charged with (TMEDA)Ni(o-tol)Cl (6.0 mg, 0.020 
mmol, 10 mol %) and (S,S)-Ph-Pybox (8.9 mg, 0.024 mmol, 12 mol %). Subsequently, it 
was suspended in 0.2 mL of THF and was allowed to stir for 5 min. Then 0.4 mL of DMSO 
was added, and was allowed to stir for 5 min, or until it was completely dissolved. 
 
After the first vial was under vacuum for 15 min, the vial was filled with nitrogen, then 
brought into the glovebox. 0.9 mL of THF was added to the vial containing boron ate 
complex. Iodide electrophile (0.24 mmol, 1.2 equiv) was added, then, 0.6 mL of nickel 
catalyst complex stock solution was added slowly. The vial was sealed with polypropylene 
cap, taped, and brought outside the glovebox and was allowed to stir for 18-24h at room 
temperature. Reaction mixture is then diluted with ether, and 0.5mL of H2O is added (for 
removal of DMSO). Crude product can be obtained after filtering through a silica gel plug 
with ether.  
 
B. General Procedure B (using alkyl boronic esters, and vinyllithium in THF) 
 
Inside the glovebox, an oven-dried 2 dram vial equipped with a stir bar was charged with 
alkyl B(mac) (0.22 mmol, 1.1 equiv). It was dissolved in 0.5mL THF, capped with septum, 
taped, and was brought outside the glovebox with vinyl lithium solution in syringe pierced 
through the septum. Vial was placed under positive pressure of N2, cooled to 0 °C in ice 
bath, then the vinyllithium in THF (0.2 mmol, 1.0 equiv) was added dropwise over about 
5 min. After the addition was complete, the vial was removed from the ice bath and allowed 
to stir for 5 min at room temperature.  
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Inside the glovebox, to another oven-dried 2 dram vial equipped with a stir bar, catalyst 
stock solution was prepared. It was charged with (TMEDA)Ni(o-tol)Cl (6.0 mg, 0.020 
mmol, 10 mol %) and (S,S)-Ph-Pybox (8.9 mg, 0.024 mmol, 12 mol %). Subsequently, it 
was suspended in 0.2 mL of THF and was allowed to stir for 5 min. Then 0.4 mL of DMSO 
was added, and was allowed to stir for 5 min, or until it was completely dissolved. 
 
The vial was taped over the top of septum, then brought into the glovebox. More THF was 
added until a total of 0.9 mL of THF was added to the vial containing boron ate complex, 
including THF contained in vinyl lithium solution. Iodide electrophile (0.24 mmol, 1.2 
equiv) was added, then, 0.6 mL of nickel catalyst complex solution was added slowly. The 
vial was sealed with polypropylene cap, taped, and brought outside the glovebox and was 
allowed to stir for 18-24h at room temperature. Reaction mixture is then diluted with ether, 
and 0.5mL of H2O is added (for removal of DMSO). Crude product can be obtained after 
filtering through a silica gel plug with ether. 
 
Preparation of vinyllithium in THF: 
 
Vinyllithium in THF was prepared according to the previous report20, using tetravinyltin 
(1.0 equiv.), and n-butyllithium solution in hexanes (2.0 equiv.). It was stored in freezer of 
the argon-filled glovebox and warmed up to room temperature prior to use.  
 
Titration method used for vinyllithium in THF, or other organolithium reagents: 
 
First, an oven dried 2-dram vial, equipped with a magnetic stir bar, was sealed with septum 
cap, and was allowed to cool to room temperature under vacuum. To the vial, an accutately 
weighed amount of 2,6-di-tert-butyl-4-methylphenol (BHT) (ca. 100.0 mg) is added, with 
1,10-phenanthroline (ca. 2.0 mg) as the endpoint indicator for the titration. The vial is then 
sealed with septum cap, atmosphere exchanged with nitrogen three times, then dissolved 
in 2mL of anhydrous THF. While under nitrogen atmosphere, the vial is placed in ice bath 
and cooled to 0 ºC, and titrated with organolithium reagent (usually in a 1.00mL syringe), 
until dark purple color persists. Total amount of volume used to reach endpoint is used for 
calculation of reagent concentration. This process is performed twice for accuracy. 
 
 
Considerations regarding General Procedure A vs. B, reaction temperatures, and 
their reaction times: 
 
If either General Procedure A and B are considered, reactions using Procedure A 
(vinylB(mac) and organolithium) results in a slightly faster reaction than Procedure B (for 
2a, full conversion (by 11B NMR) by Procedure A is in 15 h, and by Procedure B it is in 
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20 h). As shown in the optimization table, conducting the reaction at 60 ºC (in oil bath), 
results in 10-15% lower yield, but without loss in enantiomeric ratio. For 2a, the reaction 
is completed in about 4 hours. 
 
 
C. General Method for Oxidation of Boronic Ester Products: (Oxidation 
Procedure) 
 
Note: Where appropriate, boronic ester products were oxidized. In these cases, the 
procedure listed below was used employed. Prior to oxidation, boronic ester products 
were purified by silica gel chromatography such that it only contains product (or may 
contain inseparable alkylB(mac), and vinylB(mac)). The initial purification was often 
required to avoid carrying over the inseparable impurities during the purification of 
secondary alcohols.  
 
The purified boronic ester product (which may or may not contain alkylB(mac) or 
vinylB(mac) as impurities) was diluted with tetrahydrofuran (1 mL). The crude mixture 
was cooled to 0 ºC and 3M NaOH (1 mL) and 30% H2O2 (1 mL) were added dropwise. 
The reaction mixture was allowed to warm to room temperature, and was allowed to stir at 
room temperature for 3 hours. The reaction mixture was cooled to 0 ºC and Na2S2O3 (aq. 
sat., 1 mL) was added dropwise (while monitoring temperature of the flask). After warming 
to room temperature the aqueous layer was extracted with ethyl acetate (3 x 7 mL). The 
combined organic layers were dried over Na2SO4, concentrated under reduced pressure, 




3.5.2.4 Characterization of the Conjunctive Cross Coupling Products and Analysis of 
Stereochemistry 
11B NMR spectra were recorded on a Varian Gemini-500 (160 MHz), with external 
standard (BF3·Et2O): 0.0 ppm. If the value is not specified, the 
11B chemical shifts for the 
compounds are 35-36 ppm.  
 
 
(R)-1-phenylnonan-5-ol (3).  
The reaction was performed according to the General Procedure A with vinylB(mac) 
(55.0 mg, 0.22 mmol, 1.1 equiv.), n-butyllithium (2.5 M in hexane, 0.08 mL, 0.2 mmol, 
1.0 equiv.), and (3-iodopropyl)benzene (59.1 mg, 0.24 mmol, 1.2 equiv.), (TMEDA)Ni(o-
tolyl)Cl (6.0 mg, 0.020 mmol, 10 mol %), and (S,S)-Ph-Pybox (8.9 mg, 0.024 mmol, 12 
mol %), in 3:1 THF:DMSO (1.5 mL). Boronic ester was purified prior to oxidation using 
1% EtOAc in Hexanes. Crude boronic ester was then subjected to Oxidation Procedure. 
The crude alcohol was purified by silica gel column chromatography (3% EtOAc in 
hexanes, stained with CAM) to afford a colorless oil (30.0 mg, 65% yield).  1H NMR (600 
MHz, CDCl3) δ 7.30-7.25 (m, 2H), 7.20-7.16 (m, 3H), 3.61-3.56 (m, 1H), 2.63 (t, J = 7.7 
Hz, 2H), 1.70-1.59 (m, 2H), 1.52-1.26 (m, 11H), 0.91 (t, J = 6.9 Hz, 3H). 13C NMR (151 
MHz, CDCl3) δ 142.8, 128.5, 128.4, 125.8, 72.1, 37.5, 37.4, 36.1, 31.7, 28.0, 25.5, 22.9, 
14.2. IR (neat) νmax 3346 (br, w), 3063 (w), 3026 (w), 2929 (s), 2857 (m), 1604 (w), 1496 
(m), 1454 (m), 1378 (w), 1126 (w), 1058 (w), 1030 (w), 1002 (w), 901 (w), 746 (m), 698 
(s) cm-1. HRMS (DART) for C16H25O2 [M+H]
+: Calc’d: 249.1849, found: 249.1840. [𝛼]𝐷
20: 
-2.382 (c = 0.850, CHCl3, l=50 mm). 
 
Analysis of Stereochemistry: 
Racemic material was prepared by reaction of 5-phenylpentanal21 and n-BuLi in THF at -
78°C. Absolute stereochemistry was assigned by analogy (see product (R)-(-)-N-Boc-
Coniine, (-)-indolizidine 209D). 
Chiral SFC (Chiracel OD-RH, 2% IPA, 3 mL/min, 100 bar, 35 °C, 210-289 nm) – 
analysis of (R)-1-phenylnonan-5-ol.  
         Racemic Material    Standard Conditions 
 
 180 







The reaction was performed according to the General Procedure B with 8-(but-3-en-1-
yl)-6b,9a-dimethyl-6b,9a-dihydroacenaphtho[1,2-d][1,3,2]dioxaborole (61.2 mg, 
0.22mmol, 1.1 equiv.), vinyllithium (1.45 M in THF, 0.137 mL, 0.2 mmol, 1.0 equiv.), and 
(3-iodopropyl)benzene (59.1 mg, 0.24 mmol, 1.2 equiv.), (TMEDA)Ni(o-tolyl)Cl (6.0 mg, 
0.020 mmol, 10 mol %), and (S,S)-Ph-Pybox (8.9 mg, 0.024 mmol, 12 mol %), in 3:1 
THF:DMSO (1.5 mL). Boronic ester was purified prior to oxidation using 1% EtOAc in 
Hexanes. Crude boronic ester was then subjected to Oxidation Procedure. The crude 
alcohol was purified by silica gel column chromatography (5% EtOAc in hexanes, stained 
with CAM) to afford a colorless oil (24.0 mg, 55% yield).  1H NMR (600 MHz, CDCl3) δ 
7.30-7.27 (m, 2H), 7.19-7.18 (m, 3H), 5.88-5.81 (m, 1H), 5.06 (d, J = 17.1 Hz, 1H), 4.98 
(d, J = 9.9 Hz, 1H), 3.65-3.60 (m, 1H), 2.63 (t, J = 7.7 Hz, 2H), 2.24-2.17 (m, 1H), 2.17-
2.10 (m, 1H), 1.71-1.60 (m, 2H), 1.49-1.37 (m, 7H). 13C NMR (151 MHz, CDCl3) δ 142.7, 
138.7, 128.5, 128.4, 125.8, 114.9, 71.5, 37.5, 36.6, 36.1, 31.6, 30.2, 25.4. IR (neat) νmax 
3340 (br, w), 3063 (w), 3026 (w), 2930 (s), 2856 (m), 1640 (w), 1604 (w), 1496 (w), 1453 
(m), 1062 (w), 1030 (w), 995 (w), 909 (m), 746 (m), 698 (s), 646 (w) cm-1. HRMS 
(DART+) for C15H21 [M+H-H2O]
+: Calc’d: 201.1638, found: 201.1634. [𝛼]𝐷
20: -2.167 (c = 
0.830, CHCl3, l=50 mm). 
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Analysis of Stereochemistry: 
Racemic material was prepared by mixing the other enantiomer prepared from running a 
second reaction according to the General Procedure B with (R,R)-Ph-Pybox (12 mol%) 
as the ligand instead of (S,S)-Ph-Pybox. Absolute stereochemistry was assigned by analogy 
(see product (R)-(-)-N-Boc-Coniine, (-)-indolizidine 209D). 
 
Chiral SFC (Chiracel AD-H, 7% IPA, 3 mL/min, 100 bar, 35 °C, 210-289 nm) – analysis 
of (S)-9-phenylnon-1-en-5-ol. 
         Racemic Material         Standard Conditions 





The reaction was performed according to the General Procedure B using 8-(4-
(benzyloxy)butyl)-6b,9a-dimethyl-6b,9a-dihydroacenaphtho[1,2-d][1,3,2]dioxaborole 
(85.0 mg, 0.22 mmol, 1.1 equiv.), vinyllithium (1.52 M in THF, 0.131 mL, 0.2 mmol, 1.0 
equiv.), 1-iodobutane (44.2 mg, 0.24 mmol, 1.2 equiv.), (TMEDA)Ni(o-tolyl)Cl (6.0 mg, 
0.020 mmol, 10 mol %), and (S,S)-Ph-Pybox (8.9 mg, 0.024 mmol, 12 mol %), in 3:1 
THF:DMSO (1.5 mL). Boronic ester was purified prior to oxidation using 1% EtOAc in 
Hexanes. Crude boronic ester was then subjected to Oxidation Procedure. The crude 
alcohol was purified by silica gel column chromatography (5% EtOAc in hexanes, stained 
with CAM) to afford a colorless oil (31.7 mg, 60% yield). 
1H NMR (500 MHz, CDCl3) δ 7.37-7.32 (m, 4H), 7.29-7.26 (m, 1H), 4.51 (s, 2H), 3.61-
3.56 (m, 1H), 3.48 (t, J = 6.5 Hz, 2H), 1.70-1.59 (m, 2H), 1.54-1.26 (m, 13H), 0.90 (t, J = 
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6.6 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 138.7, 128.5, 127.8, 127.6, 73.0, 72.0, 70.4, 
37.6, 37.3, 32.0, 29.9, 25.5, 22.8, 22.5, 14.2. IR (neat) νmax 3403 (br, w), 3030 (w), 2928 
(s), 2857 (s), 2359 (w), 1496 (w), 1454 (m), 1363 (m), 1260 (w), 1204 (w), 1101 (s), 1028 
(m), 908 (w), 805 (w), 734 (s), 697 (s), 614 (w) cm-1. HRMS (DART+) for C17H29O2 
[M+H]+: Calc’d: 265.2162, found: 265.2159. [𝛼]𝐷
20: -0.230 (c = 0.870, CHCl3, l=50 mm). 
 
Analysis of Stereochemistry: 
Racemic material was prepared by mixing the other enantiomer prepared from running a 
second reaction according to the General Procedure B with (R,R)-Ph-Pybox (12 mol%) 
as the ligand instead of (S,S)-Ph-Pybox. Absolute stereochemistry was assigned by analogy 
(see product (R)-(-)-N-Boc-Coniine, (-)-indolizidine 209D). 
 
Chiral SFC (Chiracel OD-H, 7% IPA, 3 mL/min, 100 bar, 35 °C, 210-289 nm) – analysis 
of (S)-1-(benzyloxy)decan-5-ol.  
         Racemic Material         Standard Conditions 
    
   
 
   
6b,9a-dimethyl-8-((S)-1-(2-methyl-1,3-dioxolan-2-yl)-9-phenylnonan-5-yl)-6b,9a-
dihydroacenaphtho[1,2-d][1,3,2]dioxaborole (6).  
The reaction was performed according to the General Procedure B with 6b,9a-dimethyl-
8-[4-(2-methyl-1,3-dioxolan-2-yl)butyl]acenaphthyleno[1,2-d][1,3,2]dioxaborole (80.6 
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mg, 0.22 mmol, 1.1 equiv.), vinylithium (1.63 M in THF, 0.123 mL, 0.2 mmol, 1.0 equiv.), 
(3-iodopropyl)benzene (59.1 mg, 0.24 mmol, 1.2 equiv.), (TMEDA)Ni(o-tolyl)Cl (6.0 mg, 
0.020 mmol, 10 mol %), and (S,S)-Ph-Pybox (8.9 mg, 0.024 mmol, 12 mol %), in 3:1 
THF:DMSO (1.5 mL). The crude product was then purified by silica gel chromatography 
(20-45% dichloromethane in hexanes, stained in CAM) to afford a clear oil (53.3 mg, 
52%).   
1H NMR (500 MHz, CDCl3) δ 7.78 (d, J = 8.1 Hz, 2H), 7.59 (t, J = 7.5 Hz, 2H), 7.53 (d, J 
= 6.9 Hz, 2H), 7.23 (t, J = 7.4 Hz, 2H), 7.14 (t, J = 7.4 Hz, 1H), 7.06 (d, J = 7.5 Hz, 2H), 
3.93-3.81 (m, 4H), 2.36 (m, 2H), 1.73 (s, 6H), 1.46-1.37 (m, 4H), 1.36-1.18 (m, 9H), 1.14-
0.98 (m, 4H), 0.95-0.86 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 145.1, 143.0, 134.7, 131.4, 
128.5 (2), 128.2, 125.6, 125.3, 119.5, 110.3, 91.6, 64.7, 39.1, 35.9, 31.6, 31.3, 31.2, 29.4, 
28.8, 24.4, 23.8, 23.6 (br), 22.1 (2). IR (neat) νmax 3025 (w), 2980 (w), 2928 (s), 2856 (m), 
2361 (w), 2014 (w), 1740 (w), 1454 (m), 1380 (m), 1308 (m), 1214 (m), 1117 (s), 1079 
(s), 805 (m) cm-1. HRMS (DART+) for C33H42BO4 [M+H]
+: Calc’d: 513.3171, found: 
513.3169. [𝛼]𝐷
20: -1.560 (c = 0.500, CHCl3, l=50 mm). 
 
Analysis of Stereochemistry: 
Racemic material was prepared by mixing the other enantiomer prepared from running a 
second reaction according to the General Procedure B with (R,R)-Ph-Pybox (12 mol%) 
as the ligand instead of (S,S)-Ph-Pybox. Absolute stereochemistry was assigned by analogy 
(see product (R)-(-)-N-Boc-Coniine, (-)-indolizidine 209D). 
 
Chiral SFC (Chiracel OJ-H, 8% IPA, 3 mL/min, 100 bar, 35 °C, 210-289 nm) – analysis 
of 6b,9a-dimethyl-8-((S)-1-(2-methyl-1,3-dioxolan-2-yl)-9-phenylnonan-5-yl)-6b,9a-
dihydroacenaphtho[1,2-d][1,3,2]dioxaborole. 
























     
(S)-1-phenylnonan-4-ol (7).  
The reaction was performed according to General Procedure B with phenylpropylB(mac) 
(75.3mg, 0.22 mmol, 1.1 equiv.), vinylithium (1.45 M in THF, 0.138 mL, 0.2 mmol, 1.0 
equiv.), 1-iodobutane (44.2 mg, 0.24 mmol, 1.2 equiv.), (TMEDA)Ni(o-tolyl)Cl (6.0 mg, 
0.020 mmol, 10 mol %), and (S,S)-Ph-Pybox (8.9 mg, 0.024 mmol, 12 mol %), in 3:1 
THF:DMSO (1.5 mL). Boronic ester was purified prior to oxidation using 1% EtOAc in 
Hexanes. Crude boronic ester was then subjected to Oxidation Procedure. The crude 
alcohol was then purified by silica gel chromatography (2-3% EtOAc in hexanes, stained 
in CAM) to afford a clear oil (27.3 mg, 62%).  
1H NMR (600 MHz, CDCl3) δ 7.30-7.25 (m, 2H), 7.20-7.16 (m, 3H), 3.64-3.59 (m, 1H), 
2.69-2.59 (m, 2H), 1.83-1.74 (m, 1H), 1.71-1.61 (m, 1H), 1.55-1.37 (m, 5H), 1.36-1.22 (m, 
5H), 0.89 (t, J = 6.9 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 142.6, 128.5, 128.4, 125.8, 
72.0, 37.6, 37.2, 36.1, 32.0, 27.6, 25.4, 22.8, 14.2. IR (neat) νmax 3347 (br), 3026 (s), 2929 
(s), 2858 (s), 2359 (w), 2182 (w), 1454 (m), 748 (m), 698 (m) cm-1. HRMS (DART+) for 
C15H28NO [M+NH4]
+: Calc’d: 238.2165, found: 238.2163. [𝛼]𝐷
20: 0.914 (c = 0.500 CHCl3, 
l=50 mm).  
Analysis of Stereochemistry: 
A stereoisomer mixture was prepared by the synthesis of racemic product. To a 2-dram 
vial equipped with a stir bar was added (3-iodopropyl)benzene (128 mg, 0.520 mmol, 1 
equiv), followed by Et2O : pentane (2:3, 2 mL: 3 mL, 0.1 M). Then the vial was flushed 
with nitrogen and cooled down to -78 °C. tert-butyllithium (1.14 mmol, 73.18 mg, 2.2 
equiv) was then added dropwise over five minutes. The reaction was then brought to room 
temperature and allowed to stir for one hour. The mixture was then cooled down to -78 °C 
and hexanal (104 mg, 1.04 mmol, 2 equiv) was added and allowed to stir at -78 °C for 3 
hours, and then warmed to room temperature and stirred for an additional 18 hours. The 
mixture was then quenched with water, followed by extraction of the aqueous layer three 
times with ethyl acetate. The organic layers were then dried with sodium sulfate and 
concentrated under reduced pressure. The crude material was then purified via silica gel 
chromatography (4% EtOAc in hexanes) to yield a colorless oil (0.281 mmol, 62 mg, 54%). 




Chiral SFC (Chiracel ODR-H, 3% IPA, 3 mL/min, 100 bar, 35 °C, 210-289 nm) – 
analysis of (S)-1-phenylnonan-4-ol. 
 















   
(S)-1-cyclohexyl-7-phenylheptan-4-ol (8).  
The reaction was performed according to the General Procedure B with 
phenylpropylB(mac) (75.3 mg, 0.22 mmol, 1.1 equiv.), vinylithium (1.45 M in THF, 0.138 
mL, 0.2 mmol, 1.0 equiv.), 2-iodoethylcyclohexane (57.2 mg, 0.24 mmol, 1.2 equiv.), 
(TMEDA)Ni(o-tolyl)Cl (6.0 mg, 0.020 mmol, 10 mol %), and (S,S)-Ph-Pybox (8.9 mg, 
0.024 mmol, 12 mol %), in 3:1 THF:DMSO (1.5 mL, 0.13M). Crude boronic ester was 
then subjected to Oxidation Procedure. The crude alcohol was then purified by silica gel 
chromatography (2% EtOAc in hexanes, stained in CAM) to afford a clear oil (34.0 mg, 
62%).  
1H NMR (500 MHz, CDCl3) δ 7.30-7.25 (m, 3H), 7.20-7.16 (m, 2H), 3.65-3.58 (m, 1H), 
2.69-2.58 (m, 2H), 1.84-1.73 (m, 1H), 1.72-1.60 (m, 6H), 1.55-1.34 (m, 5H), 1.34-1.23 (m, 
3H), 1.23-1.08 (m, 5H), 0.91-0.80 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 142.6, 128.5, 
128.4, 125.8, 72.0, 37.9, 37.8, 37.6, 37.2, 36.1, 33.6, 33.5, 27.6, 26.9, 26.6, 23.0. IR (neat) 
νmax 3463 (br), 2920 (s), 2850 (m), 2360 (m), 2335 (m), 1453 (w), 744 (w) cm
-1. HRMS 
(DART+) for C19H34NO [M+NH4]
+: Calc’d: 292.2635, found: 292.2632. [𝛼]𝐷
20: 0.400 (c = 
0.500, CHCl3, l=50 mm). 
 
Analysis of Stereochemistry: 
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Racemic material was prepared by mixing the other enantiomer prepared from running a 
second reaction according to the General Procedure B with (R,R)-Ph-Pybox (12 mol %) 
as the ligand instead of (S,S)-Ph-Pybox. Absolute stereochemistry was assigned by analogy 
(see product (R)-(-)-N-Boc-Coniine, (-)-indolizidine 209D). 
 
Chiral SFC (Chiracel OJ-H, 8% IPA, 3 mL/min, 100 bar, 35 °C, 210-289 nm) – analysis 
of (S)-1-cyclohexyl-7-phenylheptan-4-ol. 
 

















   
(R)-8-((tert-butyldimethylsilyl)oxy)-1-phenyloctan-4-ol (9).  
The reaction was performed according to General Procedure B with phenylpropylB(mac) 
(75.3 mg, 0.22 mmol, 1.1 equiv.), vinylithium (1.45 M in THF, 0.138 mL, 0.2 mmol, 1.0 
equiv.), tert-butyl-(3-iodopropoxy)-dimethyl-silane (72.1 mg, 0.24 mmol, 1.2 equiv.), 
(TMEDA)Ni(o-tolyl)Cl (6.0 mg, 0.020 mmol, 10 mol %), and (S,S)-Ph-Pybox (8.9 mg, 
0.024 mmol, 12 mol %), in 3:1 THF:DMSO (1.5 mL). Crude boronic ester was then 
subjected to Oxidation Procedure. The crude product was then purified by silica gel 
chromatography (2-3% EtOAc in hexanes, stained in CAM) to afford a clear oil (39.7 mg, 
59%). 1H NMR (600 MHz, CDCl3) δ 7.30-7.25 (m, 3H), 7.20-7.16 (m, 2H), 3.65-3.59 (m, 
1H), 3.61 (t, J = 6.4 Hz, 2H), 2.66-2.60 (m, 2H), 1.83-1.74 (m, 1H), 1.71-1.62 (m, 1H) 
1.56-1.33 (m, 8H), 0.89 (s, 10H), 0.05 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 142.5, 128.5, 
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128.4, 125.9, 71.9, 63.2, 37.3, 37.1, 36.1, 32.9, 27.6, 26.1, 22.1, 18.5, -5.1. IR (neat) νmax 
3374 (br), 3026 (s), 2929 (s), 2857 (s), 1471 (m), 1255 (m), 1098 (s), 836 (s), 775 (s) cm-
1. HRMS (DART+) for C20H37O2Si [M+H]
+: Calc’d: 337.2557, found: 337.2543. [𝛼]𝐷
20: 
1.400 (c = 0.500, CHCl3, l=50 mm). 
 
Analysis of Stereochemistry: 
Racemic material was prepared by mixing the other enantiomer prepared from running a 
second reaction according to the General Procedure B with (R,R)-Ph-Pybox (12 mol %) 
as the ligand instead of (S,S)-Ph-Pybox. Absolute stereochemistry was assigned by analogy 
(see product (R)-(-)-N-Boc-Coniine, (-)-indolizidine 209D). 
 
 
Chiral SFC (Chiracel OJ-H, 3% IPA, 3 mL/min, 100 bar, 35 °C, 210-289 nm) – analysis 
of (R)-8-((tert-butyldimethylsilyl)oxy)-1-phenyloctan-4-ol.  





























The reaction was performed according to the General Procedure B with n-butylB(mac) 
(61.6 mg, 0.22 mmol, 1.1 equiv.), vinyllithium (1.51 M in THF, 0.131 mL, 0.2 mmol, 1.0 
equiv.), ((4-iodobutoxy)methyl)benzene (69.6 mg, 0.24 mmol, 1.2 equiv.), (TMEDA)Ni(o-
tolyl)Cl (6.0 mg, 0.020 mmol, 10 mol %), and (S,S)-Ph-Pybox (8.9 mg, 0.024 mmol, 12 
mol %), in 3:1 THF:DMSO (1.5 mL). The crude boronic ester was purified by silica gel 
column chromatography (5% EtOAc in hexanes, stained with CAM) to afford a colorless 
oil (51.2 mg, 55% yield). 1H NMR (600 MHz, CDCl3) δ 7.76 (d, J = 8.1 Hz, 2H), 7.59-
7.56 (m, 2H), 7.53 (d, J = 6.5 Hz, 2H), 7.34-7.32 (m, 4H), 7.27-7.26 (m, 1H), 4.44 (s, 2H), 
3.29 (t, J = 6.8 Hz, 2H), 1.75 (s, 6H), 1.44-1.38 (m, 2H), 1.32-1.24 (m, 4H), 1.17-0.99 (m, 
8H), 0.92-0.87 (m, 1H), 0.69 (t, J = 7.1 Hz, 3H). 13C NMR (151 MHz, CDCl3) δ 145.0, 
138.9, 134.7, 131.4, 128.5, 128.4, 127.7, 127.5, 125.2, 119.5, 91.6, 72.9, 70.6, 31.4, 31.3, 
31.0, 29.7, 29.0, 26.3, 23.7 (br), 22.9, 22.2, 14.1. 11B NMR (160 MHz, CDCl3) δ 35.9. IR 
(neat) νmax  3031 (w), 2925 (m), 2853 (m), 1497 (w), 1454 (m), 1380 (m), 1306 (m), 1252 
(m), 1230 (m), 1213 (m), 1174 (m), 1115 (s), 1077 (s), 1028 (m), 968 (m), 885 (m), 825 
(s), 777 (s), 733 (m), 696 (m), 612 (w) cm-1 HRMS (DART+) for C31H40BO3[M+H]
+: 
Calc’d: 471.3065, found: 471.3076. [𝛼]𝐷
20: -0.471 (c = 0.425, CHCl3, l=50 mm). 
 
Analysis of Stereochemistry: 
Racemic compound was prepared by mixing the other enantiomer prepared from running 
a second reaction according to the General Procedure B with (R,R)-Ph-Pybox (12 mol%) 
as the ligand instead of (S,S)-Ph-Pybox. Absolute stereochemistry was assigned by analogy 
(see product (R)-(-)-N-Boc-Coniine, (-)-indolizidine 209D). 
 











   Racemic Material               Standard Conditions 
                                                                                          






The reaction was performed according to the General Procedure B with  
phenylpropylB(mac) (75.3 mg, 0.22 mmol, 1.1 equiv.), vinyllithium (1.51 M in THF, 0.131 
mL, 0.2 mmol, 1.0 equiv.), 3-iodooxetane (44.2 mg, 0.24mmol, 1.2 equiv.), 
(TMEDA)Ni(o-tolyl)Cl (6.0 mg, 0.020 mmol, 10 mol %), and (S,S)-Ph-Pybox (8.9 mg, 
0.024 mmol, 12 mol %), in 3:1 THF:DMSO (1.5 mL). The crude boronic ester was purified 
by silica gel column chromatography (10% EtOAc in hexanes, stained with CAM) to afford 
a colorless oil (37.2 mg, 44% yield). 1H NMR (600 MHz, CDCl3) δ 7.80 (d, J = 8.1 Hz, 
2H), 7.60 (ddd, J = 8.0, 6.9, 3.4 Hz, 2H), 7.54 (d, J = 6.8 Hz, 2H), 7.23-7.20 (m, 2H), 7.16-
7.13 (m, 1H), 7.00 – 6.91 (m, 2H), 4.54 (dd, J = 7.8, 5.8 Hz, 1H), 4.40 (dd, J = 7.8, 5.8 Hz, 
1H), 4.19 (t, J = 6.2 Hz, 1H), 4.09 (t, J = 6.2 Hz, 1H), 2.79 (hept, J = 7.4 Hz, 1H), 2.48-
2.39 (m, 2H), 1.76 (s, 6H), 1.71-1.25 (m, 6H), 0.93-0.87 (m, 1H). 13C NMR (151 MHz, 
CDCl3) δ 144.7 (2), 142.6, 134.6, 131.4, 128.6, 128.3 (2), 125.6, 125.5, 119.6, 119.5, 91.9, 
78.1, 78.0, 36.1, 35.6, 35.1, 31.2, 30.8, 22.2, 22.1. Due to the quadrupolar nature of boron, 
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the carbon adjacent to boron was not detectable. IR (neat) νmax 3025 (w), 2929 (s), 2859 
(s), 1602 (w), 1496 (m), 1454 (m), 1383 (s), 1314 (s), 1262 (m), 1213 (m), 1175 (m), 1116 
(s), 1078 (s), 1031 (w), 977 (m), 886 (w), 845 (s), 826 (w), 805 (w), 779 (s), 749 (m), 700 
(m), 684 (w) cm-1. HRMS (DART+) for C28H32BO3 [M+H]
+: Calc’d: 427.3439, found: 
427.2431. [𝛼]𝐷
20: -0.200 (c = 1.00, CHCl3, l=50 mm). 
 
Analysis of Stereochemistry: 
Racemic material was prepared by mixing the other enantiomer prepared from running a 
second reaction according to the General Procedure B with (R,R)-Ph-Pybox (12 mol%) 
as the ligand instead of (S,S)-Ph-Pybox. Absolute stereochemistry was assigned by analogy 
(see product (R)-(-)-N-Boc-Coniine, (-)-indolizidine 209D). 
 




      Racemic Material      Standard Conditions 
 
  






The reaction was performed according to the General Procedure B with 
phenylpropylB(mac) (75.3 mg, 0.22 mmol, 1.1 equiv.), vinylithium (1.45 M in THF, 0.138 
mL, 0.2 mmol, 1.0 equiv.), 5-iodopentan-2-one  (50.9 mg, 0.24 mmol, 1.2 equiv.), 
(TMEDA)Ni(o-tolyl)Cl (6.0 mg, 0.020 mmol, 10 mol %), and (S,S)-Ph-Pybox (8.9 mg, 
0.024 mmol, 12 mol %), in 3:1 THF:DMSO (1.5 mL). The crude product was then purified 
by silica gel chromatography (6% EtOAc in hexanes, stained in CAM) to afford a clear oil 
(20.0 mg, 22%).   
1H NMR (600 MHz, CDCl3) δ 7.78 (d, J = 8.1 Hz, 2H), 7.59 (ddd, J = 8.1, 7.0, 2.3 Hz, 
2H), 7.54 (d, J = 7.3 Hz, 2H), 7.19 (t, J = 7.4 Hz, 2H), 7.12 (t, J = 7.3 Hz, 1H), 6.93 (d, J 
= 7.0 Hz, 2H), 2.45-2.37 (m, 2H), 2.17 (td, J = 7.9, 2.3 Hz, 2H), 2.04 (s, 3H), 1.76 (s, 6H), 
1.43-1.20 (m, 8H), 1.12-0.99 (m, 2H), 0.99-0.93 (m, 1H). 13C NMR (151 MHz, CDCl3) δ 
209.4, 145.0 (2), 142.9, 134.7, 131.5, 128.6, 128.4, 128.2, 125.5, 125.3, 119.5, 91.7, 43.8, 
36.1, 31.1, 31.0, 30.9, 29.9, 28.6, 24.1, 22.2. Due to the quadrupolar nature of boron, the 
carbon adjacent to boron was not detectable. IR (neat) νmax 3026 (w), 2972 (w), 2926 (m), 
2852 (w), 2361 (w), 2195 (w), 1974 (w), 1715 (m), 1382 (m), 1308 (m), 1117 (w), 1079 
(w), 826 (m), 780 (m) cm-1. HRMS (DART+) for C30H36BO3 [M+H]
+: Calc’d: 455.2752, 
found: 455.2763. [𝛼]𝐷
20: 0.540 (c = 0.370, CHCl3, l=50 mm). 
 
Analysis of Stereochemistry: 
Racemic material was prepared by mixing the other enantiomer prepared from running a 
second reaction according to the General Procedure B with (R,R)-Ph-Pybox (12 mol%) 
as the ligand instead of (S,S)-Ph-Pybox. Absolute stereochemistry was assigned by analogy 
(see product (R)-(-)-N-Boc-Coniine, (-)-indolizidine 209D). 
 



























   
6b,9a-dimethyl-8-((S)-8-(2-methyl-1,3-dioxolan-2-yl)-1-phenyloctan-4-yl)-6b,9a-
dihydroacenaphtho[1,2-d][1,3,2]dioxaborole (13). 
The reaction was performed according to the General Procedure B with 
phenylpropylB(mac) (75.3 mg, 0.22 mmol, 1.1 equiv.), vinylithium (1.45 M in THF, 0.138 
mL, 0.2 mmol, 1.0 equiv.), 2-(3-iodopropyl)-2-methyl-1,3-dioxolane (61.5 mg, 0.24 mmol, 
1.2 equiv.), (TMEDA)Ni(o-tolyl)Cl (6.0 mg, 0.020 mmol, 10 mol %), and (S,S)-Ph-Pybox 
(8.9 mg, 0.024 mmol, 12 mol %), in 3:1 THF:DMSO (1.5 mL). The crude product was 
then purified by silica gel chromatography (7% EtOAc in hexanes, stained in CAM) to 
afford a clear oil (56.1 mg, 56%).  
1H NMR (600 MHz, CDCl3) δ 7.78 (d, J = 8.1 Hz, 2H), 7.58 (ddd, J = 8.1, 7.0, 3.0 Hz, 
2H), 7.54 (dd, J = 6.9, 2.1 Hz, 2H) 7.18 (t, J = 7.4 Hz, 2H), 7.11 (t, J = 7.4 Hz, 1H), 6.91 
(d, J = 7.0 Hz, 2H), 3.92-3.84 (m, 4H), 2.44-2.35 (m, 2H), 1.75 (s, 6H), 1.48-1.41 (m, 2H), 
1.38-1.29 (m, 5H), 1.29-1.20 (m, 5H), 1.15-1.02 (m, 3H), 0.99-0.93 (m, 1H). 13C NMR 
(126 MHz, CDCl3) δ 145.0 (2), 142.9, 134.7, 131.4, 128.5, 128.3, 128.2, 125.5, 125.3, 
119.5, 110.3, 91.7, 91.6, 64.6, 39.1, 36.1, 31.3, 31.1, 30.9, 29.4, 24.4, 23.8, 22.2, 22.1. Due 
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to the quadrupolar nature of boron, the carbon adjacent to boron was not detectable. IR 
(neat) νmax 3444 (br), 3026 (w), 3026 (w), 2933 (m), 2858 (m), 2365 (w), 1714 (w), 1461 
(s), 1380 (s), 1309 (m), 1079 (s), 989 (s), 780 (m) cm-1. HRMS (DART+) for C32H40BO4 
[M+H]+: Calc’d: 449.3014, found: 499.3033. [𝛼]𝐷
20: 0.514 (c = 0.500, CHCl3, l=50 mm). 
 
Analysis of Stereochemistry: 
Racemic material was prepared by mixing the other enantiomer prepared from running a 
second reaction according to the General Procedure B with (R,R)-Ph-Pybox (12 mol%) 
as the ligand instead of (S,S)-Ph-Pybox. Absolute stereochemistry was assigned by analogy 
(see product (R)-(-)-N-Boc-Coniine, (-)-indolizidine 209D). 
 




























The reaction was performed according to the General Procedure B with  
phenylpropylB(mac) (75.3 mg, 0.22 mmol, 1.1 equiv.), vinyllithium (1.51 M in THF, 
0.131mL, 0.2mmol, 1.0 equiv.), and methyl 4-iodobutanoate (54.7 mg, 0.24 mmol, 1.2 
equiv.), (TMEDA)Ni(o-tolyl)Cl (6.0 mg, 0.020 mmol, 10 mol %), and (S,S)-Ph-Pybox (8.9 
mg, 0.024 mmol, 12 mol %), in 3:1 THF:DMSO (1.5 mL). The crude boronic ester was 
purified by silica gel column chromatography (5% EtOAc in hexanes, stained with CAM) 
to afford a colorless oil (56.1 mg, 60% yield). 1H NMR (500 MHz, CDCl3) δ 7.80 (d, J = 
7.9 Hz, 2H), 7.62-7.58 (m, 2H), 7.57-7.55 (m, 2H),  7.22-7.19 (m, 2H), 7.15-7.12 (m, 1H), 
6.94-6.92 (m, 2H), 3.64 (s, 3H), 2.47-2.37 (m, 2H), 2.13 (t, J = 7.9 Hz, 2H), 1.78 (s, 6H), 
1.53-1.45 (m, 2H), 1.41-1.27 (m, 6H), 1.19-1.06 (m, 2H), 1.03-0.95 (m, 1H). 13C NMR 
(126 MHz, CDCl3) δ 174.3, 145.0 (2), 142.8, 134.7, 131.4, 128.5, 128.3, 128.2, 125.5, 
125.3, 119.5, 91.7, 51.5, 36.1, 34.1, 31.0, 30.9, 30.8, 28.6, 25.2, 23.4 (br), 22.1 (2).  IR 
(neat) νmax 3025 (w), 2928 (m), 2854 (m), 1738 (s), 1602 (w), 1497 (w), 1454 (m), 1435 
(m), 1413 (m), 1382 (m), 1308 (m), 1262 (m), 1213 (m), 1174 (m), 1117 (s), 1078 (m), 968 
(w), 885 (w), 826 (m), 779 (m), 750 (m), 700 (m) cm-1. HRMS (DART+) for C30H36BO4 
[M+H]+: Calc’d: 471.2701, found: 471.2706. [𝛼]𝐷
20: +1.571 (c = 1.00, CHCl3, l=50 mm). 
Analysis of Stereochemistry: 
Racemic material was prepared by mixing the other enantiomer prepared from running a 
second reaction according to the General Procedure B with (R,R)-Ph-Pybox (12 mol%) 
as the ligand instead of (S,S)-Ph-Pybox. Absolute stereochemistry was assigned by analogy 
(see product (R)-(-)-N-Boc-Coniine, (-)-indolizidine 209D). 
 
Chiral SFC (Chiracel OJ-H, 6% IPA, 3 mL/min, 100 bar, 35 °C, 210-289 nm) – analysis 
of methyl (6S)-6-(6b,9a-dimethyl-6b,9a-dihydroacenaphtho[1,2-d][1,3,2]dioxaborol-8-
yl)-9-phenylnonanoate. 









The reaction was performed according to the General Procedure B with 
phenylpropylB(mac) (75.3 mg, 0.22 mmol, 1.1 equiv.), vinyllithium (1.51 M in THF, 
0.131mL, 0.2mmol, 1.0 equiv.), and tert-butyl N-(3-iodopropyl)carbamate (68.4 mg, 0.24 
mmol, 1.2 equiv.), (TMEDA)Ni(o-tolyl)Cl (6.0 mg, 0.020 mmol, 10 mol %), and (S,S)-Ph-
Pybox (8.9 mg, 0.024 mmol, 12 mol %), in 3:1 THF:DMSO (1.5 mL). The crude boronic 
ester was purified by silica gel column chromatography (10% EtOAc in hexanes, stained 
with CAM) to afford a colorless oil (63.3 mg, 60% yield). 1H NMR (500 MHz, CDCl3) δ 
7.79 (d, J = 8.1 Hz, 2H), 7.60 (ddd, J = 8.1, 6.8, 1.8 Hz, 2H), 7.55 (d, J = 6.9 Hz, 2H), 7.20 
(t, J = 7.4 Hz, 2H), 7.13 (t, J = 7.3 Hz, 1H), 6.94 (d, J = 7.3 Hz, 2H), 4.34-4.11 (br s, 1H), 
2.99-2.79 (m, 2H), 2.48-2.36 (m, 2H), 1.77 (s, 6H), 1.46 (s, 9H), 1.41-1.23 (m, 8H), 1.17-
1.03 (m, 2H), 1.01-0.93 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 156.0, 144.9, 142.8, 134.7, 
131.4, 128.6, 128.3, 128.2, 125.5, 125.3, 119.5, 119.5, 91.7, 79.0, 40.5, 36.1, 31.1, 30.9, 
30.8, 30.0,  28.6, 26.2, 23.6 (br), 22.1. IR (neat) νmax 3360 (br, w), 3025 (w), 2975 (m), 
2928 (m), 2856 (m), 1713 (s), 1498 (m), 1454 (m), 1389 (m), 1365 (m), 1307 (m), 1249 
(m), 1174 (s), 1117 (s), 1078 (m), 1041 (w), 968 (w), 886 (w), 826 (m), 779 (m), 749 (w), 
699 (m), 683 (w), 668 (w) cm-1. HRMS (DART+) for C33H43BNO4 [M+H]
+: Calc’d: 
528.3280, found: 528.3286. [𝛼]𝐷
20: +0.057 (c = 1.00, CHCl3, l=50 mm). 
 
Analysis of Stereochemistry: 
Racemic material was prepared by mixing the other enantiomer prepared from running a 
second reaction according to the General Procedure B with (R,R)-Ph-Pybox (12 mol%) 
as the ligand instead of (S,S)-Ph-Pybox. Absolute stereochemistry was assigned by analogy 
(see product (R)-(-)-N-Boc-Coniine, (-)-indolizidine 209D). 
 
Chiral SFC (Chiracel AD-H, 12% IPA, 3 mL/min, 100 bar, 35 °C, 210-289 nm) – analysis 
of tert-butyl ((5R)-5-(6b,9a-dimethyl-6b,9a-dihydroacenaphtho[1,2-d][1,3,2]dioxaborol-
8-yl)-8-phenyloctyl)carbamate.  
        Racemic Material      Standard Conditions 
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yl)nonan-4-yl) 6b,9a-dihydroacenaphtho[1,2-d][1,3,2]dioxaborole (16). 
The reaction was performed according to General Procedure B with phenylpropylB(mac) 
(75.3 mg, 0.22 mmol, 1.1 equiv.), vinylithium (1.63 M in THF, 0.123mL, 0.2 mmol, 1.0 
equiv.), 2-(4-iodobutyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (74.4 mg, 0.24 mmol, 1.2 
equiv.), (TMEDA)Ni(o-tolyl)Cl (6.0 mg, 0.020 mmol, 10 mol %), and (S,S)-Ph-Pybox (8.9 
mg, 0.024 mmol, 12 mol %), in 3:1 THF:DMSO (1.5 mL). The crude boronic ester was 
then purified by silica gel chromatography (30-60% dichloromethane in hexanes, stained 
in CAM) to afford a clear oil (60.8 mg, 55%).  1H NMR (500 MHz, CDCl3) δ 7.77 (d, J = 
8.0 Hz, 2H), 7.58 (tdd, J=8.1, 2.1, 1.0 Hz, 2H), 7.55-7.52 (m, 2H), 7.17 (t, J = 7.7 Hz, 2H), 
7.11 (t, J = 6.7 Hz, 1H) 6.89 (d, J = 8.0 Hz, 2H), 2.44-2.32 (m, 2H), 1.75 (s, 6H), 1.37-1.29 
(m, 5H), 1.24 (s, 14H), 1.18-1.05 (m, 5H), 0.99-0.91 (m, 1H), 0.65 (t, J = 7.9 Hz, 2H). 13C 
NMR (126 MHz, CDCl3) δ 145.1, 145.0, 142.9, 134.7, 131.4, 128.5, 128.3, 128.2, 125.4, 
125.3, 119.5, 91.6, 82.9, 36.1, 32.7, 31.3, 31.1, 30.9, 28.9, 25.0, 24.0, 23.6 (br), 22.2 (2), 
11.2 (br). IR (neat) νmax 3025 (w), 2977 (m), 2925 (s), 2855 (m), 2361 (w), 2235 (w), 1379 
(s), 1310 (s), 1146 (m), 1079 (m), 847 (m), 825 (m), 805 (m), 536 (m) cm-1. HRMS 
(DART+) for C35H47B2O4 [M+H]
+: Calc’d: 553.3655, found: 553.3681. [𝛼]𝐷
20: -0.743 (c = 
0.500, CHCl3, l=50 mm). 
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Analysis of Stereochemistry: 
Racemic material was prepared by mixing the other enantiomer prepared from running a 
second reaction according to the General Procedure B with (R,R)-Ph-Pybox (12 mol%) 
as the ligand instead of (S,S)-Ph-Pybox. Absolute stereochemistry was assigned by analogy 
(see product (R)-(-)-N-Boc-Coniine, (-)-indolizidine 209D). 
 
Chiral SFC (Chiracel OJ-H, 1% IPA, 3 mL/min, 100 bar, 35 °C, 210-289 nm) – analysis 
of 6b,9a-dimethyl-8-((S)-1-phenyl-9-(4,4,5,5 tetramethyl-1,3,2-dioxaborolan-2-yl)nonan-
4-yl) 6b,9a-dihydroacenaphtho[1,2-d][1,3,2]dioxaborole. 





















yl)-10-methylundecanoate (17).  
The reaction was performed according to general procedure General Procedure B with 8-
isohexyl-6b,9a-dimethyl-acenaphthyleno[1,2-d][1,3,2]dioxaborole (67.8 mg, 0.22 mmol, 
1.1 equiv.), vinylithium (1.63 M in THF, 0.123 mL, 0.2 mmol, 1.0 equiv.), methyl 4-
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iodobutanoate (54.7 mg, 0.24 mmol, 1.2 equiv.), (TMEDA)Ni(o-tolyl)Cl (6.0 mg, 0.020 
mmol, 10 mol %), and (S,S)-Ph-Pybox (8.9 mg, 0.024 mmol, 12 mol %), in 3:1 
THF:DMSO (1.5 mL). The crude product was then purified by silica gel chromatography 
(6% EtOAc in hexanes, stained in CAM) to afford a clear oil (47.1 mg, 54%).  
1H NMR (500 MHz, CDCl3) δ 7.77 (d, J = 8.0 Hz, 2H), 7.58 (t, J = 7.5 Hz, 2H), 7.53 (d, J 
= 6.8 Hz, 2H), 3.62 (s, 3H), 2.11 (t, J = 7.5 Hz, 2H), 1.76 (s, 6H), 1.46 (p, J = 7.8 Hz, 2H), 
1.37-1.18 (m, 5H), 1.18-0.87 (m, 7H), 0.66 (dd, J = 8.7, 6.9 Hz, 6H). 13C NMR (126 MHz, 
CDCl3) δ 174.4, 145.0, 134.7, 131.5, 128.5, 125.3, 119.5, 91.6, 51.5, 39.1, 34.1, 31.6, 31.0, 
28.7, 27.8, 26.8, 25.2, 23.7 (br), 22.6, 22.5, 22.1. IR (neat) νmax 2951 (s), 2925 (s), 2854 
(m), 2360 (w), 2335 (w), 2181 (w), 1978 (w), 1740 (s), 1382 (m), 1308 (m), 1117 (s), 1079 
(m), 826 (m), 779 (m) cm-1. HRMS (DART+) for C27H38BO4 [M+H]
+: Calc’d: 437.2858, 
found: 437.2874. [𝛼]𝐷
20: 0.550° (c = 0.500, CHCl3, l=50 mm). 
 
Analysis of Stereochemistry: 
Racemic material was prepared by mixing the other enantiomer prepared from running a 
second reaction according to the General Procedure B with (R,R)-Ph-Pybox (12 mol%) 
as the ligand instead of (S,S)-Ph-Pybox. Absolute stereochemistry was assigned by analogy 
(see product (R)-(-)-N-Boc-Coniine, (-)-indolizidine 209D). 
 


























(S)-2-methyl-7-phenylheptan-3-ol (18).  
The reaction was performed according to the General Procedure A with vinylB(pin) (33.9 
mg, 0.22 mmol, 1.1 equiv.), isopropyllithium (0.643 M in pentane, 0.31 mL, 0.2 mmol, 1.0 
equiv.), and (3-iodopropyl)benzene (59.1 mg, 0.24 mmol, 1.2 equiv.), (TMEDA)Ni(o-
tolyl)Cl (6.0 mg, 0.020 mmol, 10 mol %), and (S,S)-Ph-Pybox (8.9 mg, 0.024 mmol, 12 
mol %), in 3:1 THF:DMSO (1.5 mL). Boronic ester was purified prior to oxidation using 
1% EtOAc in Hexanes. Crude boronic ester was then subjected to Oxidation Procedure. 
The crude alcohol was purified by silica gel column chromatography (3% EtOAc in 
hexanes, stained with CAM) to afford a colorless oil (21.2 mg, 51% yield). 1H NMR (600 
MHz, CDCl3) δ 7.28-7.25 (m, 2H), 7.18-7.16 (m, 3H), 3.37-3.33 (m, 1H), 2.66-2.59 (m, 
2H), 1.71-1.59 (m, 3H), 1.56-1.46 (m, 2H), 1.44-1.34 (m, 2H), 1.30 (br s, 1H), 0.90 (t, J = 
6.4 Hz, 6H). 13C NMR (151 MHz, CDCl3) δ 142.8, 128.5, 128.4, 125.8, 76.8, 36.1, 34.1, 
33.6, 31.7, 25.9, 19.0, 17.2. IR (neat) νmax 3026 (w), 3363 (br, w), 3063 (w), 3026 (w), 2932 
(s), 2857 (m), 1604 (w), 1496 (m), 1463 (m), 1453 (m), 1385 (w), 1367 (w), 1130 (w), 
1056 (w), 1030 (w), 983 (m), 875 (w), 746 (m), 698 (s), 568 (w) cm-1. HRMS (DART+) 
for C14H26NO [M+NH4]
+: Calc’d: 224.2009, found: 224.2007. [𝛼]𝐷
20: -18.618 (c = 0.830, 
CHCl3, l=50 mm). 
 
Analysis of Stereochemistry: 
Racemic material was prepared by mixing the other enantiomer prepared from running a 
second reaction according to the general procedure A with (R,R)-Ph-Pybox (12 mol%) as 
the ligand instead of (S,S)-Ph-Pybox. Absolute stereochemistry was assigned by analogy 
(see product (R)-(-)-N-Boc-Coniine, (-)-indolizidine 209D). 
Chiral SFC (Chiracel OD-RH, 4% IPA, 3 mL/min, 100 bar, 35 °C, 210-289 nm) – analysis 
of (S)-2-methyl-7-phenylheptan-3-ol. 






(S)-2,2-dimethyl-7-phenylheptan-3-ol (19).  
The reaction was performed according to the General Procedure A with vinylB(pin) (33.9 
mg, 0.22 mmol, 1.1 equiv.), tert-butyllithium (1.70 M in pentane, 0.118 mL, 0.2 mmol, 1.0 
equiv.), and (3-iodopropyl)benzene (59.1 mg, 0.24 mmol, 1.2 equiv.), (TMEDA)Ni(o-
tolyl)Cl (6.0 mg, 0.020 mmol, 10 mol %), and (S,S)-Ph-Pybox (8.9 mg, 0.024 mmol, 12 
mol %), in 3:1 THF:DMSO (1.5 mL). The reaction was also run at 45 °C, in an oil bath. 
Boronic ester was purified prior to oxidation using 1% EtOAc in Hexanes. Crude boronic 
ester was then subjected to Oxidation Procedure. The crude alcohol was purified by silica 
gel column chromatography (20-50% DCM in hexanes, stained with CAM) to afford a 
colorless oil (11.0 mg, 25% yield). 1H NMR (600 MHz, CDCl3) δ 7.29-7.26 (m, 2H), 7.19-
7.16 (m, 3H), 3.18 (d, J = 10.5 Hz, 1H), 2.67-2.59 (m, 2H), 1.72-1.24 (m, 7H), 0.89 (s, 9H). 
13C NMR (151 MHz, CDCl3) δ 142.9, 128.6, 128.4, 125.8, 80.0, 36.2, 35.1, 31.7, 31.5, 
26.9, 25.8. IR (neat) νmax 3404 (br, w), 3063 (w), 3026 (w), 2936 (s), 2858 (s), 1604 (w), 
1496 (m), 1478 (m), 1464 (m), 1454 (m), 1392 (m), 1363 (m), 1328 (w), 1084 (m), 1030 
(w), 995 (m), 908 (w), 746 (m), 698 (s) cm-1. HRMS (DART) for C15H23 [M+H-H2O]
+: 
Calc’d: 203.1794, found: 203.1786. [𝛼]𝐷
20: -28.323 (c = 0.475, CHCl3, l=50 mm). 
 
Analysis of Stereochemistry: 
Racemic material was prepared by mixing the other enantiomer prepared from running a 
second reaction according to the General Procedure A with (R,R)-Ph-Pybox (12 mol%) 
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as the ligand instead of (S,S)-Ph-Pybox. Absolute stereochemistry was assigned by analogy 
(see product (R)-(-)-N-Boc-Coniine, (-)-indolizidine 209D). 
Chiral SFC (Chiracel OD-RH, 3% IPA, 3 mL/min, 100 bar, 35 °C, 210-289 nm) – analysis 
of (S)-2,2-dimethyl-7-phenylheptan-3-ol. 






The reaction was performed according to the General Procedure B, with 8-cyclopentyl-
6b,9a-dimethyl-acenaphthyleno[1,2-d][1,3,2]dioxaborole (64.3 mg, 0.22 mmol, 1.1 
equiv.), vinylithium (1.63 M in THF, 0.123 mL, 0.2 mmol, 1.0 equiv.), (3-
iodopropyl)benzene (59.1 mg, 0.24 mmol, 1.2 equiv.), (TMEDA)Ni(o-tolyl)Cl (6.0 mg, 
0.020 mmol, 10 mol %), and (S,S)-Ph-Pybox (8.9 mg, 0.024 mmol, 12 mol %), in 3:1 
THF:DMSO (1.5 mL). Crude boronic ester was then subjected to Oxidation Procedure. 
The crude alcohol was then purified by silica gel chromatography (2-3% EtOAc in 
hexanes, stained in CAM) to afford a clear oil (21.8 mg, 47%).  1H NMR (500 MHz, CDCl3) 
δ 7.30-7.24 (m, 3H), 7.18 (d, J = 7.2 Hz, 2H), 3.43-3.36 (m, 1H), 2.63 (t, J = 6.6Hz, 2H), 
1.91-1.81 (m, 1H), 1.81-1.73 (m, 1H), 1.71-1.58 (m, 4H), 1.58-1.49 (s, 4H), 1.45-1.36 (m, 
2H), 1.36-1.28 (m, 2H), 1.24-1.14 (m, 1H) 13C NMR (126 MHz, CDCl3) δ 142.8, 128.5, 
128.4, 125.8, 76.0, 46.5, 36.2, 36.1, 31.7, 29.3, 28.6, 25.9, 25.7, 25.6. IR (neat) νmax 3376 
(br), 2935 (s), 2859 (s), 2361 (w), 1453 (m), 1051 (w), 746 (w), 698 (w) cm-1. HRMS 
(DART) for C16H28NO [M+NH4]
+: Calc’d: 250.2165, found: 250.2168. [𝛼]𝐷
20: -6.998 (c = 
0.500, CHCl3, l=50 mm). 
 
Analysis of Stereochemistry: 
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Racemic material was prepared by mixing the other enantiomer prepared from running a 
second reaction according to the General Procedure B with (R,R)-Ph-Pybox (12 mol%) 
as the ligand instead of (S,S)-Ph-Pybox. Absolute stereochemistry was assigned by analogy 
(see product (R)-(-)-N-Boc-Coniine, (-)-indolizidine 209D). 
 
Chiral SFC (Chiracel ODR-H, 6% IPA, 3 mL/min, 100 bar, 35 °C, 210-289 nm) – analysis 
of (S)-1-cyclopentyl-5-phenylpentan-1-ol. 
 


























tert-butyl (S)-4-(1-hydroxy-5-phenylpentyl)piperidine-1-carboxylate (21). 
The reaction was performed according to the General Procedure B with tert-butyl 4-
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)piperidine-1-carboxylate (68.5 mg, 0.22 
mmol, 1.1 equiv.), vinyllithium (1.52 M in THF, 0.131 mL, 0.2 mmol, 1.0 equiv.), (3-
iodopropyl)benzene (59.1 mg, 0.24 mmol, 1.2 equiv.), (TMEDA)Ni(o-tolyl)Cl (6.0 mg, 
0.020 mmol, 10 mol %), and (S,S)-Ph-Pybox (8.9 mg, 0.024 mmol, 12 mol %), in 3:1 
THF:DMSO (1.5 mL). Boronic ester was purified prior to oxidation using 1% EtOAc in 
Hexanes. Crude boronic ester was then subjected to Oxidation Procedure. The crude 
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alcohol was purified by silica gel column chromatography (1:4:5 EtOAc/DCM/hexanes, 
stained with CAM) to afford a colorless oil (36.8 mg, 53% yield). 1H NMR (600 MHz, 
CDCl3) δ 7.29-7.26 (m, 2H), 7.19-7.16 (m, 3H), 4.14 (br s, 2H), 3.37 (m, 1H), 2.78-2.50 
(m, 2H), 2.62 (t, J = 7.6 Hz, 2H), 1.79-1.72 (m, 1H) 1.69-1.17 (m, 11H), 1.45 (s, 9H). 13C 
NMR (126 MHz, CDCl3) δ 154.9, 142.6, 128.5, 128.4, 125.8, 79.4, 75.2, 44.0 (br), 42.2, 
36.0, 34.1, 31.6, 28.6, 28.4 (br), 27.3 (br), 25.6. IR (neat) νmax 3456 (br, w), 2931 (m), 2856 
(m), 2361 (w), 1693 (s), 1671 (s), 1496 (w), 1452 (m), 1427 (s), 1366 (m), 1280 (m), 1235 
(m), 1169 (s), 1076 (m), 1003 (w), 976 (w), 942 (w), 867 (w), 748 (w), 699 (m) cm-1. 
HRMS (DART+) for C21H34NO3 [M+H]
+: Calc’d: 348.2533 , found: 348.2525. [𝛼]𝐷
20: -
7.369 (c = 1.00, CHCl3, l=50 mm). 
 
Analysis of Stereochemistry: 
Racemic material was prepared by mixing the other enantiomer prepared from running a 
second reaction according to the General Procedure B with (R,R)-Ph-Pybox (12 mol%) 
as the ligand instead of (S,S)-Ph-Pybox. Absolute stereochemistry was assigned by analogy 
(see product (R)-(-)-N-Boc-Coniine, (-)-indolizidine 209D). 
Chiral SFC (Chiracel OD-RH, 10% IPA, 3 mL/min, 100 bar, 35 °C, 210-289 nm) – analysis 
of tert-butyl (S)-4-(1-hydroxy-5-phenylpentyl)piperidine-1-carboxylate. 
 
      Racemic Material      Standard Conditions 





3.5.2.5 Procedures and Characterization of Compounds for the Synthesis of (R)-(-)-N-





The reaction was performed according to the General Procedure A with vinylB(mac) 
(55.0 mg, 0.22 mmol, 1.1 equiv.), n-butyllithium (2.5 M in hexanes, 0.08 mL, 0.20 mmol, 
1.0 equiv.), tert-butyl N-(3-iodopropyl)-N-methoxy-carbamate (75.6 mg, 0.24mmol, 1.2 
equiv.), (TMEDA)Ni(o-tolyl)Cl (6.0 mg, 0.020 mmol, 10 mol %), and (S,S)-Ph-Pybox (8.9 
mg, 0.024 mmol, 12 mol %), in 3:1 THF:DMSO (1.5 mL). The crude boronic ester was 
purified by silica gel column chromatography (3% EtOAc in hexanes, stained with CAM) 
to afford a colorless oil (61.4 mg, 62% yield). 1H NMR (500 MHz, CDCl3) δ 7.77 (d, J = 
8.1 Hz, 2H), 7.58 (t, J = 7.5 Hz, 2H), 7.53 (d, J = 6.9 Hz, 2H), 3.59 (s, 3H), 3.27-3.17 (m, 
2H), 1.76 (s, 6H), 1.47 (s, 9H), 1.48-1.40 (m, 2H), 1.38-1.23 (m, 4H), 1.18-0.97 (m, 6H), 
0.91 (p, J = 7.6 Hz, 1H), 0.68 (t, J = 7.1 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 156.4, 
145.0, 134.7, 131.4, 128.5, 125.2, 119.5, 91.6, 81.0, 62.3, 49.2, 31.3, 30.9 (2), 28.5, 27.4, 
26.3, 23.7 (br), 22.9, 22.2, 14.0. IR (neat) νmax 2974 (m), 2929 (s), 2857 (m), 1703 (s), 1498 
(w), 1458 (m), 1435 (m), 1382 (s), 1367 (s), 1307 (s), 1262 (m), 1233 (m), 1174 (s), 1159 
(s), 1117 (s), 1079 (s), 995 (w), 968 (w), 886 (w), 859 (w), 826 (m), 778 (m), 684 (w), 668 
(w) cm-1. HRMS (DART+) for C29H46BN2O5 [M+NH4]
+: Calc’d: 513.3494, found: 
513.3488. [𝛼]𝐷
20: -1.171 (c = 1.00, CHCl3, l=50 mm). 
 
Analysis of Stereochemistry: 
Racemic material was prepared by mixing the other enantiomer prepared from running a 
second reaction according to the General Procedure A with (R,R)-Ph-Pybox (12 mol %) 
as the ligand instead of (S,S)-Ph-Pybox. Absolute stereochemistry was assigned by analogy 
(see product (R)-(-)-N-Boc-Coniine, (-)-indolizidine 209D). 
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Chiral SFC (Chiracel OJ-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-289 nm) – analysis 
of tert-butyl ((5R)-5-(6b,9a-dimethyl-6b,9a-dihydroacenaphtho[1,2-d][1,3,2]dioxaborol-
8-yl)nonyl)(methoxy)carbamate. 
        Racemic Material      Standard Conditions 
      






The reaction was performed according to the General Procedure B with propylB(mac) 
(58.6 mg, 0.22 mmol, 1.1 equiv.), vinyllithium (1.51 M in hexanes, 0.131 mL, 0.2 mmol, 
1.0 equiv.), tert-butyl N-(3-iodopropyl)-N-methoxy-carbamate (75.6 mg, 0.24mmol, 1.2 
equiv.), (TMEDA)Ni(o-tolyl)Cl (6.0 mg, 0.020 mmol, 10 mol %), and (S,S)-Ph-Pybox (8.9 
mg, 0.024 mmol, 12 mol %), in 3:1 THF:DMSO (1.5 mL). The crude boronic ester was 
purified by silica gel column chromatography (3% EtOAc in hexanes, stained with CAM), 
which was then treated with TFA (0.08 mL, 1.0 mmol, 8.6 equiv.) in DCM (0.6 mL, 
[substrate] = 0.2 M) for 4 hours at room temperature. 
The title compound was purified by silica gel column chromatography (10% EtOAc in 
hexanes, stained with CAM) to afford a pale yellow oil (44.9 mg, 59% yield). 1H NMR 
(500 MHz, CDCl3) δ 7.78 (d, J = 8.1 Hz, 2H), 7.59 (t, J = 7.5 Hz, 2H), 7.54 (d, J = 6.9 Hz, 
2H), 5.07 (br s, 1H), 3.47 (s, 3H), 2.68 (t, J = 7.1 Hz, 1H), 1.76 (s, 6H), 1.36-1.01 (m, 10H), 
0.94 (p, J = 8.2 Hz, 2H), 0.76 (t, J = 7.3 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 145.0, 
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134.7, 131.4, 128.5, 125.3, 119.5 (2), 91.6 (2), 61.8, 51.8, 33.5, 31.1, 27.4, 26.6, 23.5 (br), 
22.2 (3), 14.4. IR (neat) νmax 3044 (w), 2930 (s), 2856 (m), 1498 (w), 1460 (m), 1435 (m), 
1411 (m), 1381 (s), 1349 (m), 1307 (s), 1263 (m), 1213 (m), 1174 (m), 1117 (s), 1079 (s), 
967 (w), 889 (w), 826 (s), 805 (w), 779 (s), 683 (w), 668 (w) cm-1. HRMS (DART+) for 
C23H33BNO3 [M+H]
+: Calc’d: 382.2548, found: 382.2547. [𝛼]𝐷
20: -1.057 (c = 1.00, CHCl3, 
l=50 mm). 
 
Analysis of Stereochemistry: 
Racemic material was prepared by mixing the other enantiomer prepared from running a 
second reaction according to the General Procedure B with (R,R)-Ph-Pybox (12 mol %) 
as the ligand instead of (S,S)-Ph-Pybox. Absolute stereochemistry was assigned by analogy 
(see product (R)-(-)-N-Boc-Coniine, (-)-indolizidine 209D). 
 
Chiral SFC (Chiracel OD-H, 4% IPA, 3 mL/min, 100 bar, 35 °C, 210-289 nm) – analysis 
of N-((5R)-5-(6b,9a-dimethyl-6b,9a-dihydroacenaphtho[1,2-d][1,3,2]dioxaborol-8-
yl)octyl)-O-methylhydroxylamine. 





   
(6R)-N-(tert-Butoxycarbonyl)-6-propylpiperidine (24). (R)-(-)-N-Boc-Coniine. 
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Following the Amination Procedure, with KOtBu (6.2 mg, 0.055 mmol, 1.1 equiv.) N-
((5R)-5-(6b,9a-dimethyl-6b,9a-dihydroacenaphtho[1,2-d][1,3,2]dioxaborol-8-yl)octyl)-O-
methylhydroxylamine (19.1 mg, 0.05 mmol, 1.0 equiv.) in 10:1 toluene/THF (1.1 mL), the 
crude product was purified by silica gel chromatography (5% EtOAc/Hexanes, stained in 
KMnO4 or Ninhydrin). Title compound was isolated as a colorless, clear oil (10.4 mg, 90% 
yield). 1H NMR (600 MHz, CDCl3) δ 4.20 (br s, 1H), 3.96 (br d, J = 8.2 Hz, 1H), 2.74 (t, 
J = 13.0 Hz, 1H), 1.63-1.20 (m, 10H), 1.45 (s, 9H), 0.92 (t, J = 7.3 Hz, 3H). 13C NMR (151 
MHz, CDCl3) δ 155.3, 79.1, 50.3 (br), 38.8 (br), 32.1, 29.9, 28.7, 25.9, 19.6, 19.2, 14.2. IR 
(neat) νmax 2930 (m), 2864 (w), 1687 (s), 1454 (m), 1415 (m), 1390 (m), 1364 (m), 1341 
(m), 1317 (w), 1244 (m), 1170 (m), 1144 (s), 1074 (m), 1018 (m), 960 (w), 925 (w), 876 
(w), 815 (w), 767 (m), 660 (w), 579 (w), 534 (w) cm-1. HRMS (DART+) for C13H26NO2 
[M+H]+: Calc’d: 228.1958, found: 228.1953. [𝛼]𝐷
20: –29.650 (c = 0.500, CHCl3, l=50 mm). 
 
Absolute stereochemistry was determined by comparison of optical rotation to the 
literature (Measured: [𝛼]𝐷
20: –29.650 (c = 0.500, CHCl3, l=50 mm). Literature: [𝛼]𝐷
20: -25.6 
(c = 0.6, CHCl3)
 22a, [𝛼]𝐷
26 : –28.1 (c = 1.0,CHCl3)
22b) and the absolute stereochemistry was 
assigned to be (6R)-N-(tert-Butoxycarbonyl)-6-propylpiperidine, or (R)-(-)-N-Boc-
Coniine. 
 
Method for Intramolecular Amination of Boronic Ester Product: (Amination 
Procedure) 
 
Inside the glovebox, to an oven-dried 2-dram vial, KOtBu (0.055 mmol, 1.1 equiv) was 
added. It was then sealed with septum, taped, and brought outside the glovebox. While 
under positive nitrogen atmosphere, 0.1mL of THF was added. Then, aminoboronic ester 
(0.05 mmol, 1 equiv) in toluene was added (1.0mL, 0.05M). It was heated to 110 ºC in an 
oil bath and allowed to stir for 16 h. Then after allowing the reaction mixture to return to 
room temperature, Boc2O (0.188M in THF, 0.4 mL, 0.075 mmol, 1.5 equiv) was added 
and allowed to stir for 3 h. Then water was added and it was extracted three times with 









6b,9a-dihydroacenaphtho[1,2-d][1,3,2]dioxaborole (25).  
The reaction was performed according to the General Procedure A, with vinylB(mac) 
(165.1 mg, 0.66 mmol, 1.1 equiv.), n-hexyllithium (2.14 M in hexanes, 0.28 mL, 0.6 mmol, 
1.0 equiv.), 2-(3-(benzyloxy)propyl)-2-(2-iodoethyl)-1,3-dioxolane (270.9 mg, 0.72 mmol, 
1.2 equiv.), (TMEDA)Ni(o-tolyl)Cl (18.0 mg, 0.060 mmol, 10 mol %), and (S,S)-Ph-Pybox 
(26.6 mg, 0.072 mmol, 12 mol %), in 3:1 THF:DMSO (4.5 mL). The reaction was 
conducted for a longer time of 48 h. The crude boronic ester was purified by silica gel 
column chromatography (10% EtOAc in hexanes, CAM stain) to afford a colorless oil 
(210.4 mg, 60% yield). 1H NMR (500 MHz, CDCl3) δ 7.77-7.75 (m, 2H), 7.58-7.55 (m, 
4H), 7.36-7.35 (m, 4H), 7.29-7.28 (m, 1H), 4.52 (s, 2H), 3.83-3.75 (m, 4H), 3.45 (t, J = 6.5 
Hz, 2H), 1.77 (s, 6H), 1.69-1.60 (m, 2H), 1.59-1.53 (m, 2H), 1.52-1.44 (m, 2H), 1.39-1.25 
(m, 4H), 1.25-1.16 (m, 2H), 1.16-1.00 (m, 8H), 0.94 (p, J = 7.6 Hz, 1H), 0.81 (t, J = 6.8 
Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 145.0 (2), 138.8, 134.7, 131.4, 128.5, 128.4, 127.7, 
127.5, 125.2, 119.5, 111.6, 91.6, 72.8, 70.6, 65.0, 37.5, 33.6, 31.8, 31.6, 31.3, 29.4, 29.0, 
24.2, 23.7 (br), 23.4, 22.5, 22.2, 14.2. 11B NMR (160 MHz, CDCl3) δ 35.8. IR (neat) νmax 
3032 (w), 2924 (s), 2854 (s), 2158 (w), 1497 (w), 1455 (w), 1380 (s), 1307 (s), 1263 (m), 
1212 (m), 1174 (m), 1116 (s), 1077 (s), 947 (w), 887 (w), 825 (s), 806 (w), 778 (s), 736 
(m), 698 (m), 554 (w) cm-1. HRMS (DART+) for C37H50BO5 [M+H]
+: Calc’d: 585.3746, 
found: 585.3746. [𝛼]𝐷
20: -3.285 (c = 1.00, CHCl3, l = 50 mm). 
 
Analysis of Stereochemistry: 
The product was treated with 3M NaOH (1.0 mL) and H2O2 (1.0 mL) to afford 
corresponding secondary alcohol. Racemic compound was prepared by mixing the other 
enantiomer prepared from running a second reaction according to the General Procedure 
A with (R,R)-Ph-Pybox (12 mol %) as the ligand instead of (S,S)-Ph-Pybox. Absolute 




Chiral SFC (Chiracel OD-RH, 10% IPA, 3 mL/min, 100 bar, 35 °C, 210-289 nm) – analysis 
of (R)-1-(2-(3-(benzyloxy)propyl)-1,3-dioxolan-2-yl)decan-4-ol. 
 
Racemic Material               Standard Conditions  
        
     
 
 
(R)-1-(2-(3-(benzyloxy)propyl)-1,3-dioxolan-2-yl)decan-4-amine (26).  
The title compound was synthesized using slightly modified literature procedure.23 To an 
oven-dried 2-dram vial, 8-((R)-1-(2-(3-(benzyloxy)propyl)-1,3-dioxolan-2-yl)decan-4-yl)-
6b,9a-dimethyl-6b,9a-dihydroacenaphtho[1,2-d][1,3,2]dioxaborole (200.0 mg, 0.34 mmol, 
1.0 equiv.) was transferred. Then it was brought into the glovebox, charged with a stir bar, 
dissolved in Toluene (2.0 mL). Then, MeONH2 (1.77 M in THF, 0.29 mL, 0.51 mmol, 1.5 
equiv.) was added. Subsequently, KOtBu (57.6 mg or 0.51 mmol, 1.5 equiv.) was added, 
sealed with septum and brought outside the glovebox and was stirred at 80 °C in oil bath 
for 16 h. It was allowed to cool to room temperature, then H2O (2 mL) was added. After 
letting it stir for 5 min, crude mixture was extracted with EtOAc (15 mL x 3). Solvents 
were removed under reduced pressure and the compound was purified by silica gel 
chromatography (5% MeOH/1% Et3N/EtOAc, stained in ninhydrin) to afford pale yellow 
oil (116.0 mg, 90% yield). 1H NMR (500 MHz, CDCl3) δ 7.34-7.33 (m, 4H), 7.28-7.26 (m, 
1H), 4.50 (s, 2H), 3.92 (s, 4H), 3.50-3.45 (m, 2H), 2.71-2.63 (m, 1H), 1.72-1.66 (m, 4H), 
1.63-1.58 (m, 2H), 1.49-1.21 (m, 16H), 0.88 (t, J = 6.8 Hz, 3H). 13C NMR (126 MHz, 
CDCl3) δ 138.8, 128.5, 127.7, 127.6, 111.7, 72.9, 70.6, 65.1, 51.3, 38.5, 38.2, 37.5, 33.8, 
32.0, 29.6, 26.3, 24.4, 22.8, 20.6, 14.2. IR (neat) νmax 2925 (s), 2855 (s), 2006 (w), 1958 
(w), 1584 (w, br), 1496 (w), 1455 (m), 1361 (m), 1310 (w), 1206 (w), 1100 (s), 1074 (s), 
1029 (m), 947 (m), 816 (w), 736 (m), 698 (m), 613 (w), 575 (w), 564 (w), 547 (w) cm-1. 
 210 
HRMS (DART+) for C23H40NO3 [M+H]
+: Calc’d: 378.3003, found: 378.3006. [𝛼]𝐷
20 : 
+1.118 (c = 1.00, CHCl3, l = 50 mm). 
  
(2R,6R)-2-(3-(benzyloxy)propyl)-6-hexylpiperidine (27). 
To a 20 mL scintillation vial equipped with a stir bar, (R)-1-(2-(3-(benzyloxy)propyl)-1,3-
dioxolan-2-yl)decan-4-amine (37.0mg , 0.098mmol) was transferred. 1.0 mL of 1 N HCl 
and 1.0 mL of THF was added and it was allowed to stir at room temperature for 16 h. 
Afterwards, the mixture was neutralized with NaHCO3 (aq. sat.) and extracted with Et2O 
three times. Solvents were removed and MeOH (1.5 mL) was added. Then Pd/C (10%) 
(10.4 mg) was added then sealed with a rubber septum. The atmosphere was exchanged 
with H2 and was allowed to stir vigorously for 3 h. After exchanging the atmosphere with 
N2, it was filtered through a short pad of celite with methanol. The crude mixture was 
purified by silica gel chromatography (Et2O, stain with KMnO4) to afford the title 
compound as pale yellow oil (26.7 mg, 85% yield). 1H NMR (500 MHz, CDCl3) δ 7.36-
7.30 (m, 4H), 7.30-7.25 (m, 1H), 4.50 (s, 2H), 3.48 (t, J = 6.6 Hz, 2H), 2.50-2.42 (m, 2H), 
1.80-1.73 (m, 1H), 1.69-1.60 (m, 4H), 1.50-1.38 (m, 2H), 1.37-1.21 (m, 12H), 1.06-0.96 
(m, 2H), 0.88 (t, J = 6.7 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 138.7, 128.4, 127.7, 127.6, 
73.0, 70.6, 57.3, 57.0, 37.6, 34.1, 32.8, 32.7, 31.9, 29.6, 26.4, 26.0, 24.9, 22.7, 14.2. IR 
(neat) νmax 3030 (w), 2926 (s), 2854 (s), 2176 (w), 1961 (w, br), 1496 (w), 1454 (m), 1361 
(w), 1331 (w), 1204 (w), 1102 (m), 1028 (w), 733 (m), 697 (m), 579 (w), 555 (w), 547 (w), 
532 (w) cm-1. HRMS (DART+) for C21H36NO [M+H]
+: Calc’d: 318.2791, found: 
318.2804. [𝛼]𝐷
20: +1.600 (c = 0.500, CHCl3, l = 50 mm). 
 
(5R,8aR)-5-hexyloctahydroindolizine (28). (-)-indolizidine 209D 
Title compound was prepared from following literature procedure24 with (2R,6R)-2-(3-
(benzyloxy)propyl)-6-hexylpiperidine (26.5 mg, 0.083 mmol, 1.0 equiv.). The title 
compound was purified using silica gel chromatography (10-20% Et2O/hexanes, KMnO4 
stain). Spectral data matches the literature.24 (-)-indolizidine 209D was isolated as yellow 
oil (14.0 mg, 80% yield). 
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Title compound can be also be prepared from (R)-1-(2-(3-(benzyloxy)propyl)-1,3-




To a 20 mL scintillation vial equipped with a stir bar, (R)-1-(2-(3-(benzyloxy)propyl)-1,3-
dioxolan-2-yl)decan-4-amine (22.7 mg, 0.072 mmol, 1.0 equiv.) was transferred. 1.0 mL 
of 1 N HCl and 1.0 mL of THF was added and it was allowed to stir at room temperature 
for 16 h. Then, the mixture was neutralized with NaHCO3 (aq. sat.) and extracted with Et2O 
three times. Solvents were removed and MeOH (1.2 mL, 0.062M) was added. Pd/C (10%) 
(7.7 mg, 0.007 mmol, 10 mol %) was added then sealed with a rubber septum. The 
atmosphere was exchanged with H2 and was allowed to stir vigorously for 3 h. After 3 h, 
6 N HCl (0.02 mL, 0.12 mmol, 2.0 equiv.) was added and allowed to stir for another 16 h. 
After exchanging the atmosphere with N2, it was filtered through a short pad of celite with 
MeOH. Solvents were removed under reduced pressure. Then to an oven-dried 2-dram vial, 
crude mixture was transferred, dissolved in 0.6mL of DCM and SOCl2 (0.02 mL, 0.275 
mmol, 3.8 equiv.) was added. It was refluxed for 1 h in an oil bath, then excess SOCl2 was 
removed under reduced pressure. Crude residue was dissolved in DCM (0.6 mL) and 
K2CO3 (86.6 mg, 0.626 mmol, 8.7 equiv.) was added. It was allowed to stir for 16 h at 
room temperature. Crude mixture was filtered through a short pad of silica gel with Et2O. 
The title compound was purified using silica gel chromatography (10-20% Et2O/Hexanes). 
(10.0 mg, 66% yield). 1H NMR (600 MHz, CDCl3) δ 3.26 (td, J = 8.8, 2.2 Hz, 1H), 1.96 
(q, J = 8.9 Hz, 1H), 1.91-1.69 (m, 8H), 1.69-1.59 (m, 2H), 1.43-1.26 (m, 12H), 0.88 (t, J = 
6.8 Hz, 3H). 13C NMR (151 MHz, CDCl3) δ 65.2, 64.1, 51.7, 34.8, 32.0, 31.2, 31.0, 30.7, 
29.9, 26.0, 24.9, 22.8, 20.6, 14.3. IR (neat) νmax 3691 (w), 2929 (s), 2857 (m), 2780 (m), 
2710 (w), 2358 (w), 2248 (w), 2217 (w), 2201 (w), 2175 (w), 2141 (w), 2128 (w), 2028 
(w), 2015 (w), 1990 (w), 1964 (w), 1457 (m), 1380 (m), 1332 (w), 1228 (w), 1173 (w), 
1128 (m), 1054 (w), 809 (w), 615 (w), 589 (m) cm-1. HRMS (DART+) for C14H28N 
[M+H]+: Calc’d: 210.2216, found: 210.2208. [𝛼]𝐷
20: -69.399 (c = 0.545, CHCl3, l = 50 
mm). 
 
Absolute stereochemistry was determined by comparison of optical rotation to the 
literature (Measured: [𝛼]𝐷
20: -69.399 (c = 0.545, CHCl3, l = 50 mm). Literature: [𝛼]𝐷
20: -
66.5 (c = 1.0, CHCl3).
25a [𝛼]𝐷
20 : -80.4 (c = 1.0, CH2Cl2).
25b) and the absolute 




3.5.2.7 Procedure for the Gram-Scale Reaction 
 
Inside the glovebox, an oven-dried 100mL round-bottom flask equipped with a magnetic 
stir bar was charged with vinylB(mac) (1.56 g, 6.26 mmol, 1.1 equiv). It was dissolved in 
15.0 mL Et2O, capped with septum, taped, and was brought outside the glovebox. The flask 
was placed under positive pressure of N2, cooled to 0 °C in ice bath, then n-butyllithium 
(2.50 M in hexanes, 2.28 mL, 5.68 mmol, 1.0 equiv) was added dropwise over about 10 
min. After the addition was complete, the vial was removed from the ice bath and allowed 
to stir for 5 minutes at room temperature. Then the solvent was carefully removed under 
reduced pressure without exposure to air, and put under vacuum for 15 min.  
Inside the glovebox, to an oven-dried 20 mL scintillation vial, equipped with a magnetic 
stir bar, catalyst stock solution was prepared. It was charged with (TMEDA)Ni(o-tol)Cl 
(171.5 mg, 0.569 mmol, 10 mol %), and (S,S)-Ph-Pybox (251.5 mg, 0.683 mmol, 12 mol 
%). Subsequently, it was suspended in 5.7 mL of THF and was allowed to stir for 5 min. 
Then 11.4 mL of DMSO was added, and was allowed to stir for 10 min, or until it was 
completely dissolved. 
After the flask containing boron ate complex was under vacuum for 15 min, the flask was 
back filled with nitrogen, then brought into the glovebox. 20.0 mL of THF was added to 
the flask containing boron ate complex. (3-iodopropyl)benzene (1.68 g, 6.83 mmol, 1.2 
equiv) was added, then, all of nickel catalyst complex stock solution (17.1 mL) was added 
slowly. The vial and syringe containing the catalyst complex was rinsed with additional 
5.7 mL of THF. The flask was sealed with septum, taped, and brought outside the glovebox 
and was allowed to stir for 22 h at room temperature. Reaction mixture is then diluted with 
ether, and 5.0 mL of H2O is added (for removal of DMSO). After filtering through a short 
pad of silica gel with ether, and removal of solvent under reduced pressure the crude 
mixture was obtained. Then title compound was then purified by silica gel chromatography 
(10-20% DCM/Hexanes, or 1-2% EtOAc/Hexanes) to afford a clear colorless oil (1.57 g, 









1H NMR (600 MHz, CDCl3) δ 7.80 (d, J = 8.0 Hz, 2H), 7.61 (t, J = 7.5 Hz, 2H), 7.56 (d, J 
= 6.9 Hz, 2H), 7.25 (t, J = 7.5 Hz, 2H), 7.16 (t, J = 7.4 Hz, 1H), 7.08 (d, J = 7.3 Hz, 2H), 
2.44-2.34 (m, 2H), 1.76 (s, 6H), 1.50-1.40 (m, 2H), 1.39-1.25 (m, 4H), 1.18-1.06 (m, 6H), 
1.06-0.99 (m, 1H), 0.71 (t, J = 7.2 Hz, 3H). 13C NMR (151 MHz, CDCl3) δ 145.1, 143.0, 
134.7, 131.4, 128.5 (2), 128.3, 125.6, 125.2, 119.5, 91.6, 35.9, 31.7, 31.4, 31.3, 31.1, 28.8, 
23.7 (br), 22.9, 22.1 (2), 14.1. 11B NMR (160 MHz, CDCl3) δ 35.2. IR (neat) νmax 3026 
(w), 2953 (m), 2926 (s), 2855 (m), 1604 (w), 1496 (w), 1455 (m), 1410 (w), 1380 (m), 
1348 (m), 1307 (s), 1263 (m), 1233 (m), 1214 (m), 1174 (m), 1117 (s), 1079 (s), 1031 (w), 
968 (w), 885 (w), 825 (m), 806 (w), 780 (s), 748 (w), 699 (m), 682 (w), 587 (w), 567 (w), 
534 (w) cm-1. HRMS (DART+) for C29H36BO2 [M+H]
+: Calc’d: 427.2803, found: 
427.2811. [𝛼]𝐷





(R)-1-phenylnonan-5-ol (3).  
In order to assess the enantioselectivity of the gram scale reaction, the title compound was 
obtained by following the Oxidation Procedure with (6bR,9aS)-6b,9a-dimethyl-8-((R)-1-
phenylnonan-5-yl)-6b,9a-dihydroacenaphtho[1,2-d][1,3,2]dioxaborole that was isolated 




Chiral SFC (Chiracel OD-RH, 2% IPA, 3 mL/min, 100 bar, 35 °C, 210-289 nm) – analysis 
of (R)-1-phenylnonan-5-ol. See Compound 3 for characterization data and racemic SFC 
trace. 
 
       Standard Conditions, Gram-Scale. 
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13C NMR (CDCl3, 151MHz) 
